sentence_id,words,labels,pos_tag
0,the,B,DT
0,number,I,NN
0,of,I,IN
0,comorbidities,I,NNS
0,",",O,","
0,the,B,DT
0,Rockall,I,NNP
0,scales,I,NNS
0,core,I,RB
0,",",O,","
0,an,B,DT
0,albumin,I,JJ
0,level,I,NN
0,<,I,VBD
0,2.6,I,CD
0,g,I,NN
0,/,I,NNP
0,dL,I,NN
0,",",O,","
0,the,B,DT
0,presence,I,NN
0,of,I,IN
0,rebleeding,I,VBG
0,and,O,CC
0,hospital,B,JJ
0,stay,I,NN
0,were,O,VBD
0,predictors,B,NNS
0,of,I,IN
0,in,B,IN
0,-,I,:
0,hospital,I,NN
0,mortality,I,NN
0,in,B,IN
0,patients,I,NNS
0,with,I,IN
0,NVUGB,I,NNP
0,.,O,.
1,The,B,DT
1,BDI,I,NNP
1,is,O,VBZ
1,a,O,DT
1,significant,B,JJ
1,predictor,B,NN
1,of,I,IN
1,long,B,JJ
1,-,I,:
1,term,I,NN
1,outcome,I,NN
1,among,B,IN
1,patients,I,NNS
1,admitted,I,VBN
1,to,I,TO
1,the,I,DT
1,Breast,I,NNP
1,Cancer,I,NNP
1,Diagnosis,I,NNP
1,Unit,I,NNP
1,in,B,IN
1,Finland,I,NNP
1,.,O,.
2,The,B,DT
2,application,I,NN
2,of,I,IN
2,1,I,CD
2,%,I,NN
2,MBD,I,NNP
2,as,I,IN
2,a,I,DT
2,single,I,JJ
2,technique,I,NN
2,in,I,IN
2,breast,I,NN
2,cancer,I,NN
2,SNB,I,NNP
2,has,B,VBZ
2,favorable,B,JJ
2,identification,I,NN
2,rates,I,NNS
2,and,I,CC
2,predictive,I,JJ
2,values,I,NNS
2,.,O,.
3,Risks,B,NNS
3,of,I,IN
3,CVD,I,NNP
3,events,I,NNS
3,and,O,CC
3,mortality,B,NN
3,increased,B,VBD
3,exponentially,B,RB
3,with,O,IN
3,eGFR,B,JJ
3,drop,I,NN
3,.,O,.
4,This,B,DT
4,study,I,NN
4,has,O,VBZ
4,found,B,VBN
4,that,O,IN
4,inappropriate,B,JJ
4,infant,I,NN
4,feeding,I,NN
4,;,O,:
4,nutritional,B,JJ
4,information,I,NN
4,gap,I,NN
4,and,O,CC
4,lack,B,NN
4,of,I,IN
4,toilet,I,NN
4,facility,I,NN
4,as,O,IN
4,significant,B,JJ
4,predictors,B,NNS
4,of,I,IN
4,malnutrition,B,NN
4,.,O,.
5,BMI,B,NNP
5,SDS,I,NNP
5,and,O,CC
5,WC,B,NNP
5,were,O,VBD
5,reduced,B,VBN
5,after,O,IN
5,1.5,B,CD
5,years,I,NNS
5,of,I,IN
5,treatment,I,NN
5,.,O,.
6,This,B,DT
6,study,I,NN
6,highlighted,B,VBD
6,the,O,DT
6,risk,B,NN
6,factors,I,NNS
6,of,I,IN
6,breast,I,NN
6,Ca,I,NNP
6,in,B,IN
6,women,I,NNS
6,living,I,VBG
6,in,I,IN
6,Bangui,I,NNP
6,to,O,TO
6,inform,B,VB
6,appropriate,B,JJ
6,control,I,NN
6,measures,I,NNS
6,.,O,.
7,Individual,B,JJ
7,symptom,I,NN
7,resolution,I,NN
7,rates,I,NNS
7,were,O,VBD
7,highly,B,RB
7,variable,B,JJ
7,.,O,.
8,Baseline,B,NNP
8,PaCO2,I,NNP
8,predicted,B,VBD
8,persistent,B,JJ
8,ventilatory,I,JJ
8,failure,I,NN
8,on,B,IN
8,treatment,I,NN
8,.,O,.
9,Epidemiological,B,JJ
9,trends,I,NNS
9,are,O,VBP
9,more,B,RBR
9,or,I,CC
9,less,I,RBR
9,common,B,JJ
9,to,I,TO
9,those,B,DT
9,of,I,IN
9,developing,I,VBG
9,countries,I,NNS
9,with,I,IN
9,a,I,DT
9,predominance,I,NN
9,of,I,IN
9,invasive,I,JJ
9,ductal,I,JJ
9,carcinoma,I,NN
9,.,O,.
10,Compared,O,VBN
10,to,O,TO
10,HbA1c,B,NNP
10,criteria,I,NNS
10,our,O,PRP$
10,diabetes,B,NNS
10,algorithm,I,RB
10,and,O,CC
10,diabetes,B,VBZ
10,predictor,I,NN
10,score,I,NN
10,had,O,VBD
10,a,O,DT
10,better,B,JJR
10,correlation,B,NN
10,with,I,IN
10,OGTT,I,NNP
10,criteria,I,NNS
10,.,O,.
11,Also,O,RB
11,",",O,","
11,the,O,DT
11,relationships,B,NNS
11,between,O,IN
11,these,B,DT
11,factors,I,NNS
11,and,O,CC
11,the,B,DT
11,childs,I,NNS
11,SSB,I,NNP
11,intake,I,VBP
11,differed,B,VBN
11,for,B,IN
11,children,I,NNS
11,with,I,IN
11,distinct,I,JJ
11,ethnic,I,JJ
11,backgrounds,I,NNS
11,.,O,.
12,In,B,IN
12,patients,I,NNS
12,with,I,IN
12,diabetic,I,JJ
12,retinopathy,I,NN
12,",",O,","
12,we,O,PRP
12,confirmed,B,VBD
12,the,O,DT
12,increase,B,NN
12,of,O,IN
12,hemoglobin,B,JJ
12,oxygen,I,NN
12,saturation,I,NN
12,as,O,IN
12,in,B,IN
12,the,I,DT
12,arterial,I,JJ
12,as,I,IN
12,in,I,IN
12,the,I,DT
12,venous,I,JJ
12,blood,I,NN
12,in,I,IN
12,retinal,I,JJ
12,vessels,I,NNS
12,;,O,:
12,and,O,CC
12,significant,B,JJ
12,decrease,B,NN
12,of,O,IN
12,arterio,B,NN
12,-,I,:
12,venous,I,JJ
12,difference,I,NN
12,according,B,VBG
12,to,I,TO
12,the,I,DT
12,severity,I,NN
12,of,I,IN
12,diabetic,I,JJ
12,involvement,I,NN
12,was,O,VBD
12,confirmed,B,VBN
12,as,O,RB
12,well,O,RB
12,.,O,.
12,Key,O,JJ
12,words,O,NNS
12,:,O,:
12,automatic,B,JJ
12,retinal,I,JJ
12,oxymetry,I,NN
12,",",O,","
12,diabetic,B,JJ
12,retinopathy,I,NN
12,",",O,","
12,oxygen,B,NN
12,saturation,I,NN
12,",",O,","
12,Oxymap,B,NNP
12,.,O,.
13,Upregulation,B,NN
13,of,O,IN
13,VEGF,B,NNP
13,and,O,CC
13,CD34,B,NNP
13,is,O,VBZ
13,indicative,B,JJ
13,of,I,IN
13,a,B,DT
13,remarkable,I,JJ
13,angiogenesis,I,NN
13,and,O,CC
13,a,B,DT
13,widespread,I,JJ
13,vascular,I,JJ
13,concentration,I,NN
13,in,I,IN
13,cholesterol,I,NN
13,granulomas,I,NN
13,.,O,.
14,Although,O,IN
14,obesity,B,NN
14,predisposed,B,VBN
14,to,I,TO
14,an,B,DT
14,elevated,I,VBN
14,risk,I,NN
14,of,I,IN
14,VTE,I,NNP
14,",",O,","
14,postoperative,B,JJ
14,mortality,I,NN
14,and,I,CC
14,morbidity,I,NN
14,were,O,VBD
14,otherwise,O,RB
14,not,B,RB
14,significantly,B,RB
14,increased,B,VBN
14,in,B,IN
14,this,I,DT
14,population,I,NN
14,.,O,.
15,These,B,DT
15,results,I,NNS
15,suggest,B,VBP
15,that,O,IN
15,a,O,DT
15,proportion,O,NN
15,of,O,IN
15,selective,B,JJ
15,eaters,I,NNS
15,continue,O,VBP
15,from,O,IN
15,childhood,O,NN
15,into,O,IN
15,adulthood,O,NN
15,with,O,IN
15,similar,O,JJ
15,eating,B,NN
15,patterns,I,NNS
15,;,O,:
15,new,B,JJ
15,onset,I,FW
15,selective,I,JJ
15,eating,I,NN
15,occurs,B,NNS
15,in,I,IN
15,adolescence,B,NN
15,or,O,CC
15,young,B,JJ
15,adulthood,I,NN
15,;,O,:
15,and,O,CC
15,selective,B,JJ
15,and,O,CC
15,non,B,JJ
15,-,I,:
15,selective,I,JJ
15,eaters,I,NNS
15,at,I,IN
15,age,I,NN
15,23,I,CD
15,do,O,VBP
15,not,B,RB
15,differ,B,VB
15,with,O,IN
15,regard,O,NN
15,to,O,TO
15,weight,B,VB
15,or,O,CC
15,eating,B,VBG
15,psychopathology,I,NN
15,.,O,.
16,Compared,O,VBN
16,to,O,TO
16,control,B,VB
16,group,I,NN
16,",",O,","
16,the,B,DT
16,isolated,I,JJ
16,species,I,NNS
16,from,I,IN
16,T2DM,I,NNP
16,group,I,NN
16,had,O,VBD
16,higher,B,JJR
16,proteinase,B,NN
16,activity,I,NN
16,.,O,.
17,Resistance,B,NN
17,to,I,TO
17,fluconazole,I,VB
17,was,O,VBD
17,considerably,B,RB
17,greater,B,JJR
17,among,O,IN
17,the,B,DT
17,C.,I,NNP
17,non,I,SYM
17,-,I,:
17,albicans,I,NNS
17,isolates,I,NNS
17,from,I,IN
17,T2DM,I,NNP
17,group,I,NN
17,.,O,.
18,Combining,O,VBG
18,eGFR,B,NN
18,and,O,CC
18,UACR,B,NNP
18,level,I,NN
18,was,O,VBD
18,more,B,RBR
18,accurate,I,JJ
18,in,O,IN
18,predicting,B,VBG
18,risk,B,NN
18,of,I,IN
18,CVD,I,NNP
18,/,I,NNP
18,mortality,I,NN
18,.,O,.
19,In,O,IN
19,a,B,DT
19,20-year,I,JJ
19,prospective,I,JJ
19,study,I,NN
19,of,O,IN
19,1339,O,CD
19,children,O,NNS
19,with,O,IN
19,genetic,B,JJ
19,risk,I,NN
19,factors,I,NNS
19,for,I,IN
19,celiac,I,JJ
19,disease,I,NN
19,",",O,","
19,we,O,PRP
19,found,B,VBD
19,the,B,DT
19,cumulative,I,JJ
19,incidence,I,NN
19,of,I,IN
19,CDA,I,NNP
19,and,I,CC
19,celiac,I,JJ
19,disease,I,NN
19,to,O,TO
19,be,O,VB
19,high,B,JJ
19,within,B,IN
19,the,I,DT
19,first,I,JJ
19,10,I,CD
19,years,I,NNS
19,.,O,.
20,There,O,EX
20,was,O,VBD
20,evidence,B,NN
20,of,I,IN
20,neurological,B,JJ
20,changes,I,NNS
20,in,B,IN
20,the,B,DT
20,cortical,I,JJ
20,location,I,NN
20,and,O,CC
20,in,B,IN
20,the,B,DT
20,bandwidth,I,NN
20,targeted,I,VBN
20,by,I,IN
20,the,I,DT
20,intervention,I,NN
20,",",O,","
20,and,O,CC
20,changes,B,NNS
20,in,I,IN
20,EEG,B,NNP
20,activity,I,NN
20,were,O,VBD
20,predictive,B,JJ
20,of,I,IN
20,symptom,B,JJ
20,reduction,B,NN
20,.,O,.
21,Reductions,B,NNS
21,in,I,IN
21,LDL,B,NNP
21,-,I,:
21,C,I,NN
21,were,O,VBD
21,greater,B,JJR
21,among,O,IN
21,women,B,NNS
21,randomized,I,VBN
21,to,I,TO
21,both,I,DT
21,calcium+vitamin,I,JJ
21,D,I,NNP
21,and,I,CC
21,hormone,I,NN
21,therapy,I,NN
21,than,O,IN
21,for,O,IN
21,those,B,DT
21,randomized,I,VBN
21,to,I,TO
21,either,I,DT
21,intervention,I,NN
21,alone,I,RB
21,or,I,CC
21,to,I,TO
21,placebo,I,VB
21,.,O,.
22,In,O,IN
22,particular,O,JJ
22,",",O,","
22,a,O,DT
22,low,B,JJ
22,BMI,B,NNP
22,was,O,VBD
22,an,O,DT
22,independent,B,JJ
22,prognostic,B,JJ
22,factor,I,NN
22,for,I,IN
22,poorer,B,JJR
22,survival,B,NN
22,in,B,IN
22,the,I,DT
22,multivariate,I,NN
22,analysis,I,NN
22,.,O,.
23,In,O,IN
23,this,B,DT
23,study,I,NN
23,",",O,","
23,patients,B,NNS
23,with,I,IN
23,chronic,I,JJ
23,myofascial,I,NN
23,pain,I,NN
23,showed,B,VBD
23,lower,B,JJR
23,intracellular,B,JJ
23,stores,I,NNS
23,of,I,IN
23,zinc,I,NN
23,and,I,CC
23,selenium,I,NN
23,and,O,CC
23,inadequate,B,JJ
23,food,I,NN
23,intake,I,NN
23,of,I,IN
23,these,I,DT
23,nutrients,I,NNS
23,.,O,.
24,Patients,B,NNS
24,with,I,IN
24,GDM,I,NNP
24,have,B,VBP
24,lower,I,JJR
24,circulating,I,NN
24,levels,I,NNS
24,of,I,IN
24,SHBG,I,NNP
24,than,O,IN
24,normal,B,JJ
24,glucose,I,JJ
24,tolerance,I,NN
24,pregnant,I,JJ
24,women,I,NNS
24,.,O,.
25,PF,B,NNP
25,decreased,B,VBD
25,more,B,RBR
25,rapidly,I,RB
25,in,O,IN
25,obese,B,JJ
25,men,I,NNS
25,and,I,CC
25,women,I,NNS
25,than,O,IN
25,among,O,IN
25,those,B,DT
25,with,I,IN
25,normal,I,JJ
25,weight,I,NN
25,.,O,.
26,The,B,DT
26,percentage,I,NN
26,of,I,IN
26,naÃ¯ve,I,JJ
26,helper,I,NN
26,T,I,NNP
26,cells,I,NNS
26,increased,B,VBD
26,and,O,CC
26,memory,B,NN
26,helper,I,NN
26,T,I,NNP
26,cells,I,NNS
26,decreased,B,VBN
26,in,O,IN
26,severe,B,JJ
26,cases,I,NNS
26,.,O,.
27,However,O,RB
27,",",O,","
27,as,O,IN
27,MHR,B,NNP
27,was,O,VBD
27,higher,B,RBR
27,in,O,IN
27,the,B,DT
27,patients,I,NNS
27,with,I,IN
27,good,I,JJ
27,prognosis,I,NN
27,compared,O,VBN
27,with,O,IN
27,the,B,DT
27,patients,I,NNS
27,with,I,IN
27,bad,I,JJ
27,prognosis,I,NN
27,",",O,","
27,we,O,PRP
27,believe,B,VBP
27,that,O,IN
27,regarding,B,VBG
27,the,I,DT
27,ISHL,I,NNP
27,",",O,","
27,MHR,B,NNP
27,is,O,VBZ
27,not,B,RB
27,a,O,DT
27,predictive,B,JJ
27,value,O,NN
27,but,O,CC
27,might,B,MD
27,have,B,VB
27,prognostic,B,JJ
27,marker,I,NN
27,.,O,.
28,Breast,B,NNP
28,Ca,I,NNP
28,risk,I,NN
28,factors,I,NNS
28,in,O,IN
28,CAR,B,NNP
28,did,O,VBD
28,not,B,RB
28,appear,B,VB
28,to,O,TO
28,be,O,VB
28,significantly,B,RB
28,different,B,JJ
28,from,O,IN
28,that,O,DT
28,observed,O,VBN
28,in,O,IN
28,other,B,JJ
28,populations,I,NNS
28,.,O,.
29,Circulating,B,VBG
29,concentrations,I,NNS
29,of,I,IN
29,SHBG,I,NNP
29,represent,O,VBP
29,a,O,DT
29,potentially,B,RB
29,useful,B,JJ
29,new,O,JJ
29,biomarker,B,NN
29,for,I,IN
29,prediction,B,NN
29,of,I,IN
29,risk,B,NN
29,of,I,IN
29,GDM,I,NNP
29,beyond,B,IN
29,the,I,DT
29,currently,I,RB
29,established,I,VBN
29,clinical,I,JJ
29,and,I,CC
29,demographic,I,JJ
29,risk,I,NN
29,factors,I,NNS
29,.,O,.
30,"""",O,NN
30,Stunting,B,VBG
30,prevalence,I,NN
30,may,B,MD
30,vary,B,VB
30,across,O,IN
30,space,B,NN
30,at,B,IN
30,different,I,JJ
30,scale,I,NN
30,.,O,.
31,Physical,B,JJ
31,exercise,I,NN
31,",",O,","
31,enough,B,JJ
31,vegetable,I,NN
31,and,I,CC
31,fruit,I,NN
31,intake,I,NN
31,are,O,VBP
31,positively,B,RB
31,associated,B,VBN
31,with,I,IN
31,HRQOL,B,NNP
31,of,I,IN
31,BCS,I,NNP
31,.,O,.
32,Build,B,NNP
32,-,I,:
32,up,I,RB
32,of,I,IN
32,AL,I,NNP
32,was,O,VBD
32,found,B,VBN
32,in,I,IN
32,adolescent,B,JJ
32,boys,I,NNS
32,and,O,CC
32,was,O,VBD
32,positively,B,RB
32,associated,B,VBN
32,with,I,IN
32,life,B,NN
32,event,I,NN
32,stress,I,NN
32,.,O,.
33,Baseline,B,NNP
33,VAT,I,NNP
33,was,O,VBD
33,inversely,B,RB
33,and,O,CC
33,independently,B,RB
33,associated,B,VBN
33,with,I,IN
33,the,B,DT
33,conversion,I,NN
33,to,I,TO
33,normal,I,JJ
33,blood,I,NN
33,pressure,I,NN
33,.,O,.
34,Ever,B,RB
34,consuming,I,VBG
34,alcohol,I,NN
34,and,O,CC
34,ever,B,RB
34,smoking,I,VBG
34,cigarette,I,NN
34,after,I,IN
34,starting,I,VBG
34,ART,I,NNP
34,",",O,","
34,depression,B,NN
34,",",O,","
34,not,B,RB
34,adhering,I,VBG
34,to,I,TO
34,ART,I,NNP
34,and,O,CC
34,being,B,VBG
34,in,I,IN
34,the,I,DT
34,second,I,JJ
34,lowest,I,JJS
34,wealth,I,NN
34,quintile,I,NN
34,were,O,VBD
34,significantly,B,RB
34,associated,B,VBN
34,with,I,IN
34,malnutrition,B,NN
34,.,O,.
35,Results,B,NNS
35,from,I,IN
35,this,I,DT
35,study,I,NN
35,suggest,B,VBP
35,a,O,DT
35,possible,B,JJ
35,association,B,NN
35,between,O,IN
35,nighttime,B,JJ
35,eating,I,VBG
35,behavior,I,NN
35,and,O,CC
35,breast,B,NN
35,cancer,I,NN
35,.,O,.
36,Omega-3,B,JJ
36,and,O,CC
36,omega-6,B,JJ
36,FA,I,NNP
36,intakes,I,NNS
36,are,O,VBP
36,inversely,B,RB
36,associated,B,VBN
36,with,I,IN
36,inflammatory,B,JJ
36,biomarkers,I,NNS
36,among,B,IN
36,CVD,I,JJ
36,patients,I,NNS
36,.,O,.
37,Epigenetic,B,JJ
37,age,I,NN
37,acceleration,I,NN
37,and,O,CC
37,CpG,B,NNP
37,island,I,VBP
37,methylation,I,NN
37,have,O,VBP
37,a,O,DT
37,weak,B,JJ
37,",",O,","
37,but,O,CC
37,statistically,B,RB
37,significant,I,JJ
37,",",O,","
37,association,B,NN
37,with,I,IN
37,breast,B,NN
37,cancer,I,NN
37,susceptibility,I,NN
37,.,O,.
38,Association,B,NNP
38,of,O,IN
38,socioeconomic,B,JJ
38,factors,I,NNS
38,with,O,IN
38,pharmacotherapy,B,NN
38,was,O,VBD
38,inconsistent,B,JJ
38,.,O,.
39,In,O,IN
39,our,B,PRP$
39,nationwide,I,JJ
39,case,I,NN
39,-,I,:
39,control,I,NN
39,study,I,NN
39,",",O,","
39,we,O,PRP
39,found,B,VBD
39,no,B,DT
39,association,B,NN
39,between,O,IN
39,statin,B,NN
39,use,I,NN
39,and,O,CC
39,risk,B,NN
39,of,I,IN
39,endometrial,I,JJ
39,cancer,I,NN
39,.,O,.
40,The,B,DT
40,highest,I,JJS
40,quartile,I,NN
40,compared,O,VBN
40,to,O,TO
40,the,B,DT
40,lowest,I,JJS
40,quartile,I,NN
40,of,I,IN
40,25OH,I,CD
40,vitamin,I,NNS
40,D,I,NNP
40,levels,I,NNS
40,is,O,VBZ
40,inversely,B,RB
40,associated,B,VBN
40,with,I,IN
40,CHD,B,NNP
40,and,O,CC
40,all,B,DT
40,-,I,:
40,cause,I,NN
40,mortality,I,NN
40,adjusting,B,VBG
40,for,I,IN
40,multiple,I,JJ
40,confounders,I,NNS
40,.,O,.
41,Presence,B,NN
41,of,I,IN
41,diabetes,I,NNS
41,mellitus,I,FW
41,is,O,VBZ
41,the,O,DT
41,most,B,RBS
41,important,I,JJ
41,risk,B,NN
41,factor,I,NN
41,for,I,IN
41,retinopathy,B,NN
41,.,O,.
42,Everolimus,B,NNP
42,based,I,VBN
42,treatment,I,NN
42,has,B,VBZ
42,meaningful,B,JJ
42,activity,I,NN
42,in,B,IN
42,heavily,I,RB
42,pretreated,I,VBN
42,patients,I,NNS
42,with,I,IN
42,HR,I,NNP
42,-,I,:
42,positive,I,JJ
42,MBC,I,NNP
42,but,O,CC
42,is,O,VBZ
42,associated,B,VBN
42,with,I,IN
42,considerable,B,JJ
42,toxicity,I,NN
42,and,O,CC
42,requirement,B,NN
42,for,I,IN
42,dose,I,JJ
42,adjustment,I,NN
42,.,O,.
43,Notably,B,RB
43,",",O,","
43,statin,B,NN
43,use,I,NN
43,was,O,VBD
43,also,O,RB
43,associated,B,VBN
43,with,I,IN
43,improved,B,JJ
43,survival,B,NN
43,.,O,.
44,IL11-RA,B,NNP
44,",",O,","
44,MLF1P,B,NNP
44,",",O,","
44,and,O,CC
44,ER+,B,NNP
44,were,O,VBD
44,the,O,DT
44,determinants,O,NNS
44,that,O,WDT
44,were,O,VBD
44,associated,B,VBN
44,with,I,IN
44,increasing,B,VBG
44,bone,B,NN
44,metastasis,I,NN
44,incidence,I,NN
44,.,O,.
45,Poor,B,NNP
45,glycemic,B,JJ
45,control,I,NN
45,among,B,IN
45,diabetics,I,NNS
45,is,O,VBZ
45,a,O,DT
45,risk,B,NN
45,factor,I,NN
45,for,I,IN
45,TB,B,NNP
45,occurrence,I,NN
45,.,O,.
46,DM,B,NNP
46,is,O,VBZ
46,associated,B,VBN
46,with,I,IN
46,poor,B,JJ
46,outcomes,B,NNS
46,in,B,IN
46,patients,I,NNS
46,undergoing,I,VBG
46,hepatectomy,I,NN
46,.,O,.
47,These,B,DT
47,findings,I,NNS
47,suggest,B,VBP
47,that,O,IN
47,obesity,B,NN
47,and,O,CC
47,possibly,B,RB
47,alcohol,B,NN
47,overuse,I,NN
47,are,O,VBP
47,independent,B,JJ
47,risk,B,NN
47,factors,I,NNS
47,for,I,IN
47,the,B,DT
47,development,I,NN
47,of,I,IN
47,infection,I,NN
47,following,I,VBG
47,surgery,I,NN
47,for,B,IN
47,a,I,DT
47,fracture,I,NN
47,of,I,IN
47,the,I,DT
47,ankle,I,NN
47,.,O,.
48,Physical,B,JJ
48,activity,I,NN
48,is,O,VBZ
48,also,O,RB
48,associated,B,VBN
48,with,I,IN
48,favorable,B,JJ
48,HDL,B,NNP
48,-,I,:
48,C.,I,NNP
49,Our,B,PRP$
49,data,I,NNS
49,suggest,B,VBP
49,that,O,IN
49,while,O,IN
49,sedentary,B,JJ
49,behavior,I,NN
49,is,O,VBZ
49,related,B,VBN
49,to,I,TO
49,worse,B,VB
49,fasting,B,VBG
49,glucose,I,RB
49,",",O,","
49,this,O,DT
49,relationship,O,NN
49,is,O,VBZ
49,attenuated,B,VBN
49,when,O,WRB
49,PA,B,NNP
49,is,O,VBZ
49,taken,O,VBN
49,into,O,IN
49,account,O,NN
49,.,O,.
50,VRIA,B,NNS
50,are,O,VBP
50,related,B,VBN
50,to,I,TO
50,outcome,B,VB
50,in,B,IN
50,patients,I,NNS
50,treated,I,VBN
50,with,I,IN
50,RZB,I,NNP
50,.,O,.
51,Diabetic,B,JJ
51,MN,I,NNP
51,usually,B,RB
51,presents,B,VBZ
51,in,I,IN
51,ageing,B,VBG
51,and,I,CC
51,clinically,I,RB
51,hypertensive,I,JJ
51,patients,I,NNS
51,and,O,CC
51,is,O,VBZ
51,associated,B,VBN
51,with,I,IN
51,severe,B,JJ
51,global,B,JJ
51,glomerulosclerosis,I,NN
51,",",O,","
51,IFTA,B,NNP
51,",",O,","
51,and,O,CC
51,afferent,B,JJ
51,arterial,I,JJ
51,lesions,I,NNS
51,histologically,B,RB
51,.,O,.
52,Other,O,JJ
52,risk,B,NN
52,factors,I,NNS
52,that,O,WDT
52,were,O,VBD
52,associated,B,VBN
52,with,I,IN
52,major,B,JJ
52,amputation,I,NN
52,in,B,IN
52,patients,I,NNS
52,included,O,VBD
52,active,B,JJ
52,infection,I,NN
52,at,I,IN
52,presentation,I,NN
52,",",O,","
52,nonunion,B,NN
52,/,I,NNP
52,instability,I,NN
52,after,I,IN
52,reconstruction,I,NN
52,",",O,","
52,and,O,CC
52,a,B,DT
52,postoperative,I,JJ
52,wound,I,NN
52,problem,I,NN
52,.,O,.
53,Significant,B,JJ
53,weight,B,NN
53,loss,I,NN
53,after,I,IN
53,bariatric,I,JJ
53,surgery,I,NN
53,is,O,VBZ
53,weakly,B,RB
53,associated,B,VBN
53,with,I,IN
53,IOP,B,NNP
53,lowering,B,VBG
53,.,O,.
54,The,B,DT
54,results,I,NNS
54,in,I,IN
54,this,I,DT
54,trial,I,NN
54,did,O,VBD
54,not,B,RB
54,highlight,B,VB
54,any,O,DT
54,differences,B,NNS
54,between,O,IN
54,those,B,DT
54,who,I,WP
54,received,I,VBD
54,the,I,DT
54,intervention,I,NN
54,and,O,CC
54,those,B,DT
54,who,I,WP
54,received,I,VBD
54,usual,I,JJ
54,care,I,NN
54,.,O,.
55,Higher,B,JJR
55,serum,B,NN
55,cholesterol,I,NN
55,levels,I,NNS
55,are,O,VBP
55,associated,B,VBN
55,with,I,IN
55,lower,B,JJR
55,AVG,B,NNP
55,failure,I,NN
55,risk,I,NN
55,over,B,IN
55,a,I,DT
55,1000-day,I,JJ
55,period,I,NN
55,",",O,","
55,which,O,WDT
55,probably,B,RB
55,corresponds,B,VBZ
55,to,I,TO
55,the,O,DT
55,worse,B,JJR
55,disease,B,NN
55,status,I,NN
55,of,B,IN
55,the,I,DT
55,patients,I,NNS
55,with,I,IN
55,lower,I,JJR
55,cholesterol,I,NN
55,values,I,NNS
55,.,O,.
56,Surprisingly,B,RB
56,",",O,","
56,UW,B,NNP
56,patients,I,NNS
56,are,O,VBP
56,associated,B,VBN
56,with,I,IN
56,higher,B,JJR
56,mortality,B,NN
56,as,O,RB
56,well,O,RB
56,as,O,IN
56,respiratory,B,JJ
56,events,I,NNS
56,postoperatively,B,RB
56,.,O,.
56,"""",O,VB
57,The,O,DT
57,association,B,NN
57,between,O,IN
57,lower,B,JJR
57,cholesterol,B,NN
57,levels,I,NNS
57,and,O,CC
57,higher,B,JJR
57,frequency,B,NN
57,of,I,IN
57,prior,I,JJ
57,ischemic,I,JJ
57,stroke,I,NN
57,in,B,IN
57,patients,I,NNS
57,with,I,IN
57,cholesterol,I,NN
57,<,I,VBP
57,5.5\\xa0mmol,I,CD
57,/,I,JJ
57,L,I,NNP
57,can,O,MD
57,not,B,RB
57,be,O,VB
57,solely,B,RB
57,an,O,DT
57,effect,B,NN
57,of,O,IN
57,aggressive,B,JJ
57,statin,I,NN
57,treatment,I,NN
57,in,B,IN
57,patients,I,NNS
57,with,I,IN
57,prior,I,JJ
57,ischemic,I,JJ
57,stroke,I,NN
57,",",O,","
57,as,O,IN
57,the,O,DT
57,association,O,NN
57,pertained,O,VBD
57,also,O,RB
57,to,O,TO
57,patients,B,NNS
57,who,I,WP
57,did,I,VBD
57,not,I,RB
57,use,I,VB
57,statin,I,NN
57,.,O,.
58,Specific,B,JJ
58,trajectories,I,NNS
58,were,O,VBD
58,associated,B,VBN
58,with,I,IN
58,greater,B,JJR
58,BMI,B,NNP
58,and,O,CC
58,waist,B,JJ
58,circumference,I,NN
58,during,B,IN
58,adulthood,I,NN
58,.,O,.
59,Overall,O,JJ
59,",",O,","
59,these,B,DT
59,results,I,NNS
59,suggest,B,VBP
59,that,O,IN
59,while,O,IN
59,milk,B,NN
59,and,I,CC
59,yogurt,I,NN
59,consumption,I,NN
59,is,O,VBZ
59,associated,B,VBN
59,with,I,IN
59,a,O,DT
59,favourable,B,JJ
59,body,B,NN
59,phenotype,I,NN
59,",",O,","
59,the,B,DT
59,blood,I,NN
59,lipid,I,JJ
59,profiles,I,NNS
59,are,I,VBP
59,less,B,RBR
59,favourable,I,JJ
59,when,B,WRB
59,eaten,I,VBN
59,as,I,IN
59,part,I,NN
59,of,I,IN
59,a,I,DT
59,low,I,JJ
59,-,I,:
59,fat,I,NN
59,high,I,JJ
59,-,I,:
59,carbohydrate,I,NN
59,dietary,I,JJ
59,pattern,I,NN
59,.,O,.
60,Our,B,PRP$
60,findings,I,NNS
60,support,B,VB
60,a,O,DT
60,significant,B,JJ
60,association,B,NN
60,between,O,IN
60,the,O,DT
60,high,B,JJ
60,level,B,NN
60,of,I,IN
60,HDL,I,NNP
60,-,I,:
60,C,I,NNP
60,",",O,","
60,triglyceride,B,NN
60,and,O,CC
60,depression,B,NN
60,in,B,IN
60,large,I,JJ
60,sample,I,NN
60,data,I,NNS
60,.,O,.
61,High,B,JJ
61,intratumoral,B,JJ
61,PTEN,I,NNP
61,gene,I,NN
61,expression,I,NN
61,was,O,VBD
61,associated,B,VBN
61,with,I,IN
61,poor,B,JJ
61,prognosis,B,NN
61,in,B,IN
61,patients,I,NNS
61,with,I,IN
61,locally,I,RB
61,advanced,I,VBN
61,breast,I,NN
61,cancers,I,NNS
61,harboring,I,VBG
61,wild,I,JJ
61,-,I,:
61,type,I,NN
61,TP53,I,NNP
61,.,O,.
62,Our,B,PRP$
62,findings,I,NNS
62,indicate,B,VBP
62,that,O,DT
62,high,B,JJ
62,consumption,B,NN
62,of,I,IN
62,snus,I,NN
62,is,O,VBZ
62,a,O,DT
62,risk,B,NN
62,factor,I,NN
62,for,I,IN
62,type,B,NN
62,2,I,CD
62,diabetes,I,NNS
62,.,O,.
63,KEY,O,NNP
63,POINTS,O,NNP
63,Middle,B,NNP
63,age,I,NN
63,",",O,","
63,low,B,JJ
63,education,B,NN
63,",",O,","
63,and,O,CC
63,low,B,JJ
63,income,B,NN
63,were,O,VBD
63,associated,B,VBN
63,with,I,IN
63,nonattainment,B,NN
63,of,I,IN
63,goals,I,NNS
63,for,I,IN
63,diabetes,I,NNS
63,care,I,NN
63,",",O,","
63,especially,B,RB
63,for,I,IN
63,lifestyle,I,JJ
63,goals,I,NNS
63,.,O,.
64,Younger,B,JJR
64,age,B,NN
64,harbours,B,RBR
64,aggressive,B,JJ
64,clinicopathologic,B,NN
64,characteristics,I,NNS
64,.,O,.
65,The,B,DT
65,results,I,NNS
65,of,I,IN
65,the,I,DT
65,present,I,JJ
65,study,I,NN
65,suggest,B,VBP
65,that,O,IN
65,the,B,DT
65,use,I,NN
65,of,I,IN
65,validated,I,JJ
65,malnutrition,I,NN
65,screening,I,NN
65,tools,I,NNS
65,is,O,VBZ
65,associated,B,VBN
65,with,I,IN
65,better,B,JJR
65,nutritional,B,JJ
65,care,I,NN
65,and,O,CC
65,lower,B,JJR
65,malnutrition,B,NN
65,prevalence,I,NN
65,rates,I,NNS
65,in,B,IN
65,hospitalized,I,JJ
65,patients,I,NNS
65,.,O,.
66,Hydroxychloroquine,B,NNP
66,use,I,NN
66,was,O,VBD
66,associated,B,VBN
66,with,I,IN
66,lower,B,JJR
66,lipid,B,NN
66,levels,I,NNS
66,but,O,CC
66,not,B,RB
66,with,B,IN
66,the,B,DT
66,plasma,I,NN
66,glucose,I,NN
66,in,B,IN
66,this,I,DT
66,RA,I,NNP
66,cohort,I,NN
66,.,O,.
67,Variation,B,NN
67,in,I,IN
67,unexpected,B,JJ
67,complication,I,NN
67,rates,I,NNS
67,is,O,VBZ
67,more,B,RBR
67,likely,I,JJ
67,to,O,TO
67,be,O,VB
67,related,B,VBN
67,to,I,TO
67,hospital,B,NN
67,rather,O,RB
67,than,O,IN
67,patient,B,JJ
67,characteristics,I,NNS
67,in,B,IN
67,Florida,I,NNP
67,.,O,.
68,The,B,DT
68,etiology,I,NN
68,of,I,IN
68,anemia,I,NN
68,appears,B,VBZ
68,to,O,TO
68,be,O,VB
68,iron,B,VBN
68,-,O,:
68,related,B,VBN
68,and,O,CC
68,precipitated,B,VBN
68,by,O,IN
68,the,B,DT
68,female,I,JJ
68,sex,I,NN
68,.,O,.
69,These,B,DT
69,results,I,NNS
69,provide,B,VBP
69,further,I,JJ
69,evidence,I,NN
69,that,O,IN
69,EZH2,B,NNP
69,expression,I,NN
69,in,I,IN
69,the,I,DT
69,normal,I,JJ
69,breast,I,NN
69,epithelium,I,NN
69,is,O,VBZ
69,independently,B,RB
69,associated,B,VBN
69,with,I,IN
69,breast,B,NN
69,cancer,I,NN
69,risk,I,NN
69,and,O,CC
69,might,B,MD
69,be,O,VB
69,used,O,VBN
69,to,O,TO
69,assist,B,VB
69,in,O,IN
69,risk,B,NN
69,stratification,I,NN
69,for,I,IN
69,women,B,NNS
69,with,I,IN
69,benign,I,JJ
69,breast,I,NN
69,biopsies,I,NNS
69,.,O,.
70,However,O,RB
70,",",O,","
70,obesity,B,NN
70,seems,B,VBZ
70,to,O,TO
70,be,O,VB
70,associated,B,VBN
70,with,I,IN
70,more,B,RBR
70,wound,B,JJ
70,complications,I,NNS
70,.,O,.
71,LDL,B,NNP
71,-,I,:
71,C,I,NN
71,levels,I,NNS
71,<,I,VBP
71,25,I,CD
71,or,I,CC
71,<,I,VB
71,15,I,CD
71,mg,I,NN
71,/,I,NNP
71,dl,I,NN
71,on,I,IN
71,alirocumab,I,NNS
71,were,O,VBD
71,not,B,RB
71,associated,B,VBN
71,with,I,IN
71,an,O,DT
71,increase,B,NN
71,in,I,IN
71,overall,B,JJ
71,treatment,I,NN
71,-,I,:
71,emergent,I,JJ
71,adverse,I,JJ
71,event,I,NN
71,rates,I,NNS
71,or,O,CC
71,neurocognitive,B,JJ
71,events,I,NNS
71,",",O,","
71,although,O,IN
71,cataract,B,JJ
71,incidence,I,NN
71,appeared,B,VBD
71,to,O,TO
71,be,O,VB
71,increased,B,VBN
71,in,O,IN
71,the,B,DT
71,group,I,NN
71,achieving,I,VBG
71,LDL,I,NNP
71,-,I,:
71,C,I,NN
71,levels,I,NNS
71,<,I,VBP
71,25,I,CD
71,mg,I,NN
71,/,I,NNP
71,dl,I,NN
71,.,O,.
72,Some,B,DT
72,of,I,IN
72,the,I,DT
72,opportunities,I,NNS
72,may,B,MD
72,be,O,VB
72,related,B,VBN
72,to,I,TO
72,differences,B,NNS
72,in,I,IN
72,hospital,B,NN
72,coding,I,NN
72,practice,I,NN
72,.,O,.
73,Risk,B,NN
73,factors,I,NNS
73,for,I,IN
73,revision,B,NN
73,surgery,I,NN
73,after,I,IN
73,SLAP,I,NNP
73,repair,I,NN
73,include,O,VBP
73,age,B,NN
73,>,I,JJ
73,40,I,CD
73,years,I,NNS
73,",",O,","
73,female,B,JJ
73,sex,I,NN
73,",",O,","
73,obesity,B,NN
73,",",O,","
73,smoking,B,NN
73,",",O,","
73,and,O,CC
73,diagnosis,B,NN
73,of,I,IN
73,biceps,I,NNS
73,tendinitis,I,NNS
73,or,O,CC
73,long,B,JJ
73,head,I,NN
73,of,I,IN
73,the,I,DT
73,biceps,I,NNS
73,tearing,I,VBG
73,.,O,.
74,The,B,DT
74,study,I,NN
74,provides,B,VBZ
74,a,O,DT
74,link,B,NN
74,between,O,IN
74,iron,B,NN
74,nutrition,I,NN
74,",",O,","
74,physiological,B,JJ
74,deregulation,I,NN
74,and,O,CC
74,stress,B,NN
74,.,O,.
75,The,B,DT
75,findings,I,NNS
75,of,I,IN
75,this,I,DT
75,study,I,NN
75,showed,B,VBD
75,that,O,IN
75,breast,B,NN
75,cancer,I,NN
75,is,O,VBZ
75,common,O,JJ
75,and,O,CC
75,mostly,B,RB
75,affected,B,JJ
75,women,B,NNS
75,.,O,.
76,Patients,B,NNS
76,with,I,IN
76,low,I,JJ
76,socioeconomic,I,JJ
76,status,I,NN
76,were,O,VBD
76,more,B,RBR
76,often,I,RB
76,obese,B,JJ
76,",",O,","
76,physically,B,RB
76,inactive,I,JJ
76,",",O,","
76,smoking,B,NN
76,",",O,","
76,and,O,CC
76,had,O,VBD
76,elevated,B,VBN
76,blood,B,NN
76,pressure,I,NN
76,.,O,.
77,Our,B,PRP$
77,findings,I,NNS
77,suggest,B,VBP
77,that,O,IN
77,extreme,B,JJ
77,high,B,JJ
77,-,I,:
77,fiber,I,NNS
77,intake,I,VBP
77,may,B,MD
77,be,O,VB
77,associated,B,VBN
77,with,I,IN
77,decreased,B,JJ
77,risk,B,NN
77,of,I,IN
77,breast,I,NN
77,cancer,I,NN
77,but,O,CC
77,the,B,DT
77,level,I,NN
77,of,I,IN
77,dietary,I,JJ
77,fiber,I,NNS
77,intake,I,VBP
77,among,B,IN
77,Japanese,I,JJ
77,population,I,NN
77,might,O,MD
77,not,O,RB
77,be,O,VB
77,sufficient,O,JJ
77,to,O,TO
77,examine,O,VB
77,the,O,DT
77,association,B,NN
77,between,O,IN
77,dietary,B,JJ
77,fiber,I,NNS
77,intake,I,NN
77,and,O,CC
77,breast,B,NN
77,cancer,I,NN
77,risk,I,NN
77,.,O,.
78,This,B,DT
78,study,I,NN
78,clearly,O,RB
78,revealed,B,VBD
78,that,O,IN
78,there,O,EX
78,is,O,VBZ
78,an,O,DT
78,increase,B,NN
78,in,I,IN
78,all,B,DT
78,deleterious,I,JJ
78,lipid,I,JJ
78,parameters,I,NNS
78,and,O,CC
78,a,O,DT
78,decrease,B,NN
78,in,I,IN
78,favorable,B,JJ
78,lipid,B,JJ
78,measures,I,NNS
78,.,O,.
79,Wide,B,NNP
79,variation,B,NN
79,in,I,IN
79,the,O,DT
79,relative,B,JJ
79,reduction,B,NN
79,in,I,IN
79,cholesterol,B,NN
79,levels,I,NNS
79,was,O,VBD
79,also,O,RB
79,observed,O,VBN
79,among,B,IN
79,patients,I,NNS
79,in,I,IN
79,whom,I,WP
79,antidrug,I,JJ
79,antibodies,I,NNS
79,did,I,VBD
79,not,I,RB
79,develop,I,VB
79,.,O,.
80,This,B,DT
80,study,I,NN
80,is,O,VBZ
80,the,O,DT
80,first,O,JJ
80,to,O,TO
80,reveal,B,VB
80,significant,B,JJ
80,associations,B,NNS
80,between,O,IN
80,SSRI,B,NNP
80,use,I,NN
80,and,O,CC
80,metabolic,B,JJ
80,abnormalities,I,NNS
80,in,B,IN
80,patients,I,NNS
80,with,I,IN
80,schizophrenia,I,NN
80,or,I,CC
80,bipolar,I,JJ
80,disorder,I,NN
80,.,O,.
81,Our,B,PRP$
81,data,I,NNS
81,suggest,B,VBP
81,that,O,IN
81,postmenopausal,B,NN
81,BMI,I,NNP
81,is,O,VBZ
81,associated,B,VBN
81,with,I,IN
81,increased,B,JJ
81,circulating,B,NN
81,levels,I,NNS
81,of,I,IN
81,parent,I,NN
81,estrogens,I,NNS
81,and,O,CC
81,reduced,B,JJ
81,methylation,B,NN
81,of,I,IN
81,catechol,I,NN
81,estrogen,I,NN
81,metabolites,I,NNS
81,",",O,","
81,the,B,DT
81,estrogen,I,NN
81,metabolism,I,NN
81,patterns,I,NNS
81,that,O,WDT
81,have,O,VBP
81,previously,B,RB
81,been,I,VBN
81,associated,B,VBN
81,with,I,IN
81,higher,B,JJR
81,breast,B,NN
81,cancer,I,NN
81,risk,I,NN
81,.,O,.
82,This,B,DT
82,may,B,MD
82,relate,B,VB
82,to,I,TO
82,the,O,DT
82,effects,B,NNS
82,of,O,IN
82,new,B,JJ
82,AEDs,I,NNP
82,on,O,IN
82,vitamin,B,NN
82,B12,I,NNP
82,and,O,CC
82,folate,B,JJ
82,metabolism,I,NN
82,.,O,.
83,Our,B,PRP$
83,results,I,NNS
83,suggest,B,VBP
83,a,O,DT
83,protective,B,JJ
83,relationship,B,NN
83,between,O,IN
83,IL1R1rs2287047,B,NNP
83,(,O,(
83,AA+AG,B,NNP
83,),O,)
83,and,O,CC
83,PCF,B,NNP
83,and,O,CC
83,provide,B,VB
83,further,I,JJR
83,evidence,I,NN
83,supporting,O,VBG
83,exercise,B,NN
83,as,O,IN
83,a,O,DT
83,potential,B,JJ
83,intervention,B,NN
83,for,I,IN
83,poorer,B,JJR
83,PCF,B,NNP
83,.,O,.
84,WtH,B,NNP
84,ratio,I,NN
84,(,O,(
84,a,B,DT
84,measure,I,NN
84,of,I,IN
84,central,I,JJ
84,fatness,I,NN
84,),O,)
84,was,O,VBD
84,not,B,RB
84,associated,B,VBN
84,to,I,TO
84,HDLc,B,NNP
84,",",O,","
84,but,O,CC
84,to,B,TO
84,MRP8/14,B,NNP
84,",",O,","
84,suggestive,B,NN
84,of,I,IN
84,central,B,JJ
84,fatness,I,NN
84,as,O,IN
84,an,O,DT
84,additional,B,JJ
84,driving,B,NN
84,factor,I,NN
84,for,I,IN
84,the,B,DT
84,chronic,I,JJ
84,inflammation,I,NN
84,in,I,IN
84,JIA,I,NNP
84,.,O,.
85,In,B,IN
85,a,I,DT
85,country,I,NN
85,with,I,IN
85,free,I,JJ
85,access,I,NN
85,to,I,TO
85,health,I,NN
85,care,I,NN
85,",",O,","
85,the,B,DT
85,socioeconomic,I,JJ
85,factors,I,NNS
85,such,O,JJ
85,as,O,IN
85,middle,B,JJ
85,age,I,NN
85,",",O,","
85,low,B,JJ
85,education,B,NN
85,",",O,","
85,and,O,CC
85,low,B,JJ
85,income,B,NN
85,were,O,VBD
85,associated,B,VBN
85,with,I,IN
85,nonattainment,B,NN
85,of,I,IN
85,goals,I,NNS
85,for,I,IN
85,diabetes,I,NNS
85,care,I,NN
85,.,O,.
86,HF,B,NNP
86,patients,I,NNS
86,with,I,IN
86,EF,I,NNP
86,missing,I,VBG
86,at,I,IN
86,medical,I,JJ
86,records,I,NNS
86,had,O,VBD
86,the,O,DT
86,worst,B,JJS
86,prognosis,B,NN
86,.,O,.
87,Adiponectin,B,NN
87,levels,I,NNS
87,were,O,VBD
87,in,O,IN
87,positive,B,JJ
87,correlation,B,NN
87,with,I,IN
87,HDL,B,NNP
87,-,I,:
87,cholesterol,I,NN
87,concentrations,I,NNS
87,.,O,.
88,Prevalence,B,NN
88,is,O,VBZ
88,highest,B,JJS
88,among,O,IN
88,those,B,DT
88,who,I,WP
88,are,I,VBP
88,positive,I,JJ
88,for,I,IN
88,viral,I,JJ
88,RNA,I,NNP
88,.,O,.
89,Obesity,B,NN
89,is,O,VBZ
89,increasingly,B,RB
89,prevalent,O,JJ
89,and,O,CC
89,associated,B,VBN
89,with,I,IN
89,a,O,DT
89,high,B,JJ
89,incidence,B,NN
89,of,I,IN
89,co,I,NN
89,-,I,:
89,morbidity,I,NN
89,and,O,CC
89,complications,B,NNS
89,.,O,.
90,Parental,B,JJ
90,BMI,I,NNP
90,and,O,CC
90,steep,B,JJ
90,weight,I,NN
90,gain,I,NN
90,in,B,IN
90,early,I,JJ
90,childhood,I,NN
90,indicate,B,VBP
90,markedly,B,RB
90,increased,B,VBN
90,risk,B,NN
90,for,I,IN
90,becoming,I,VBG
90,overweight,I,NN
90,.,O,.
91,Increased,B,VBN
91,age,B,NN
91,is,O,VBZ
91,a,O,DT
91,predictor,B,NN
91,of,I,IN
91,complications,B,NNS
91,after,I,IN
91,bariatric,I,JJ
91,surgery,I,NN
91,.,O,.
92,Activity,B,NNP
92,restriction,I,NN
92,was,O,VBD
92,the,O,DT
92,strongest,B,JJS
92,predictor,B,NN
92,of,I,IN
92,risk,B,NN
92,of,I,IN
92,overweight,I,NN
92,and,I,CC
92,obesity,I,NN
92,at,B,IN
92,follow,I,JJ
92,-,I,:
92,up,I,RB
92,.,O,.
93,Older,B,JJR
93,age,B,NN
93,",",O,","
93,white,B,JJ
93,race,I,NN
93,",",O,","
93,and,O,CC
93,recurrence,B,NN
93,predicted,B,VBD
93,testing,B,NN
93,.,O,.
94,This,B,DT
94,study,I,NN
94,found,B,VBD
94,that,O,IN
94,children,B,NNS
94,exposed,I,VBN
94,to,I,TO
94,the,I,DT
94,Jazan,I,NNP
94,war,I,NN
94,had,O,VBD
94,more,B,JJR
94,anxiety,B,NN
94,.,O,.
95,Men,B,NN
95,appeared,B,VBD
95,more,B,RBR
95,susceptible,B,JJ
95,to,I,TO
95,T2D,I,NNP
95,than,O,IN
95,women,B,NNS
95,.,O,.
96,RHR,B,NNP
96,is,O,VBZ
96,positively,B,RB
96,associated,B,VBN
96,with,I,IN
96,baPWV,B,NN
96,in,B,IN
96,healthy,I,JJ
96,Chinese,I,JJ
96,population,I,NN
96,.,O,.
97,Elevated,B,VBN
97,serum,B,NN
97,triglycerides,I,NNS
97,were,O,VBD
97,associated,B,VBN
97,with,I,IN
97,increased,B,JJ
97,risk,B,NN
97,of,I,IN
97,prostate,I,NN
97,cancer,I,NN
97,recurrence,I,NN
97,.,O,.
98,However,O,RB
98,",",O,","
98,serum,B,JJ
98,folate,I,NN
98,levels,I,NNS
98,were,O,VBD
98,decreased,B,VBN
98,in,O,IN
98,postadolescent,B,JJ
98,acne,I,NN
98,patients,I,NNS
98,.,O,.
99,Ultraprocessed,B,VBN
99,food,I,NN
99,consumption,I,NN
99,was,O,VBD
99,associated,B,VBN
99,with,I,IN
99,a,O,DT
99,higher,B,JJR
99,risk,B,NN
99,of,I,IN
99,overweight,I,NN
99,and,I,CC
99,obesity,I,NN
99,in,B,IN
99,a,I,DT
99,prospective,I,JJ
99,cohort,I,NN
99,of,I,IN
99,Spanish,I,JJ
99,middle,I,FW
99,-,I,:
99,aged,I,VBN
99,adult,I,NN
99,university,I,NN
99,graduates,I,NNS
99,.,O,.
100,Male,B,JJ
100,sex,I,NN
100,predicted,B,VBD
100,lateral,B,JJ
100,meniscal,I,JJ
100,tears,I,NNS
100,and,O,CC
100,management,B,NN
100,.,O,.
101,Patients,B,NNS
101,that,I,WDT
101,received,I,VBD
101,fast,I,RB
101,track,I,JJ
101,care,I,NN
101,had,O,VBD
101,a,O,DT
101,decreased,B,JJ
101,length,B,NN
101,of,I,IN
101,stay,I,NN
101,.,O,.
102,Mini,B,NNP
102,Nutritional,I,NNP
102,Assessment,I,NNP
102,was,O,VBD
102,able,B,JJ
102,to,O,TO
102,predict,B,VB
102,the,B,DT
102,development,I,NN
102,of,I,IN
102,PUs,I,NNP
102,.,O,.
103,Age,B,NNP
103,predicted,B,VBD
103,chondral,B,JJ
103,injuries,I,NNS
103,.,O,.
104,Middle,B,NNP
104,-,I,:
104,age,I,NN
104,adult,I,NN
104,Asians,I,NNPS
104,with,I,IN
104,the,I,DT
104,ADRB3,I,NNP
104,rs4994,I,NN
104,minor,I,NN
104,alleles,I,NNS
104,are,O,VBP
104,at,O,IN
104,increased,B,JJ
104,risk,B,NN
104,of,I,IN
104,T2DM,I,NNP
104,.,O,.
105,Not,B,RB
105,meeting,I,VBG
105,relative,I,JJ
105,MVPA,I,NNP
105,and,I,CC
105,VPA,I,NNP
105,recommendation,I,NN
105,was,O,VBD
105,associated,B,VBN
105,with,I,IN
105,significantly,B,RB
105,higher,B,JJR
105,likelihood,I,NN
105,for,O,IN
105,presence,B,NN
105,of,I,IN
105,MetS.,I,NNP
106,Oral,B,JJ
106,impacts,I,NNS
106,were,I,VBD
106,more,B,RBR
106,frequently,I,RB
106,reported,I,VBN
106,in,O,IN
106,T2D,B,NNP
106,cases,I,NNS
106,than,O,IN
106,controls,B,NNS
106,.,O,.
107,Mothers,B,NNS
107,from,I,IN
107,food,I,NN
107,insecure,I,NN
107,households,I,NNS
107,had,O,VBD
107,a,O,DT
107,high,B,JJ
107,risk,B,NN
107,of,I,IN
107,dietary,I,JJ
107,inadequacy,I,NN
107,and,O,CC
107,obesity,B,NN
107,.,O,.
108,Moreover,O,RB
108,",",O,","
108,there,O,EX
108,is,O,VBZ
108,a,O,DT
108,direct,B,JJ
108,correlation,B,NN
108,between,O,IN
108,fasting,B,VBG
108,serum,I,NN
108,glucose,I,NN
108,levels,I,NNS
108,and,O,CC
108,changes,B,NNS
108,in,I,IN
108,IOP,B,NNP
108,.,O,.
109,We,O,PRP
109,observed,B,VBD
109,an,O,DT
109,association,B,NN
109,between,O,IN
109,EH,B,NNP
109,/,I,NNP
109,EC,I,NNP
109,and,O,CC
109,a,B,DT
109,history,I,NN
109,of,I,IN
109,gestational,I,JJ
109,diabetes,I,NNS
109,specific,B,JJ
109,to,I,TO
109,younger,I,JJR
109,women,I,NNS
109,.,O,.
110,It,O,PRP
110,provided,O,VBD
110,the,O,DT
110,evidence,O,NN
110,for,O,IN
110,association,B,NN
110,of,O,IN
110,SCAP,B,NNP
110,with,O,IN
110,SBP,B,NNP
110,.,O,.
111,Significant,B,NNP
111,",",O,","
111,positive,B,JJ
111,associations,B,NNS
111,between,O,IN
111,breast,B,NN
111,cancer,I,NN
111,risk,I,NN
111,and,O,CC
111,PCBs,B,NNP
111,and,O,CC
111,PFAAs,B,NNP
111,were,O,VBD
111,observed,B,VBN
111,.,O,.
112,The,B,DT
112,prevalence,I,NN
112,of,I,IN
112,overweight,I,NN
112,was,O,VBD
112,higher,B,JJR
112,for,O,IN
112,natives,B,NNS
112,than,O,IN
112,immigrants,B,NNS
112,.,O,.
113,Herbalife,B,NNP
113,NC,I,NNP
113,membership,I,NN
113,was,O,VBD
113,positively,B,RB
113,associated,B,VBN
113,with,I,IN
113,perceived,B,JJ
113,health,I,NN
113,and,O,CC
113,measured,B,VBN
113,cardiometabolic,I,JJ
113,benefits,I,NNS
113,.,O,.
114,It,O,PRP
114,also,O,RB
114,showed,B,VBD
114,increased,B,JJ
114,inflammation,B,NN
114,in,O,IN
114,both,O,DT
114,T1D,B,NNP
114,and,O,CC
114,IA,B,NNP
114,children,I,NNS
114,when,O,WRB
114,compared,O,VBN
114,to,O,TO
114,controls,B,NNS
114,.,O,.
115,In,O,IN
115,the,B,DT
115,subgroup,I,NN
115,analysis,I,NN
115,",",O,","
115,significantly,B,RB
115,increased,B,VBD
115,breast,B,NN
115,cancer,I,NN
115,risk,I,NN
115,was,O,VBD
115,identified,O,VBN
115,among,O,IN
115,Caucasians,B,NNPS
115,.,O,.
116,This,B,DT
116,finding,I,NN
116,confirmed,B,VBD
116,the,O,DT
116,linear,B,JJ
116,relationship,B,NN
116,of,O,IN
116,FPG,B,NNP
116,-,I,:
116,CV,I,NN
116,and,O,CC
116,HbA1c,B,NNP
116,-,I,:
116,CV,I,NN
116,to,O,TO
116,COPD,B,NNP
116,.,O,.
117,The,B,DT
117,risk,I,NN
117,of,I,IN
117,TB,I,NNP
117,was,O,VBD
117,reversely,B,RB
117,associated,B,VBN
117,with,I,IN
117,initial,B,JJ
117,BMI,I,NNP
117,.,O,.
118,Obese,B,JJ
118,patients,I,NNS
118,have,O,VBP
118,a,O,DT
118,higher,B,JJR
118,mean,B,JJ
118,IOP,I,NNP
118,and,O,CC
118,lower,B,JJR
118,flow,B,NN
118,velocity,I,NN
118,than,O,IN
118,non,B,JJ
118,-,I,:
118,obese,I,JJ
118,patients,I,NNS
118,.,O,.
119,In,O,IN
119,women,B,NNS
119,with,I,IN
119,nipple,I,JJ
119,discharge,I,NN
119,and,I,CC
119,negative,I,JJ
119,or,I,CC
119,inconclusive,I,JJ
119,mammography,I,NN
119,findings,I,NNS
119,",",O,","
119,the,B,DT
119,risk,I,NN
119,of,I,IN
119,malignancy,I,NN
119,is,O,VBZ
119,low,B,JJ
119,",",O,","
119,at,B,IN
119,5.7,I,CD
119,%,I,NN
119,.,O,.
120,BC,B,NNP
120,risk,I,NN
120,in,B,IN
120,female,I,JJ
120,HL,I,NNP
120,survivors,I,NNS
120,sign+,B,VBD
120,linearly,B,RB
120,with,O,IN
120,radiation,B,NN
120,dose,I,NN
120,.,O,.
121,Multi,B,NNP
121,-,I,:
121,level,I,NN
121,obstruction,I,NN
121,is,O,VBZ
121,more,B,RBR
121,prevalent,I,JJ
121,in,O,IN
121,obstructive,B,JJ
121,sleep,I,NN
121,apnoea,I,NN
121,and,O,CC
121,is,O,VBZ
121,associated,B,VBN
121,with,I,IN
121,increased,B,JJ
121,severity,B,NN
121,.,O,.
122,LOHS,B,NNP
122,and,O,CC
122,IHM,B,NNP
122,were,O,VBD
122,also,O,RB
122,higher,B,JJR
122,among,O,IN
122,RHA,B,JJ
122,patients,I,NNS
122,with,I,IN
122,diabetes,I,NNS
122,.,O,.
123,Several,B,JJ
123,glycerophospholipids,I,NNS
123,were,O,VBD
123,inversely,B,RB
123,related,B,VBN
123,to,I,TO
123,advanced,B,JJ
123,stage,I,NN
123,disease,I,NN
123,.,O,.
124,There,O,EX
124,was,O,VBD
124,also,O,RB
124,a,O,DT
124,link,B,NN
124,between,O,IN
124,slow,B,JJ
124,-,I,:
124,wave,I,NN
124,sleep,I,JJ
124,duration,I,NN
124,and,O,CC
124,insulin,B,NN
124,resistance,I,NN
124,.,O,.
125,The,B,DT
125,present,I,JJ
125,study,I,NN
125,suggests,B,VBZ
125,a,O,DT
125,link,B,NN
125,between,O,IN
125,overweight,B,JJ
125,/,I,NNP
125,obesity,I,NN
125,and,O,CC
125,altered,B,VBD
125,sleep,I,JJ
125,quality,I,NN
125,due,O,JJ
125,to,O,TO
125,compromised,B,VBN
125,non,I,SYM
125,-,I,:
125,rapid,I,JJ
125,eye,I,NN
125,movement,I,NN
125,sleep,I,NN
125,",",O,","
125,an,O,DT
125,indirect,B,JJ
125,marker,B,NN
125,of,I,IN
125,sleep,B,JJ
125,quality,I,NN
125,.,O,.
126,Obesity,B,NN
126,is,O,VBZ
126,predictive,B,JJ
126,of,I,IN
126,an,O,DT
126,increased,B,VBN
126,risk,B,NN
126,for,I,IN
126,cardiovascular,I,JJ
126,and,I,CC
126,respiratory,I,JJ
126,complications,I,NNS
126,following,I,VBG
126,trauma,I,NN
126,.,O,.
127,High,B,JJ
127,BMI,B,NNP
127,and,O,CC
127,alcohol,B,NN
127,consumption,I,NN
127,and,O,CC
127,abstinence,B,NN
127,are,O,VBP
127,risk,B,JJ
127,factors,I,NNS
127,for,I,IN
127,CLD,B,NNP
127,in,B,IN
127,post,I,NN
127,-,I,:
127,menopausal,I,NN
127,women,I,NNS
127,.,O,.
128,Postoperative,B,JJ
128,SRS,I,NNP
128,was,O,VBD
128,associated,B,VBN
128,with,I,IN
128,the,O,DT
128,highest,B,JJS
128,rate,B,NN
128,of,I,IN
128,RN,I,NNP
128,.,O,.
129,OSA,B,NNP
129,confers,O,VBZ
129,a,O,DT
129,higher,B,JJR
129,risk,B,NN
129,of,I,IN
129,CAEs,I,NNP
129,independent,B,JJ
129,of,I,IN
129,BMI,B,NNP
129,and,O,CC
129,sedation,B,NN
129,type,I,NN
129,.,O,.
130,Female,B,NNP
130,gender,I,NN
130,and,O,CC
130,rapid,B,JJ
130,weight,I,JJ
130,loss,I,NN
130,were,O,VBD
130,major,B,JJ
130,risk,B,NN
130,factors,I,NNS
130,for,I,IN
130,postoperative,B,JJ
130,cholelithiasis,I,NN
130,.,O,.
131,DME,B,NNP
131,demonstrated,B,VBD
131,a,O,DT
131,convincing,B,NN
131,relationship,B,NN
131,between,O,IN
131,BCVA,B,NNP
131,and,O,CC
131,CRT,B,NNP
131,.,O,.
132,In,O,IN
132,the,B,DT
132,present,I,JJ
132,study,I,NN
132,",",O,","
132,large,B,JJ
132,tumour,I,NN
132,size,I,NN
132,and,O,CC
132,positive,B,JJ
132,or,I,CC
132,uncertain,I,JJ
132,margin,I,NN
132,status,I,NN
132,were,O,VBD
132,associated,B,VBN
132,with,I,IN
132,a,O,DT
132,higher,B,JJR
132,risk,B,NN
132,of,I,IN
132,death,I,NN
132,from,I,IN
132,breast,I,NN
132,cancer,I,NN
132,after,B,IN
132,treatment,I,NN
132,for,I,IN
132,primary,I,JJ
132,DCIS,I,NNP
132,.,O,.
133,In,B,IN
133,our,I,PRP$
133,sample,I,NN
133,of,I,IN
133,the,I,DT
133,general,I,JJ
133,population,I,NN
133,",",O,","
133,resistin,B,NN
133,was,O,VBD
133,inversely,B,RB
133,associated,B,VBN
133,with,I,IN
133,measures,B,NNS
133,and,I,CC
133,levels,I,NNS
133,of,I,IN
133,PA,I,NNP
133,and,O,CC
133,HDL,B,NNP
133,cholesterol,I,NN
133,.,O,.
134,Rates,B,NNS
134,of,I,IN
134,PTMS,I,NNP
134,were,O,VBD
134,comparable,B,JJ
134,between,O,IN
134,EVR,B,NNP
134,-,I,:
134,containing,I,NN
134,and,O,CC
134,TAC,B,NNP
134,control,I,NN
134,regimens,I,VBZ
134,.,O,.
135,The,B,DT
135,presence,I,NN
135,of,I,IN
135,PU,I,NNP
135,is,O,VBZ
135,also,O,RB
135,related,B,VBN
135,to,I,TO
135,adverse,B,JJ
135,outcomes,I,NNS
135,",",O,","
135,such,O,JJ
135,as,O,IN
135,MV,B,NNP
135,duration,I,NN
135,and,O,CC
135,ICU,B,NNP
135,and,O,CC
135,hospital,B,JJ
135,mortality,I,NN
135,.,O,.
136,High,B,JJ
136,concentration,B,NN
136,oxygen,I,NN
136,therapy,I,NN
136,sign+,B,NN
136,Ptco2,B,NNP
136,in,B,IN
136,morbidly,I,RB
136,obese,I,JJ
136,patients,I,NNS
136,.,O,.
137,Furthermore,O,RB
137,",",O,","
137,these,B,DT
137,findings,I,NNS
137,reveal,B,VBP
137,that,O,IN
137,the,O,DT
137,benefits,O,NNS
137,of,O,IN
137,physical,B,JJ
137,activity,I,NN
137,to,O,TO
137,improvements,B,NNS
137,in,I,IN
137,cognitive,B,JJ
137,function,I,NN
137,are,O,VBP
137,particularly,B,RB
137,evident,O,JJ
137,among,B,IN
137,children,I,NNS
137,who,I,WP
137,are,I,VBP
137,obese,I,JJ
137,.,O,.
138,Possibly,B,RB
138,the,B,DT
138,polyphenols,I,NNS
138,and,O,CC
138,DF,B,NNP
138,contributed,B,VBD
138,to,I,TO
138,the,B,DT
138,beneficial,I,JJ
138,effects,I,NNS
138,.,O,.
139,A,B,DT
139,structured,I,JJ
139,PA,I,NNP
139,program,I,NN
139,reduced,B,VBD
139,the,B,DT
139,risk,I,NN
139,of,I,IN
139,MMD,I,NNP
139,even,B,RB
139,in,I,IN
139,older,I,JJR
139,adults,I,NNS
139,with,I,IN
139,extreme,I,JJ
139,obesity,I,NN
139,.,O,.
140,Our,B,PRP$
140,study,I,NN
140,demonstrated,B,VBD
140,how,O,WRB
140,tested,B,JJ
140,SNPs,I,NNP
140,make,O,VBP
140,differential,B,JJ
140,contributions,B,NNS
140,to,I,TO
140,obesity,B,NN
140,and,O,CC
140,overweight,B,JJ
140,risk,I,NN
140,.,O,.
141,The,B,DT
141,present,I,JJ
141,meta,I,NN
141,-,I,:
141,analysis,I,NN
141,confirms,B,NNS
141,and,O,CC
141,reinforces,B,VBZ
141,the,I,DT
141,evidence,I,NN
141,of,I,IN
141,a,O,DT
141,diabetogenic,B,JJ
141,effect,B,NN
141,by,O,IN
141,statins,B,NNS
141,utilization,I,NN
141,.,O,.
142,The,B,DT
142,practice,I,NN
142,of,I,IN
142,sufficient,I,JJ
142,levels,I,NNS
142,of,I,IN
142,MVPA,I,NNP
142,was,O,VBD
142,a,O,DT
142,protective,B,JJ
142,factor,B,NN
142,against,I,IN
142,immunometabolic,B,JJ
142,disorders,I,NNS
142,in,B,IN
142,postmenopausal,I,JJ
142,women,I,NNS
142,.,O,.
143,Based,O,VBN
143,on,O,IN
143,the,B,DT
143,results,I,NNS
143,of,I,IN
143,this,I,DT
143,study,I,NN
143,",",O,","
143,health,B,NN
143,coaching,I,NN
143,improved,B,VBD
143,the,B,DT
143,QoL,I,NNP
143,of,I,IN
143,T2D,I,NNP
143,and,I,CC
143,CAD,I,NNP
143,patients,I,NNS
143,with,B,IN
143,moderate,I,JJ
143,costs,I,NNS
143,.,O,.
144,HbA1c,B,NNP
144,-,I,:
144,CV,I,NNP
144,improves,B,VBZ
144,3-year,B,JJ
144,prediction,B,NN
144,of,I,IN
144,new,B,JJ
144,-,I,:
144,onset,I,NN
144,albuminuria,I,NN
144,.,O,.
145,Moreover,O,RB
145,",",O,","
145,TT,B,NNP
145,genotype,I,NN
145,may,B,MD
145,reduce,B,VB
145,the,B,DT
145,risk,I,NN
145,of,I,IN
145,CAD,I,NNP
145,in,B,IN
145,diabetic,I,JJ
145,patients,I,NNS
145,.,O,.
146,Increasing,B,VBG
146,the,B,DT
146,adherence,I,NN
146,to,I,TO
146,healthy,I,JJ
146,lifestyle,I,JJ
146,behaviors,I,NNS
146,might,B,MD
146,strengthen,B,VB
146,and,O,CC
146,balance,B,VB
146,body,B,NN
146,constitution,I,NN
146,",",O,","
146,which,O,WDT
146,could,B,MD
146,improve,B,VB
146,supportive,B,JJ
146,care,I,NN
146,in,B,IN
146,breast,I,NN
146,cancer,I,NN
146,survivors,I,NNS
146,.,O,.
147,In,B,IN
147,long,I,JJ
147,-,I,:
147,term,I,NN
147,home,I,NN
147,PN,I,NNP
147,patients,I,NNS
147,",",O,","
147,higher,B,JJR
147,zinc,B,NN
147,and,O,CC
147,selenium,B,NN
147,doses,I,NNS
147,may,B,MD
147,be,O,VB
147,necessary,O,JJ
147,to,O,TO
147,maintain,B,VB
147,their,B,PRP$
147,normal,I,JJ
147,serum,I,NN
147,concentrations,I,NNS
147,.,O,.
148,The,B,DT
148,present,I,JJ
148,meta,I,NN
148,-,I,:
148,analysis,I,NN
148,suggests,B,VBZ
148,that,O,IN
148,insulin,B,NN
148,therapy,I,NN
148,may,B,MD
148,increase,B,VB
148,the,B,DT
148,risk,I,NN
148,of,I,IN
148,CRC,I,NNP
148,.,O,.
149,The,B,DT
149,retrobulbar,I,NN
149,arterial,I,JJ
149,circulation,I,NN
149,seems,B,VBZ
149,to,O,TO
149,be,O,VB
149,affected,B,VBN
149,in,O,IN
149,all,B,DT
149,diabetics,I,NNS
149,with,I,IN
149,DR,I,NNP
149,.,O,.
150,We,O,PRP
150,would,O,MD
150,postulate,B,VB
150,that,O,IN
150,SMS,B,NNP
150,could,B,MD
150,affect,B,VB
150,peoples,B,NNS
150,adherence,I,RB
150,to,I,TO
150,preventive,I,JJ
150,programs,I,NNS
150,.,O,.
151,In,O,IN
151,general,O,JJ
151,in,B,IN
151,Poland,I,NNP
151,",",O,","
151,the,B,DT
151,PCOS,I,NNP
151,phenotype,I,NN
151,is,O,VBZ
151,more,B,RBR
151,severe,I,JJ
151,in,O,IN
151,women,B,NNS
151,living,I,VBG
151,in,I,IN
151,rural,I,JJ
151,areas,I,NNS
151,.,O,.
152,Bariatric,B,NNP
152,surgery,I,NN
152,induced,B,VBD
152,the,B,DT
152,disappearance,I,NN
152,of,I,IN
152,NASH,I,NNP
152,from,B,IN
152,nearly,I,RB
152,85,I,CD
152,%,I,NN
152,of,I,IN
152,patients,I,NNS
152,and,O,CC
152,reduced,B,VBD
152,the,B,DT
152,pathologic,I,NN
152,features,I,NNS
152,of,I,IN
152,the,I,DT
152,disease,I,NN
152,after,B,IN
152,1,I,CD
152,year,I,NN
152,of,I,IN
152,follow,I,NN
152,-,I,:
152,up,I,RB
152,.,O,.
153,Reduction,B,NN
153,of,O,IN
153,CV,B,NNP
153,diseases,I,NNS
153,is,O,VBZ
153,mediated,B,VBN
153,by,O,IN
153,the,B,DT
153,pleiotropic,I,NN
153,effects,I,NNS
153,of,I,IN
153,weight,I,JJ
153,loss,I,NN
153,through,I,IN
153,surgery,I,NN
153,.,O,.
154,This,B,DT
154,evidence,I,NN
154,indicates,B,VBZ
154,that,O,IN
154,AVNFH,B,NNP
154,was,O,VBD
154,significantly,B,RB
154,associated,B,VBN
154,with,I,IN
154,blood,B,NN
154,lipid,I,JJ
154,abnormalities,I,NNS
154,in,B,IN
154,elderly,I,JJ
154,patients,I,NNS
154,with,B,IN
154,low,I,JJ
154,-,I,:
154,energy,I,NN
154,femoral,I,JJ
154,neck,I,NN
154,fractures,I,NNS
154,.,O,.
155,However,O,RB
155,",",O,","
155,stenting,B,VBG
155,is,O,VBZ
155,associated,B,VBN
155,with,I,IN
155,early,B,JJ
155,restenosis,I,NN
155,and,O,CC
155,recurrent,B,NN
155,symptoms,I,NNS
155,requiring,I,VBG
155,secondary,I,JJ
155,procedures,I,NNS
155,.,O,.
156,The,O,DT
156,effects,B,NNS
156,of,O,IN
156,TRT,B,NNP
156,on,O,IN
156,cardiovascular,B,JJ
156,risk,I,NN
156,markers,I,NNS
156,were,O,VBD
156,ambiguous,B,JJ
156,.,O,.
157,The,B,DT
157,prevalence,I,NN
157,of,I,IN
157,PEW,I,NNP
157,varied,B,VBD
157,depending,O,VBG
157,on,O,IN
157,the,B,DT
157,tool,I,NN
157,applied,I,VBD
158,Type,B,NN
158,of,I,IN
158,treatment,I,NN
158,had,O,VBD
158,little,B,JJ
158,impact,B,NN
158,on,I,IN
158,mortality,B,NN
158,",",O,","
158,morbidity,B,NN
158,or,O,CC
158,functional,B,JJ
158,outcome,I,NN
158,.,O,.
159,Success,B,NN
159,of,I,IN
159,dental,I,JJ
159,implant,I,NN
159,is,O,VBZ
159,significantly,B,RB
159,affected,B,VBN
159,by,O,IN
159,bruxism,B,NN
160,The,B,DT
160,pharmacokinetics,I,NNS
160,of,I,IN
160,ezetimibe,I,NNS
160,were,O,VBD
160,not,B,RB
160,affected,B,VBN
160,by,O,IN
160,coadministration,B,NN
160,with,I,IN
160,fluvastatin,I,NN
160,.,O,.
161,Changing,B,VBG
161,childrens,I,NNS
161,dairy,I,JJ
161,food,I,NN
161,choices,I,NNS
161,to,I,TO
161,reduced,I,VB
161,-,I,:
161,fat,I,JJ
161,varieties,I,NNS
161,did,O,VBD
161,not,B,RB
161,adversely,B,RB
161,affect,B,VBP
161,overall,B,JJ
161,food,I,NN
161,intake,I,NN
161,.,O,.
162,SLN,B,NNP
162,involvement,I,NN
162,did,O,VBD
162,not,B,RB
162,worsen,B,VB
162,the,B,DT
162,prognosis,I,NN
162,in,B,IN
162,our,I,PRP$
162,cohort,I,NN
162,.,O,.
163,Statins,B,NNS
163,equivalent,I,JJ
163,to,I,TO
163,or,I,CC
163,stronger,I,JJR
163,than,I,IN
163,atorvastatin,I,RB
163,20,I,CD
163,mg,I,NNS
163,are,O,VBP
163,more,B,RBR
163,effective,I,JJ
163,than,O,IN
163,lower,B,JJR
163,intensity,I,NN
163,statins,I,NNS
163,.,O,.
164,Coronary,B,JJ
164,artery,I,NN
164,disease,I,NN
164,negatively,B,RB
164,influences,B,VBZ
164,the,B,DT
164,cumulative,I,JJ
164,patency,I,NN
164,of,I,IN
164,vascular,I,JJ
164,access,I,NN
164,.,O,.
165,However,O,RB
165,",",O,","
165,use,B,NN
165,of,I,IN
165,metformin,I,NN
165,may,B,MD
165,reduce,B,VB
165,mortality,B,NN
165,from,I,IN
165,other,I,JJ
165,causes,I,NNS
165,.,O,.
166,Indoor,B,NNP
166,air,I,NN
166,pollution,I,NN
166,and,O,CC
166,delayed,B,JJ
166,measles,I,NNS
166,vaccination,I,NN
166,increase,B,NN
166,the,B,DT
166,risk,I,NN
166,for,I,IN
166,severe,I,JJ
166,pneumonia,I,NN
166,among,B,IN
166,children,I,NNS
166,aged,I,VBN
166,below,I,IN
166,five,I,CD
166,years,I,NNS
166,.,O,.
167,Clozapine,B,NNP
167,is,O,VBZ
167,of,B,IN
167,benefit,I,NN
167,in,O,IN
167,reducing,B,VBG
167,the,B,DT
167,clinical,I,JJ
167,severity,I,NN
167,of,I,IN
167,ASPD,I,NNP
168,These,B,DT
168,data,I,NNS
168,emphasize,B,VBP
168,the,O,DT
168,importance,O,NN
168,of,O,IN
168,radiotherapy,B,NN
168,techniques,I,NNS
168,that,O,WDT
168,limit,B,VBP
168,MCRD,B,NNP
168,during,B,IN
168,breast,I,NN
168,cancer,I,NN
168,treatment,I,NN
168,.,O,.
169,Whey,B,NNP
169,-,I,:
169,protein,I,NN
169,supplementation,I,NN
169,also,O,RB
169,lowered,B,VBD
169,24-h,B,JJ
169,ambulatory,I,NN
169,SBP,I,NNP
169,and,O,CC
169,DBP,B,NNP
170,Breast,B,NNP
170,reconstruction,I,NN
170,with,I,IN
170,implants,I,NNS
170,increased,B,VBN
170,patient,B,JJ
170,satisfaction,I,NN
170,with,I,IN
170,the,I,DT
170,surgical,I,JJ
170,outcome,I,NN
171,Mind,B,NNP
171,subtraction,I,NN
171,meditation,I,NN
171,may,B,MD
171,have,O,VB
171,positive,B,JJ
171,therapeutic,B,JJ
171,effects,B,NNS
171,among,B,IN
171,breast,I,JJ
171,cancer,I,NN
171,survivors,I,NNS
172,Age,B,NNP
172,",",O,","
172,female,B,JJ
172,sex,I,NN
172,",",O,","
172,BMI,B,NNP
172,",",O,","
172,non,B,SYM
172,-,I,:
172,HDL,I,NNP
172,cholesterol,I,NN
172,",",O,","
172,and,O,CC
172,polyps,B,NNS
172,are,O,VBP
172,independent,B,JJ
172,determinants,B,NNS
172,for,I,IN
172,gallstone,B,NN
172,formation,I,NN
172,.,O,.
173,The,B,DT
173,consumption,I,NN
173,of,I,IN
173,unhydrolyzed,I,JJ
173,milk,I,NN
173,proteins,I,NNS
173,(,O,(
173,56,O,CD
173,g,O,NN
173,/,O,NNP
173,d,O,NN
173,),O,)
173,for,O,IN
173,8,O,CD
173,wk,O,NNS
173,improved,B,VBN
173,vascular,B,JJ
173,reactivity,I,NN
173,",",O,","
173,biomarkers,B,NNS
173,of,I,IN
173,endothelial,I,JJ
173,function,I,NN
173,",",O,","
173,and,O,CC
173,lipid,B,JJ
173,risk,I,NN
173,factors,I,NNS
173,.,O,.
174,In,O,IN
174,this,B,DT
174,pilot,I,NN
174,study,I,NN
174,",",O,","
174,applying,B,VBG
174,TNP,I,NNP
174,to,I,TO
174,acute,I,VB
174,high,I,JJ
174,-,I,:
174,risk,I,NN
174,foot,I,NN
174,wounds,I,NNS
174,in,B,IN
174,patients,I,NNS
174,with,I,IN
174,diabetes,I,NNS
174,or,I,CC
174,end,I,VB
174,-,I,:
174,stage,I,NN
174,renal,I,JJ
174,failure,I,NN
174,improved,B,VBD
174,the,B,DT
174,wound,I,NN
174,healing,I,VBG
174,rate,I,NN
174,in,B,IN
174,reference,I,NN
174,to,I,TO
174,wound,I,VB
174,depth,I,NN
174,.,O,.
175,Routine,B,JJ
175,involvement,I,NN
175,of,I,IN
175,GMS,I,NNP
175,improved,B,JJ
175,glycemic,B,JJ
175,control,I,NN
175,in,B,IN
175,patients,I,NNS
175,undergoing,I,VBG
175,LER,I,NNP
176,Both,O,DT
176,a,B,DT
176,low,I,JJ
176,-,I,:
176,fat,I,NN
176,vegan,I,JJ
176,diet,I,JJ
176,and,O,CC
176,a,B,DT
176,diet,I,JJ
176,based,I,VBN
176,on,I,IN
176,ADA,I,NNP
176,guidelines,I,NNS
176,improved,B,VBN
176,glycemic,B,JJ
176,and,I,CC
176,lipid,I,JJ
176,control,I,NN
176,in,B,IN
176,type,I,NN
176,2,I,CD
176,diabetic,I,JJ
176,patients,I,NNS
176,.,O,.
177,HIV,B,NNP
177,infection,I,NN
177,contributed,B,VBD
177,to,I,TO
177,decreased,B,JJ
177,TC,B,NNP
177,",",O,","
177,LDL,B,NNP
177,-,I,:
177,C,I,NNP
177,and,O,CC
177,HDL,B,NNP
177,-,I,:
177,C.,I,NNP
178,Weight,B,NNP
178,reduction,B,NN
178,is,O,VBZ
178,an,O,DT
178,effective,B,JJ
178,treatment,B,NN
178,for,I,IN
178,overweight,B,NN
178,and,I,CC
178,obese,I,JJ
178,women,I,NNS
178,with,I,IN
178,UI,I,NNP
178,.,O,.
179,In,B,IN
179,patients,I,NNS
179,with,I,IN
179,active,I,JJ
179,ophthalmopathy,I,NN
179,",",O,","
179,teprotumumab,B,NN
179,was,O,VBD
179,more,B,RBR
179,effective,I,JJ
179,than,O,IN
179,placebo,B,NN
179,in,O,IN
179,reducing,B,VBG
179,proptosis,B,NN
179,and,O,CC
179,the,B,DT
179,Clinical,I,JJ
179,Activity,I,NNP
179,Score,I,NNP
179,.,O,.
180,Each,B,DT
180,1,I,CD
180,mg,I,JJ
180,dL(-1,I,NN
180,),I,)
180,increase,B,NN
180,in,I,IN
180,HDL,B,NNP
180,decreased,B,VBD
180,the,I,DT
180,odds,I,NNS
180,of,I,IN
180,severe,B,JJ
180,sepsis,I,NN
180,by,B,IN
180,3,I,CD
180,%,I,NN
180,during,B,IN
180,hospitalization,I,NN
180,.,O,.
181,Stosstherapy,B,NNP
181,is,O,VBZ
181,a,O,DT
181,safe,B,JJ
181,",",O,","
181,cheap,B,JJ
181,and,O,CC
181,effective,B,JJ
181,method,B,NN
181,of,O,IN
181,treating,B,VBG
181,nutritional,B,JJ
181,rickets,I,NNS
182,This,B,DT
182,study,I,NN
182,found,B,VBD
182,that,O,IN
182,27OHC,B,CD
182,does,O,VBZ
182,not,B,RB
182,independently,B,RB
182,increase,B,VB
182,the,B,DT
182,risk,I,NN
182,of,I,IN
182,CHD,I,NNP
182,",",O,","
182,does,O,VBZ
182,not,B,RB
182,modify,B,VB
182,the,O,DT
182,increased,B,VBN
182,risk,B,NN
182,of,I,IN
182,CHD,I,NNP
182,resulting,O,VBG
182,from,O,IN
182,MHT,B,NNP
182,",",O,","
182,and,O,CC
182,does,O,VBZ
182,not,B,RB
182,mediate,B,VB
182,the,O,DT
182,interaction,B,NN
182,of,O,IN
182,LDLC,B,NNP
182,with,O,IN
182,MHT,B,NNP
182,.,O,.
183,This,B,DT
183,effect,I,NN
183,is,O,VBZ
183,independent,B,JJ
183,of,I,IN
183,the,B,DT
183,presence,I,NN
183,of,I,IN
183,coronary,I,JJ
183,artery,I,NN
183,disease,I,NN
183,and,O,CC
183,also,O,RB
183,systemic,B,JJ
183,inflammation,I,NN
183,.,O,.
184,Lower,B,JJR
184,plasma,B,NN
184,concentration,I,NN
184,of,I,IN
184,high,I,JJ
184,-,I,:
184,density,I,NN
184,lipoprotein,I,NN
184,cholesterol,I,NN
184,",",O,","
184,total,B,JJ
184,antioxidant,I,JJ
184,capacity,I,NN
184,",",O,","
184,and,O,CC
184,ÃÂ±-tocopherol,B,NN
184,levels,I,NNS
184,",",O,","
184,and,O,CC
184,a,B,DT
184,dietary,I,JJ
184,pattern,I,NN
184,that,I,WDT
184,is,I,VBZ
184,low,I,JJ
184,in,I,IN
184,fish,I,NN
184,and,I,CC
184,high,I,JJ
184,in,I,IN
184,red,I,JJ
184,meat,I,NN
184,might,B,MD
184,contribute,B,VB
184,to,I,TO
184,the,B,DT
184,cognition,I,NN
184,impairment,I,NN
184,in,B,IN
184,older,I,JJR
184,Chinese,I,JJ
184,adults,I,NNS
184,.,O,.
185,In,B,IN
185,patients,I,NNS
185,with,I,IN
185,HIV,I,NNP
185,",",O,","
185,pitavastatin,B,VBZ
185,4\u200amg,I,CD
185,/,I,NN
185,dl,I,NN
185,lowered,B,VBD
185,both,B,DT
185,RLP,I,NNP
185,-,I,:
185,C,I,NN
185,and,O,CC
185,established,B,VBN
185,apolipoprotein,I,NN
185,and,I,CC
185,lipid,I,JJ
185,risk,I,NN
185,ratios,I,NNS
185,more,B,RBR
185,so,O,RB
185,than,O,IN
185,pravastatin,B,NN
185,40\u200amg,I,CD
185,/,I,NN
185,dl,I,NN
185,.,O,.
186,Dietary,B,NNP
186,intervention,I,NN
186,was,O,VBD
186,able,B,JJ
186,to,O,TO
186,maintain,B,VB
186,body,B,NN
186,weight,I,NN
186,and,O,CC
186,food,B,NN
186,intake,I,NN
186,.,O,.
187,Results,B,NNS
187,are,O,VBP
187,encouraging,O,JJ
187,and,O,CC
187,demonstrate,B,VB
187,that,O,DT
187,exercise,B,NN
187,was,O,VBD
187,popular,O,JJ
187,and,O,CC
187,conveyed,B,JJ
187,benefit,B,NN
187,to,I,TO
187,participants,I,NNS
187,.,O,.
188,Interventions,B,NNS
188,targeting,I,VBG
188,replacing,I,VBG
188,sedentary,I,JJ
188,behavior,I,NN
188,with,I,IN
188,PA,I,NNP
188,may,B,MD
188,improve,B,VB
188,metabolic,B,NN
188,risk,I,NN
189,Patients,B,NNS
189,experience,I,VBP
189,WL,I,NNP
189,following,I,VBG
189,RC,I,NNP
189,",",O,","
189,which,O,WDT
189,may,B,MD
189,be,O,VB
189,indicative,B,JJ
189,of,I,IN
189,malnutrition,B,NN
189,.,O,.
190,Treatment,B,NN
190,with,I,IN
190,tocilizumab,I,NN
190,and,I,CC
190,rituximab,I,NN
190,reduces,B,NNS
190,PWV,B,NNP
190,",",O,","
190,a,O,DT
190,marker,B,NN
190,of,I,IN
190,CVD,B,NNP
190,risk,I,NN
190,",",O,","
190,in,B,IN
190,patients,I,NNS
190,with,I,IN
190,RA,I,NNP
190,.,O,.
191,Central,B,JJ
191,adiposity,I,NN
191,may,B,MD
191,have,O,VB
191,a,O,DT
191,stronger,B,JJR
191,effect,B,NN
191,on,O,IN
191,stroke,B,NN
191,risk,I,NN
192,The,B,DT
192,result,I,NN
192,of,I,IN
192,this,I,DT
192,study,I,NN
192,suggests,B,VBZ
192,that,O,IN
192,30,B,CD
192,minutes,I,NNS
192,of,I,IN
192,needling,I,VBG
192,at,I,IN
192,CV-12,I,NNP
192,might,B,MD
192,be,O,VB
192,useful,B,JJ
192,in,O,IN
192,reducing,B,VBG
192,blood,B,NN
192,glucose,I,JJ
192,level,I,NN
192,in,B,IN
192,patients,I,NNS
192,with,I,IN
192,T2DM,I,NNP
192,.,O,.
193,Laparoscopic,B,NNP
193,-,I,:
193,assisted,I,VBD
193,vaginal,I,JJ
193,hysterectomy,I,NN
193,appears,B,VBZ
193,to,O,TO
193,confer,B,VB
193,no,B,DT
193,specific,I,JJ
193,advantage,I,NN
193,over,O,IN
193,the,B,DT
193,vaginal,I,JJ
193,or,O,CC
193,laparoscopic,B,JJ
193,approaches,I,NNS
194,SPA,B,NN
194,can,O,MD
194,be,O,VB
194,considered,B,VBN
194,a,O,DT
194,prognostic,B,JJ
194,factor,I,NN
194,in,I,IN
194,postoperative,B,JJ
194,morbimortality,I,NN
194,for,B,IN
194,patients,I,NNS
194,with,I,IN
194,cancer,I,NN
194,.,O,.
195,A,O,DT
195,model,O,NN
195,using,O,VBG
195,routinely,B,RB
195,available,I,JJ
195,clinical,I,JJ
195,measurements,I,NNS
195,can,O,MD
195,accurately,B,RB
195,predict,B,VB
195,CKD,B,NNP
195,progression,I,NN
195,in,I,IN
195,T2DM,I,NNP
195,.,O,.
196,Low,B,JJ
196,educational,B,JJ
196,level,I,NN
196,is,O,VBZ
196,confirmed,B,VBN
196,as,I,IN
196,an,B,DT
196,independent,I,JJ
196,risk,I,NN
196,factor,I,NN
196,",",O,","
196,but,O,CC
196,belonging,B,VBG
196,to,I,TO
196,a,I,DT
196,family,I,NN
196,that,I,WDT
196,receives,I,VBZ
196,government,I,NN
196,assistance,I,NN
196,can,O,MD
196,be,O,VB
196,interpreted,B,VBN
196,as,I,IN
196,a,O,DT
196,social,B,JJ
196,marker,I,NN
196,of,I,IN
196,families,B,NNS
196,and/or,I,VBP
196,areas,I,NNS
196,lacking,I,VBG
196,of,I,IN
196,government,I,NN
196,intervention,I,NN
196,to,O,TO
196,increase,B,VB
196,access,B,NN
196,to,I,TO
196,breast,I,VB
196,cancer,I,NN
196,control,I,NN
196,programs,I,NNS
196,.,O,.
197,Orally,B,RB
197,administered,I,VBN
197,nutritional,I,JJ
197,supplements,I,NNS
197,can,O,MD
197,help,B,VB
197,to,O,TO
197,prevent,B,VB
197,the,B,DT
197,onset,I,NN
197,of,I,IN
197,sarcopenic,I,JJ
197,obesity,I,NN
197,.,O,.
198,National,B,NNP
198,health,I,NN
198,insurance,I,NN
198,can,O,MD
198,increase,B,VB
198,access,B,NN
198,to,I,TO
198,health,I,NN
198,care,I,NN
198,.,O,.
199,Based,O,VBN
199,on,O,IN
199,these,B,DT
199,results,I,NNS
199,",",O,","
199,cumulative,B,JJ
199,comorbidity,I,NN
199,can,O,MD
199,help,B,VB
199,explain,B,VB
199,survival,B,JJ
199,variability,I,NN
199,and,O,CC
199,improve,B,VB
199,prognostic,B,JJ
199,accuracy,I,NN
199,.,O,.
200,Prompt,B,JJ
200,diagnosis,I,NN
200,and,O,CC
200,anticoagulation,B,NN
200,therapy,I,NN
200,led,B,VBD
200,to,I,TO
200,favorable,B,JJ
200,outcomes,I,NNS
200,in,B,IN
200,most,I,JJS
200,cases,I,NNS
201,Greater,B,NNP
201,encouragement,B,NN
201,of,I,IN
201,these,I,DT
201,skills,I,NNS
201,may,B,MD
201,help,B,VB
201,reduce,B,VB
201,reliance,B,NN
201,on,I,IN
201,UPF,I,NNP
202,Gender,B,NNP
202,(,O,(
202,male,B,NN
202,),O,)
202,",",O,","
202,duration,B,NN
202,of,I,IN
202,diabetes,I,NNS
202,",",O,","
202,and,O,CC
202,diabetic,B,JJ
202,retinopathy,I,NN
202,may,B,MD
202,serve,O,VB
202,as,O,IN
202,indicators,B,NNS
202,of,I,IN
202,DN,B,NNP
202,.,O,.
203,Elevated,B,VBN
203,weight,B,NN
203,and,O,CC
203,obesity,B,NN
203,may,B,MD
203,cause,B,VB
203,these,O,DT
203,children,O,NNS
203,significant,O,JJ
203,additional,B,JJ
203,health,I,NN
203,burdens,I,NNS
203,.,O,.
204,CTRP3,B,NNP
204,may,B,MD
204,serve,O,VB
204,as,O,IN
204,a,O,DT
204,novel,B,JJ
204,biomarker,B,NN
204,for,I,IN
204,DR,B,NNP
204,severity,I,NN
204,.,O,.
205,The,O,DT
205,effect,B,NN
205,of,O,IN
205,fasting,B,VBG
205,on,O,IN
205,glucose,B,NN
205,was,O,VBD
205,small,B,JJ
205,and,O,CC
205,may,O,MD
205,not,O,RB
205,be,O,VB
205,clinically,O,RB
205,important,O,JJ
205,.,O,.
206,Severe,B,JJ
206,childhood,I,NN
206,diarrhea,I,NN
206,is,O,VBZ
206,mostly,B,RB
206,caused,B,VBN
206,by,O,IN
206,rotavirus,B,JJ
206,infection,I,NN
206,.,O,.
207,The,B,DT
207,use,I,NN
207,of,I,IN
207,a,I,DT
207,water,I,NN
207,-,I,:
207,based,I,VBN
207,HS,I,NNP
207,did,O,VBD
207,not,B,RB
207,have,O,VB
207,an,O,DT
207,additive,B,JJ
207,effect,B,NN
207,.,O,.
208,Steroid,B,NNP
208,therapy,I,NN
208,did,O,VBD
208,not,B,RB
208,influence,B,VB
208,mortality,B,NN
208,",",O,","
208,but,O,CC
208,increased,B,VBD
208,the,B,DT
208,risk,I,NN
208,of,I,IN
208,superinfection,I,NN
208,.,O,.
209,ARFI,B,NNP
209,elastography,I,NN
209,shows,O,VBZ
209,excellent,B,JJ
209,correlation,B,NN
209,with,I,IN
209,AST,B,NNP
209,/,I,NNP
209,ALT,I,NNP
209,ratios,I,NNS
209,in,B,IN
209,obese,I,JJ
209,children,I,NNS
209,and,O,CC
209,may,B,MD
209,be,O,VB
209,used,O,VBN
209,as,O,IN
209,a,O,DT
209,noninvasive,O,JJ
209,tool,O,NN
209,to,O,TO
209,detect,B,VB
209,nonalcoholic,B,JJ
209,fatty,I,RB
209,liver,I,JJ
209,disease,I,NN
209,(,O,(
209,NAFLD,B,NNP
209,),O,)
209,and,O,CC
209,associated,B,VBN
209,hepatic,B,JJ
209,changes,I,NNS
209,",",O,","
209,especially,B,RB
209,in,I,IN
209,pediatric,I,JJ
209,patients,I,NNS
209,",",O,","
209,for,B,IN
209,whom,I,WP
209,liver,I,NN
209,biopsy,I,NN
209,is,I,VBZ
209,not,I,RB
209,always,I,RB
209,feasible,I,JJ
209,.,O,.
210,Metformin,B,NNP
210,may,B,MD
210,protect,B,VB
210,against,I,IN
210,coronary,B,JJ
210,atherosclerosis,I,NN
210,in,B,IN
210,prediabetes,I,NNS
210,and,B,CC
210,early,I,JJ
210,diabetes,I,NNS
210,mellitus,I,VBP
210,among,B,IN
210,men,I,NNS
210,.,O,.
211,The,O,DT
211,association,B,NN
211,of,O,IN
211,testosterone,B,NN
211,deficiency,I,NN
211,with,O,IN
211,frequency,B,NN
211,and,I,CC
211,severity,I,NN
211,of,I,IN
211,lower,I,JJR
211,urinary,I,JJ
211,tract,I,NN
211,symptoms,I,NNS
211,",",O,","
211,partially,B,RB
211,related,B,VBN
211,with,I,IN
211,benign,B,JJ
211,prostatic,I,JJ
211,hyperplasia,I,NN
211,and,O,CC
211,clinically,B,RB
211,defined,I,VBD
211,detrusor,I,NN
211,cistopathy,I,NN
211,",",O,","
211,has,O,VBZ
211,been,O,VBN
211,proven,B,VBN
211,.,O,.
212,Clusters,B,NNS
212,of,I,IN
212,risk,I,NN
212,factors,I,NNS
212,relate,B,VBP
212,to,I,TO
212,increased,B,JJ
212,common,B,JJ
212,CIMT,I,NNP
212,in,O,IN
212,a,O,DT
212,graded,B,JJ
212,manner,O,NN
212,",",O,","
212,similar,B,JJ
212,in,I,IN
212,men,I,NNS
212,",",I,","
212,women,I,NNS
212,and,I,CC
212,across,I,IN
212,race,I,NN
212,-,I,:
212,ethnic,I,JJ
212,groups,I,NNS
212,.,O,.
213,The,B,DT
213,diagnosis,I,NN
213,of,I,IN
213,biceps,I,NNS
213,tendinitis,I,NN
213,(,O,(
213,OR,O,NNP
213,",",O,","
213,3.5,O,CD
213,),O,)
213,or,O,CC
213,long,B,JJ
213,head,I,NN
213,of,I,IN
213,the,I,DT
213,biceps,I,NNS
213,tearing,I,VBG
213,(,O,(
213,OR,O,NNP
213,",",O,","
213,5.1,O,CD
213,),O,)
213,at,B,IN
213,or,I,CC
213,before,I,IN
213,the,I,DT
213,time,I,NN
213,of,I,IN
213,surgery,I,NN
213,was,O,VBD
213,an,O,DT
213,especially,B,RB
213,significant,B,JJ
213,risk,B,NN
213,factor,I,NN
213,for,I,IN
213,revision,B,NN
213,surgery,I,NN
213,.,O,.
214,Triglyceride,B,NNP
214,was,O,VBD
214,highly,B,RB
214,associated,B,VBN
214,with,I,IN
214,suicidality,B,NN
214,in,B,IN
214,younger,I,JJR
214,and,I,CC
214,middle,I,VB
214,-,I,:
214,aged,I,VBN
214,adults,I,NNS
214,",",O,","
214,but,O,CC
214,not,B,RB
214,in,I,IN
214,elderly,I,JJ
214,adults,I,NNS
214,.,O,.
215,Risk,B,NN
215,of,I,IN
215,caesarean,I,JJ
215,delivery,I,NN
215,for,I,IN
215,unengaged,I,JJ
215,fetal,I,JJ
215,head,I,NN
215,beyond,I,IN
215,3hours,I,CD
215,of,I,IN
215,passive,I,JJ
215,second,I,JJ
215,stage,I,NN
215,of,I,IN
215,labor,I,NN
215,is,O,VBZ
215,associated,B,VBN
215,with,I,IN
215,maternal,B,JJ
215,",",O,","
215,fetal,B,JJ
215,and,O,CC
215,obstetrical,B,JJ
215,factors,I,NNS
215,.,O,.
216,Neuropathy,B,JJ
216,appears,B,VBZ
216,to,O,TO
216,be,O,VB
216,associated,B,VBN
216,with,I,IN
216,the,B,DT
216,length,I,NN
216,of,I,IN
216,exposure,I,NN
216,to,I,TO
216,new,I,JJ
216,AEDs,I,NNP
216,.,O,.
217,Nutrition,B,NN
217,status,I,NN
217,was,O,VBD
217,associated,B,VBN
217,with,I,IN
217,age,B,NN
217,",",O,","
217,nutrition,B,NN
217,support,I,NN
217,",",O,","
217,and,O,CC
217,food,B,NN
217,intake,I,NN
217,",",O,","
217,which,O,WDT
217,was,O,VBD
217,closely,B,RB
217,related,B,JJ
217,to,I,TO
217,patients,B,NNS
217,clinical,I,JJ
217,outcome,I,NN
217,",",O,","
217,such,O,JJ
217,as,O,IN
217,prolonged,B,JJ
217,hospital,I,NN
217,stays,I,NNS
217,as,O,IN
217,confirmed,B,VBN
217,in,O,IN
217,this,B,DT
217,study,I,NN
217,.,O,.
218,Among,B,IN
218,patients,I,NNS
218,with,I,IN
218,DFU,I,NNP
218,",",O,","
218,the,B,DT
218,WIfI,I,NNP
218,classification,I,NN
218,system,I,NN
218,correlated,B,VBN
218,well,I,RB
218,with,I,IN
218,wound,B,NN
218,healing,I,VBG
218,but,O,CC
218,was,O,VBD
218,not,B,RB
218,associated,B,VBN
218,with,I,IN
218,risk,B,NN
218,of,I,IN
218,major,I,JJ
218,amputation,I,NN
218,at,B,IN
218,1\\xa0year,I,CD
218,.,O,.
219,Multiple,B,NNP
219,HDL,I,NNP
219,proteins,I,NNS
219,",",O,","
219,not,B,RB
219,limited,I,VBN
219,to,I,TO
219,apoA1,I,VB
219,",",O,","
219,showed,O,VBD
219,a,O,DT
219,correlation,B,NN
219,with,I,IN
219,HDL,B,NNP
219,functions,I,NNS
219,.,O,.
220,Irrespective,B,NNP
220,of,I,IN
220,the,I,DT
220,strategy,I,NN
220,",",O,","
220,increasing,B,VBG
220,from,B,IN
220,1,I,CD
220,to,I,TO
220,2,I,CD
220,SMBG,B,NNP
220,tests,I,NNS
220,/,I,VBD
220,day,I,NN
220,was,O,VBD
220,associated,B,VBN
220,with,I,IN
220,HbA1c,B,NNP
220,reduction,B,NN
220,in,B,IN
220,both,I,DT
220,groups,I,NNS
220,",",O,","
220,without,B,IN
220,pharmacologic,I,JJ
220,interventions,I,NNS
220,.,O,.
221,This,B,DT
221,study,I,NN
221,demonstrates,B,VBZ
221,that,O,IN
221,hypercholesterolemia,B,NN
221,is,O,VBZ
221,associated,B,VBN
221,with,I,IN
221,NAION,B,NNP
221,in,B,IN
221,younger,I,JJR
221,patients,I,NNS
221,.,O,.
222,Antidepressive,B,JJ
222,drug,I,NN
222,treatment,I,NN
222,was,O,VBD
222,not,B,RB
222,associated,B,VBN
222,with,I,IN
222,RLS,B,NNP
222,.,O,.
223,Hypercoagulability,B,NNP
223,also,O,RB
223,correlated,B,VBD
223,with,I,IN
223,inflammatory,B,JJ
223,markers,I,NNS
223,.,O,.
224,Cholesterol,B,NNP
224,",",O,","
224,LDL,B,NNP
224,",",O,","
224,or,O,CC
224,HDL,B,NNP
224,were,O,VBD
224,not,B,RB
224,associated,B,VBN
224,with,I,IN
224,recurrence,B,NN
224,risk,I,NN
224,among,B,IN
224,all,I,DT
224,men,I,NNS
224,.,O,.
225,CEC,B,NNP
225,is,O,VBZ
225,independently,B,RB
225,associated,B,VBN
225,with,I,IN
225,carotid,B,NN
225,plaque,I,NN
225,in,B,IN
225,patients,I,NNS
225,with,I,IN
225,RA,I,NNP
225,.,O,.
226,We,O,PRP
226,describe,B,VBP
226,a,B,DT
226,gene,I,NN
226,signature,I,NN
226,associated,B,VBN
226,with,I,IN
226,immune,B,JJ
226,function,I,NN
226,and,O,CC
226,favorable,B,JJ
226,outcome,B,NN
226,in,I,IN
226,basal,I,JJ
226,-,I,:
226,like,I,IN
226,breast,I,NN
226,cancer,I,NN
226,.,O,.
227,Most,O,JJS
227,POPs,B,NNS
227,were,O,VBD
227,positively,B,RB
227,but,O,CC
227,not,B,RB
227,significantly,B,RB
227,associated,B,VBN
227,with,I,IN
227,incident,B,NN
227,diabetes,I,NNS
227,.,O,.
228,BCPS,B,NNP
228,in,I,IN
228,three,I,CD
228,or,I,CC
228,more,I,JJR
228,anatomical,I,JJ
228,areas,I,NNS
228,following,I,VBG
228,MWL,I,NNP
228,is,O,VBZ
228,associated,B,VBN
228,with,I,IN
228,a,B,DT
228,long,I,JJ
228,-,I,:
228,term,I,NN
228,weight,I,JJ
228,loss,I,NN
228,following,I,VBG
228,BCPS,I,NNP
228,.,O,.
229,GDM,B,NNP
229,is,O,VBZ
229,associated,B,VBN
229,with,I,IN
229,lower,B,JJR
229,cord,B,NN
229,blood,I,NN
229,apelin,I,NN
229,levels,I,NNS
229,than,O,IN
229,control,B,NN
229,subjects,I,NNS
229,.,O,.
230,Specifically,O,RB
230,",",O,","
230,CT,B,NNP
230,heterozygote,I,NN
230,seems,B,VBZ
230,to,O,TO
230,be,O,VB
230,associated,B,VBN
230,with,I,IN
230,a,O,DT
230,lower,B,JJR
230,risk,B,NN
230,of,I,IN
230,T2DM,I,NNP
230,than,O,IN
230,CC,B,NNP
230,or,O,CC
230,TT,B,NNP
230,genotype,I,NN
230,",",O,","
230,especially,B,RB
230,in,I,IN
230,male,I,JJ
230,older,I,JJR
230,adults,I,NNS
230,.,O,.
231,Surgical,B,JJ
231,weight,I,NN
231,loss,I,NN
231,resulted,B,VBD
231,in,I,IN
231,the,O,DT
231,significant,B,JJ
231,improvement,B,NN
231,of,O,IN
231,OSA,B,NNP
231,associated,B,VBD
231,with,I,IN
231,obesity,B,NN
231,.,O,.
232,Analyses,B,NNS
232,by,I,IN
232,time,I,NN
232,to,I,TO
232,diagnosis,I,VB
232,indicated,B,JJ
232,that,O,IN
232,citrulline,B,NN
232,may,B,MD
232,be,O,VB
232,a,O,DT
232,marker,B,NN
232,of,I,IN
232,subclinical,B,JJ
232,prostate,I,NN
232,cancer,I,NN
232,",",O,","
232,while,O,IN
232,other,B,JJ
232,metabolites,I,NNS
232,might,B,MD
232,be,O,VB
232,related,B,VBN
232,to,I,TO
232,aetiology,B,NN
232,.,O,.
233,Treatment,B,NN
233,with,I,IN
233,exenatide,I,JJ
233,BID,I,NNP
233,resulted,B,VBD
233,in,I,IN
233,stable,B,JJ
233,weight,B,NN
233,but,O,CC
233,more,B,JJR
233,gastrointestinal,B,JJ
233,adverse,I,JJ
233,events,I,NNS
233,.,O,.
234,Treatment,B,NN
234,with,I,IN
234,insulin,I,JJ
234,lispro,I,NN
234,resulted,B,VBD
234,in,I,IN
234,weight,B,JJ
234,gain,I,NN
234,and,O,CC
234,an,O,DT
234,increased,B,VBN
234,risk,B,NN
234,of,I,IN
234,hypoglycemia,I,NN
234,.,O,.
235,Ten,B,CD
235,years,I,NNS
235,of,I,IN
235,behavioral,I,JJ
235,weight,I,JJ
235,loss,I,NN
235,intervention,I,NN
235,did,O,VBD
235,not,B,RB
235,result,B,VB
235,in,I,IN
235,an,O,DT
235,overall,B,JJ
235,difference,B,NN
235,in,I,IN
235,the,B,DT
235,prevalence,I,NN
235,of,I,IN
235,cognitive,I,JJ
235,impairment,I,NN
235,among,B,IN
235,overweight,I,JJ
235,or,I,CC
235,obese,I,JJ
235,adults,I,NNS
235,with,B,IN
235,type,I,JJ
235,2,I,CD
235,diabetes,I,NNS
235,.,O,.
236,The,B,DT
236,distribution,I,NN
236,of,I,IN
236,high,I,JJ
236,blood,I,NN
236,pressure,I,NN
236,subtypes,I,VBZ
236,in,O,IN
236,boys,B,NNS
236,differed,B,VBN
236,from,O,IN
236,those,O,DT
236,in,O,IN
236,girls,B,NNS
236,",",O,","
236,and,O,CC
236,boys,B,VBZ
236,with,I,IN
236,adiposity,I,NN
236,showed,B,VBD
236,a,O,DT
236,higher,B,JJR
236,risk,B,NN
236,of,I,IN
236,high,I,JJ
236,blood,I,NN
236,pressure,I,NN
236,than,O,IN
236,their,B,PRP$
236,female,I,JJ
236,counterpart,I,NN
236,.,O,.
237,Chemerin,B,NNP
237,showed,B,VBD
237,positive,B,JJ
237,correlations,B,NNS
237,with,I,IN
237,potent,B,JJ
237,health,I,NN
237,threatening,I,VBG
237,components,I,NNS
237,of,I,IN
237,lipid,I,JJ
237,profile,I,NN
237,including,O,VBG
237,triglyceride,B,NN
237,and,O,CC
237,cholesterol,B,NN
237,levels,I,NNS
237,in,I,IN
237,adolescents,I,NNS
237,.,O,.
238,ApoD,B,NNP
238,expression,I,NN
238,is,O,VBZ
238,likely,B,JJ
238,not,B,RB
238,a,O,DT
238,predictor,B,NN
238,of,I,IN
238,recurrence,B,NN
238,in,B,IN
238,tamoxifen,I,JJ
238,-,I,:
238,treated,I,JJ
238,patients,I,NNS
238,.,O,.
239,BCS,B,NNP
239,who,I,WP
239,adopted,I,VBD
239,several,I,JJ
239,healthy,I,JJ
239,behaviors,I,NNS
239,simultaneously,B,RB
239,had,O,VBD
239,better,B,RBR
239,HRQOL,B,NNP
239,than,O,IN
239,one,B,CD
239,healthy,I,JJ
239,behavior,I,NN
239,alone,I,RB
239,.,O,.
240,The,B,DT
240,relative,I,JJ
240,risk,I,NN
240,of,I,IN
240,HFpEF,I,NNP
240,sign+,B,NN
240,with,I,IN
240,increasing,B,VBG
240,cardiac,B,JJ
240,radiation,I,NN
240,exposure,I,NN
240,during,B,IN
240,contemporary,I,JJ
240,conformal,I,JJ
240,breast,I,NN
240,cancer,I,NN
240,radiotherapy,I,NN
240,.,O,.
241,The,B,DT
241,findings,I,NNS
241,of,I,IN
241,this,I,DT
241,study,I,NN
241,show,B,NN
241,that,O,IN
241,the,B,DT
241,optimal,I,JJ
241,cut,I,NN
241,-,I,:
241,off,I,IN
241,value,I,NN
241,for,I,IN
241,the,I,DT
241,PNI,I,NNP
241,for,I,IN
241,prognosis,I,NN
241,differs,B,NNS
241,among,O,IN
241,the,B,DT
241,TNM,I,NNP
241,stages,I,NNS
241,and,O,CC
241,that,O,IN
241,the,B,DT
241,preoperative,I,JJ
241,PNI,I,NNP
241,is,O,VBZ
241,a,O,DT
241,favorable,B,JJ
241,prognostic,B,JJ
241,factor,I,NN
241,for,I,IN
241,stage,B,NN
241,I,I,PRP
241,HCC,I,NNP
241,.,O,.
242,Nonetheless,O,RB
242,",",O,","
242,the,B,DT
242,level,I,NN
242,of,I,IN
242,HDLc,I,NNP
242,was,O,VBD
242,negatively,B,RB
242,associated,B,VBN
242,with,I,IN
242,the,B,DT
242,level,I,NN
242,of,I,IN
242,the,I,DT
242,inflammatory,I,JJ
242,marker,I,NN
242,MRP8/14,I,NNP
242,",",O,","
242,which,O,WDT
242,is,O,VBZ
242,in,O,IN
242,accordance,O,NN
242,with,O,IN
242,the,O,DT
242,concept,O,NN
242,of,O,IN
242,inflammation,B,NN
242,as,O,IN
242,an,O,DT
242,important,B,JJ
242,driver,B,NN
242,for,I,IN
242,premature,B,NN
242,development,I,NN
242,of,I,IN
242,atherosclerosis,I,NN
242,in,I,IN
242,JIA,I,NNP
242,.,O,.
243,There,O,EX
243,was,O,VBD
243,no,B,DT
243,difference,B,NN
243,in,I,IN
243,MHRs,B,NNP
243,between,O,IN
243,study,B,NN
243,and,O,CC
243,control,B,NN
243,groups,I,NNS
243,.,O,.
244,Both,O,DT
244,serum,B,JJ
244,UA,I,NNP
244,and,O,CC
244,lactate,B,NN
244,were,O,VBD
244,positively,B,RB
244,correlated,B,VBN
244,with,I,IN
244,the,B,DT
244,degree,I,NN
244,of,I,IN
244,hypoxia,I,NN
244,in,B,IN
244,OSAS,I,NNP
244,.,O,.
245,A,O,DT
245,minor,B,NN
245,increased,B,VBN
245,risk,B,NN
245,of,I,IN
245,breast,I,NN
245,cancer,I,NN
245,was,O,VBD
245,found,O,VBN
245,in,O,IN
245,women,B,NNS
245,with,I,IN
245,a,I,DT
245,history,I,NN
245,of,I,IN
245,uterine,I,JJ
245,myoma,I,NN
245,.,O,.
246,Daily,B,JJ
246,glucose,I,JJ
246,fluctuation,I,NN
246,may,B,MD
246,have,O,VB
246,an,O,DT
246,effect,B,NN
246,on,O,IN
246,coronary,B,JJ
246,plaque,I,NN
246,vulnerability,I,NN
246,in,B,IN
246,patients,I,NNS
246,with,I,IN
246,CAD,I,NNP
246,pre,I,SYM
246,-,I,:
246,treated,I,VBN
246,with,I,IN
246,lipid,I,JJ
246,-,I,:
246,lowering,I,VBG
246,therapy,I,NN
246,.,O,.
247,Thus,O,RB
247,",",O,","
247,CETP,B,NNP
247,gene,I,NN
247,variation,I,NN
247,may,B,MD
247,affect,B,VB
247,coronary,B,JJ
247,risk,I,NN
247,apart,B,RB
247,from,I,IN
247,the,I,DT
247,level,I,NN
247,of,I,IN
247,HDL,I,NNP
247,-,I,:
247,C,I,NN
248,Also,O,RB
248,",",O,","
248,these,B,DT
248,fatty,I,JJ
248,acids,I,NNS
248,may,B,MD
248,able,B,JJ
248,to,O,TO
248,decrease,B,VB
248,serum,B,NN
248,hs,I,SYM
248,-,I,:
248,CRP,I,NN
248,and,O,CC
248,LDL,B,NNP
248,cholesterol,I,NN
248,.,O,.
249,Persistence,B,NN
249,of,I,IN
249,an,I,DT
249,acute,I,JJ
249,phase,I,NN
249,response,I,NN
249,was,O,VBD
249,also,O,RB
249,correlated,B,VBN
249,with,I,IN
249,an,B,DT
249,adverse,I,JJ
249,lipid,I,NN
249,profile,I,NN
249,.,O,.
250,This,B,DT
250,study,I,NN
250,provides,B,VBZ
250,evidence,I,NN
250,that,O,IN
250,higher,B,JJR
250,intensity,I,NN
250,statins,I,NNS
250,are,O,VBP
250,beneficial,B,JJ
250,for,I,IN
250,cardiovascular,B,JJ
250,outcomes,I,NNS
250,in,B,IN
250,patients,I,NNS
250,with,I,IN
250,stable,I,JJ
250,CAD,I,NNP
250,and,I,CC
250,very,I,RB
250,low,I,JJ
250,LDL,I,NNP
250,-,I,:
250,C.,I,NNP
251,Our,B,PRP$
251,findings,I,NNS
251,suggest,B,VBP
251,that,O,IN
251,Mg,B,NNP
251,may,B,MD
251,inhibit,B,VB
251,vascular,B,JJ
251,calcification,I,NN
251,.,O,.
252,Findings,B,NNS
252,of,I,IN
252,this,I,DT
252,study,I,NN
252,showed,B,VBD
252,that,O,IN
252,a,B,DT
252,consumer,I,NN
252,education,I,NN
252,program,I,NN
252,increased,B,VBD
252,participants,B,NNS
252,use,I,NN
252,of,I,IN
252,the,I,DT
252,NRF,I,NNP
252,approach,I,NN
252,and,O,CC
252,improved,B,VBN
252,diet,B,JJ
252,quality,I,NN
252,.,O,.
253,AHI,B,NNP
253,contributed,B,VBD
253,to,I,TO
253,higher,B,JJR
253,AIP,B,NNP
253,level,I,NN
254,TyG,B,NNP
254,is,O,VBZ
254,effective,B,JJ
254,to,O,TO
254,identify,B,VB
254,individuals,B,NNS
254,at,I,IN
254,risk,I,NN
254,for,I,IN
254,NAFLD,I,NNP
254,.,O,.
255,The,B,DT
255,specific,I,JJ
255,fatty,I,JJ
255,acid,I,JJ
255,pattern,I,NN
255,may,B,MD
255,be,O,VB
255,influenced,B,VBN
255,by,O,IN
255,metabolic,B,NN
255,",",O,","
255,genetic,B,JJ
255,",",O,","
255,and,O,CC
255,dietary,B,JJ
255,factors,I,NNS
256,The,B,DT
256,AusHSI,I,NNP
256,process,I,NN
256,has,O,VBZ
256,minimised,B,VBN
256,the,B,DT
256,time,I,NN
256,from,I,IN
256,submission,I,NN
256,to,I,TO
256,notification,I,NN
256,of,I,IN
256,funding,I,NN
256,outcomes,I,NNS
256,.,O,.
257,The,B,DT
257,mid,I,NN
257,-,I,:
257,pregnancy,I,NN
257,HbA1c,I,NNP
257,level,I,NN
257,was,O,VBD
257,associated,B,VBN
257,with,I,IN
257,various,B,JJ
257,adverse,I,JJ
257,pregnancy,I,NN
257,outcomes,I,NNS
257,in,B,IN
257,high,I,JJ
257,-,I,:
257,risk,I,NN
257,Taiwanese,I,JJ
257,women,I,NNS
257,.,O,.
258,Worse,B,JJR
258,QOL,B,NNP
258,was,O,VBD
258,correlated,B,VBN
258,with,I,IN
258,poorer,B,JJR
258,values,B,NNS
258,for,I,IN
258,FEF,I,NNP
258,25,I,CD
258,-,I,:
258,75,I,CD
258,%,I,NN
258,.,O,.
259,However,O,RB
259,",",O,","
259,supplementation,B,NN
259,of,I,IN
259,1,I,CD
259,RDA,I,NNP
259,before,I,IN
259,and,O,CC
259,2,B,CD
259,RDAs,I,NNP
259,after,I,IN
259,surgery,I,NN
259,resulted,B,VBD
259,in,I,IN
259,better,B,JJR
259,improvements,B,NNS
259,on,O,IN
259,iron,B,NN
259,metabolism,I,NN
259,.,O,.
260,Wheatgrass,B,NNP
260,supplementation,I,NN
260,at,I,IN
260,a,I,DT
260,dose,I,NN
260,of,I,IN
260,3.5,I,CD
260,g,I,NNS
260,per,I,IN
260,day,I,NN
260,for,I,IN
260,a,I,DT
260,period,I,NN
260,of,I,IN
260,10,I,CD
260,weeks,I,NNS
260,results,B,NNS
260,in,I,IN
260,significant,B,JJ
260,reductions,B,NNS
260,in,O,IN
260,Apo,B,NNP
260,B,I,NNP
260,fraction,I,NN
260,",",O,","
260,TC,B,NNP
260,",",O,","
260,and,O,CC
260,TAG,B,NNP
260,without,B,IN
260,significantly,B,RB
260,reducing,B,VBG
260,the,B,DT
260,HDL,I,NNP
260,cholesterol,I,NN
260,.,O,.
261,The,O,DT
261,promise,O,NN
261,of,O,IN
261,combining,O,VBG
261,risk,B,NN
261,assessment,I,NN
261,",",O,","
261,communication,B,NN
261,and,O,CC
261,management,B,NN
261,within,B,IN
261,one,I,CD
261,consultation,I,NN
261,was,O,VBD
261,not,O,RB
261,realised,O,VBN
261,.,O,.
262,The,B,DT
262,STAMP,I,NNP
262,may,B,MD
262,be,O,VB
262,an,O,DT
262,alternative,B,JJ
262,method,O,NN
262,for,O,IN
262,assessing,B,VBG
262,nutritional,B,JJ
262,status,I,NN
262,in,B,IN
262,Chinese,I,JJ
262,children,I,NNS
262,with,I,IN
262,SCI,I,NNP
262,.,O,.
263,Nutritional,B,JJ
263,screening,I,NN
263,in,B,IN
263,all,I,DT
263,pediatric,I,JJ
263,SCI,I,NNP
263,patients,I,NNS
263,should,B,MD
263,be,O,VB
263,performed,O,VBN
263,periodically,B,RB
263,.,O,.
264,Nutrition,B,NN
264,education,I,NN
264,should,B,MD
264,be,O,VB
264,part,O,NN
264,of,O,IN
264,programs,B,NNS
264,in,I,IN
264,food,I,NN
264,insecure,I,NN
264,settings,I,NNS
264,aiming,O,VBG
264,at,O,IN
264,ameliorating,B,VBG
264,food,B,NN
264,insecurity,I,NN
264,among,B,IN
264,communities,I,NNS
264,.,O,.
265,A,B,DT
265,-,I,:
265,HIT1,I,NN
265,and,O,CC
265,A,B,NNP
265,-,I,:
265,HIT2,I,NN
265,are,O,VBP
265,the,O,DT
265,first,O,JJ
265,nationwide,O,JJ
265,FH,B,NNP
265,registries,I,NNS
265,in,B,IN
265,Turkey,I,NNP
265,and,O,CC
265,will,B,MD
265,provide,O,VB
265,important,B,JJ
265,information,O,NN
265,on,O,IN
265,the,B,DT
265,management,I,NN
265,of,I,IN
265,Turkish,I,JJ
265,FH,I,NNP
265,patients,I,NNS
265,.,O,.
266,Larger,B,NNP
266,prospective,I,JJ
266,studies,I,NNS
266,are,O,VBP
266,required,O,VBN
266,before,O,IN
266,it,O,PRP
266,can,O,MD
266,be,O,VB
266,concluded,O,VBN
266,that,O,IN
266,this,B,DT
266,extra,I,JJ
266,surgery,I,NN
266,should,B,MD
266,be,O,VB
266,advised,O,VBN
266,in,B,IN
266,these,I,DT
266,patients,I,NNS
266,.,O,.
267,There,O,EX
267,is,O,VBZ
267,an,O,DT
267,urgent,B,JJ
267,need,O,NN
267,for,O,IN
267,new,B,JJ
267,strategies,I,NNS
267,",",O,","
267,including,O,VBG
267,an,B,DT
267,understanding,I,NN
267,of,I,IN
267,why,I,WRB
267,growth,I,NN
267,falters,I,NNS
267,.,O,.
268,These,B,DT
268,observations,I,NNS
268,confirm,B,VBP
268,the,O,DT
268,need,O,NN
268,of,O,IN
268,a,O,DT
268,rigorous,O,JJ
268,monitoring,B,NN
268,of,O,IN
268,patients,B,NNS
268,taking,I,VBG
268,statins,I,NNS
268,",",O,","
268,in,O,IN
268,particular,O,JJ
268,pre,B,NN
268,-,I,:
268,diabetic,I,JJ
268,patients,I,NNS
268,or,O,CC
268,patients,B,NNS
268,presenting,I,VBG
268,with,I,IN
268,established,I,VBN
268,risk,I,NN
268,factors,I,NNS
268,for,I,IN
268,diabetes,I,NNS
268,.,O,.
269,We,O,PRP
269,present,O,VBP
269,BMI,B,NNP
269,outcomes,I,NNS
269,to,O,TO
269,allow,O,VB
269,an,O,DT
269,objective,O,JJ
269,basis,O,NN
269,for,O,IN
269,patient,B,NN
269,counseling,I,NN
269,",",O,","
269,risk,B,NN
269,stratification,I,NN
269,",",O,","
269,maintaining,B,VBG
269,access,I,NN
269,to,I,TO
269,orthopaedic,I,VB
269,surgical,I,JJ
269,care,I,NN
269,",",O,","
269,and,O,CC
269,maintaining,B,VBG
269,hospital,I,NN
269,operating,I,NN
269,margins,I,NNS
269,.,O,.
270,BE,B,NNP
270,is,O,VBZ
270,one,O,CD
270,of,O,IN
270,the,O,DT
270,most,O,RBS
270,severe,B,JJ
270,complications,B,NNS
270,of,I,IN
270,LAGB,I,NNP
270,.,O,.
271,For,B,IN
271,regular,I,JJ
271,monitoring,I,NN
271,",",O,","
271,only,O,RB
271,ALP,B,NNP
271,assay,I,NN
271,is,O,VBZ
271,recommended,O,VBN
271,",",O,","
271,provided,O,VBD
271,one,B,CD
271,abstains,I,NNS
271,from,I,IN
271,repeat,I,NN
271,injection,I,NN
271,of,I,IN
271,vitamin,I,NN
271,D,I,NNP
271,based,O,VBN
271,on,O,IN
271,high,B,JJ
271,ALP,B,NNP
271,levels,I,NNS
271,.,O,.
272,Biochemical,B,JJ
272,tests,I,NNS
272,at,I,IN
272,initial,I,JJ
272,presentation,I,NN
272,followed,O,VBN
272,by,O,IN
272,vitamin,B,NN
272,D,I,NNP
272,assay,I,VBP
272,at,I,IN
272,6,I,CD
272,weeks,I,NNS
272,and,O,CC
272,calcium,B,NN
272,",",O,","
272,phosphate,B,NN
272,and,O,CC
272,ALP,B,NNP
272,assays,I,NNS
272,at,I,IN
272,6,I,CD
272,months,I,NNS
272,is,O,VBZ
272,recommended,O,VBN
272,in,O,IN
272,the,B,DT
272,monitoring,I,NN
272,of,I,IN
272,these,I,DT
272,patients,I,NNS
272,.,O,.
273,Our,B,PRP$
273,study,I,NN
273,suggests,B,VBZ
273,that,O,IN
273,osteosarcopenic,B,JJ
273,elements,I,NNS
273,exist,B,VBP
273,even,B,RB
273,in,I,IN
273,very,I,RB
273,young,I,JJ
273,populations,I,NNS
273,.,O,.
274,Obesity,B,NNP
274,'s,O,POS
274,effect,B,NN
274,on,O,IN
274,HeRO,B,NNP
274,catheters,I,NNS
274,has,O,VBZ
274,not,B,RB
274,been,I,VBN
274,amply,I,RB
274,addressed,I,VBN
274,;,O,:
274,therefore,O,RB
274,further,O,RBR
274,prospective,B,JJ
274,studies,I,NNS
274,are,O,VBP
274,warranted,O,VBN
274,.,O,.
275,The,B,DT
275,specific,I,JJ
275,mechanisms,I,NNS
275,underlying,B,VBG
275,the,O,DT
275,association,B,NN
275,between,O,IN
275,AMD,B,NNP
275,and,O,CC
275,LIPC,B,NNP
275,require,B,VBP
275,further,I,JJ
275,investigation,I,NN
275,.,O,.
276,HeRO,B,NNP
276,catheters,I,NNS
276,offer,O,VBP
276,a,O,DT
276,reliable,B,JJ
276,",",O,","
276,and,O,CC
276,possibly,B,RB
276,the,O,DT
276,last,O,JJ
276,",",O,","
276,alternative,B,JJ
276,in,O,IN
276,hemodialysis,B,NN
276,access,I,NN
276,-,I,:
276,challenged,I,VBD
276,patients,I,NNS
276,.,O,.
277,Our,B,PRP$
277,data,I,NNS
277,describe,B,VB
277,the,O,DT
277,good,O,JJ
277,compliance,B,NN
277,of,O,IN
277,paediatric,B,JJ
277,T1D,I,NNP
277,patients,I,NNS
277,treated,I,VBD
277,at,I,IN
277,eight,I,CD
277,paediatric,I,JJ
277,units,I,NNS
277,in,B,IN
277,Spain,I,NNP
277,following,O,VBG
277,international,O,JJ
277,standards,O,NNS
277,of,O,IN
277,metabolic,B,JJ
277,control,I,NN
277,.,O,.
278,Our,B,PRP$
278,findings,I,NNS
278,support,B,NN
278,guidelines,O,NNS
278,that,O,WDT
278,advocate,O,VBP
278,oxygen,B,NN
278,therapy,I,NN
278,",",O,","
278,if,O,IN
278,required,O,VBN
278,in,O,IN
278,patients,B,NNS
278,with,I,IN
278,morbid,I,JJ
278,obesity,I,NN
278,",",O,","
278,be,O,VB
278,titrated,O,VBN
278,to,O,TO
278,achieve,O,VB
278,a,O,DT
278,target,O,NN
278,Spo2,B,NNP
278,of,O,IN
278,88,O,CD
278,-,O,:
278,92,O,CD
278,%,O,NN
278,.,O,.
279,Similarities,B,NNS
279,in,I,IN
279,the,B,DT
279,pregabalin,I,NN
279,efficacy,I,NN
279,profiles,I,NNS
279,",",O,","
279,including,O,VBG
279,time,B,NN
279,to,I,TO
279,onset,I,VB
279,and,O,CC
279,magnitude,B,VB
279,of,I,IN
279,response,I,NN
279,",",O,","
279,were,O,VBD
279,confirmed,B,VBN
279,regardless,B,RB
279,of,I,IN
279,the,I,DT
279,neuropathic,I,JJ
279,pain,I,NN
279,condition,I,NN
279,.,O,.
280,Therefore,O,RB
280,",",O,","
280,it,O,PRP
280,has,O,VBZ
280,not,O,RB
280,been,O,VBN
280,registered,O,VBN
280,as,O,IN
280,a,B,DT
280,clinical,I,JJ
280,intervention,I,NN
280,trial,I,NN
280,.,O,.
281,MNA,B,NNP
281,is,O,VBZ
281,a,O,DT
281,well,O,RB
281,-,O,:
281,developed,O,VBN
281,questionnaire,B,NN
281,which,O,WDT
281,evaluates,B,VBZ
281,malnutrition,B,NN
281,in,B,IN
281,COPD,I,NNP
281,patients,I,NNS
281,.,O,.
282,The,O,DT
282,decreasing,B,VBG
282,trends,I,NNS
282,in,I,IN
282,nutritional,B,JJ
282,status,I,NN
282,and,O,CC
282,appetite,B,VB
282,level,I,NN
282,after,B,IN
282,SCI,I,NNP
282,require,O,VBP
282,special,O,JJ
282,attention,O,NN
282,.,O,.
283,In,O,IN
283,addition,O,NN
283,",",O,","
283,it,O,PRP
283,is,O,VBZ
283,planned,B,VBN
283,that,O,IN
283,they,B,PRP
283,will,B,MD
283,guide,B,VB
283,establishment,O,NN
283,of,O,IN
283,a,B,DT
283,national,I,JJ
283,policy,I,NN
283,for,I,IN
283,the,I,DT
283,diagnosis,I,NN
283,and,I,CC
283,treatment,I,NN
283,of,I,IN
283,FH,I,NNP
283,in,B,IN
283,Turkey,I,NNP
283,.,O,.
284,Interventions,B,NNS
284,to,O,TO
284,reduce,B,VB
284,indoor,B,JJ
284,air,I,NN
284,pollution,I,NN
284,and,O,CC
284,to,O,TO
284,promote,B,VB
284,timely,B,JJ
284,administration,I,NN
284,of,I,IN
284,measles,B,NNS
284,vaccination,I,NN
284,are,O,VBP
284,urgently,B,RB
284,needed,I,VBN
284,to,O,TO
284,reduce,B,VB
284,the,B,DT
284,burden,I,NN
284,of,I,IN
284,severe,I,JJ
284,pneumonia,I,NN
284,in,B,IN
284,children,I,NNS
284,in,I,IN
284,Tanzania,I,NNP
284,.,O,.
285,Progress,O,NN
285,in,O,IN
285,reducing,B,VBG
285,breast,B,NN
285,cancer,I,NN
285,deaths,I,NNS
285,through,O,IN
285,early,B,JJ
285,detection,I,NN
285,needs,O,NNS
285,to,O,TO
285,focus,O,VB
285,on,O,IN
285,attitudinal,B,JJ
285,change,I,NN
285,among,B,IN
285,African,I,JJ
285,migrants,I,NNS
285,.,O,.
286,This,B,DT
286,study,I,NN
286,sets,O,VBZ
286,the,O,DT
286,foundation,O,NN
286,for,O,IN
286,larger,B,JJR
286,studies,I,NNS
286,to,O,TO
286,evaluate,B,VB
286,the,O,DT
286,superiority,B,NN
286,of,O,IN
286,TNP,B,NNP
286,over,O,IN
286,traditional,B,JJ
286,dressings,I,NNS
286,in,O,IN
286,high,B,JJ
286,-,I,:
286,risk,I,NN
286,foot,I,NN
286,wounds,I,NNS
286,.,O,.
287,Future,B,NNP
287,research,I,NN
287,could,B,MD
287,investigate,B,VB
287,how,O,WRB
287,to,O,TO
287,improve,B,VB
287,engagement,B,NN
287,at,B,IN
287,initial,I,JJ
287,invitations,I,NNS
287,.,O,.
288,Costs,B,NNS
288,of,I,IN
288,care,I,NN
288,for,B,IN
288,patients,I,NNS
288,who,I,WP
288,were,I,VBD
288,super,I,JJ
288,obese,I,JJ
288,",",O,","
288,likewise,O,RB
288,",",O,","
288,were,O,VBD
288,increased,B,VBN
288,.,O,.
289,This,B,DT
289,study,I,NN
289,is,O,VBZ
289,the,O,DT
289,first,O,JJ
289,to,O,TO
289,document,B,VB
289,amelioration,B,NN
289,of,O,IN
289,urinary,B,JJ
289,incontinence,I,NN
289,symptoms,I,NNS
289,in,B,IN
289,massive,I,JJ
289,weight,I,NN
289,loss,I,NN
289,patients,I,NNS
289,undergoing,I,VBG
289,body,I,NN
289,-,I,:
289,contouring,I,NN
289,procedures,I,NNS
289,.,O,.
290,Future,B,JJ
290,work,I,NN
290,will,O,MD
290,focus,O,VB
290,on,O,IN
290,evaluating,B,VBG
290,the,B,DT
290,mechanism,I,NN
290,of,I,IN
290,this,I,DT
290,outcome,I,NN
290,and,O,CC
290,documenting,B,VBG
290,improvement,B,NN
290,in,B,IN
290,an,I,DT
290,objective,I,NN
290,",",I,","
290,prospective,I,JJ
290,manner,I,NN
290,.,O,.
291,Although,O,IN
291,the,O,DT
291,inverse,B,JJ
291,association,B,NN
291,attributable,O,JJ
291,to,O,TO
291,these,B,DT
291,biomarkers,I,NNS
291,is,O,VBZ
291,substantial,B,JJ
291,",",O,","
291,future,B,JJ
291,research,I,NN
291,should,B,MD
291,explore,B,VB
291,benefits,B,NNS
291,of,O,IN
291,exercise,B,NN
291,beyond,O,IN
291,these,B,DT
291,biomarkers,I,NNS
291,of,I,IN
291,risk,I,NN
291,.,O,.
292,As,O,IN
292,the,B,DT
292,implementation,I,NN
292,of,I,IN
292,EN,I,NNP
292,is,O,VBZ
292,simple,O,JJ
292,and,O,CC
292,has,O,VBZ
292,good,O,JJ
292,compliance,B,NN
292,",",O,","
292,family,B,NN
292,EN,I,NNP
292,is,O,VBZ
292,proven,B,VBN
292,to,O,TO
292,be,O,VB
292,feasible,B,JJ
292,.,O,.
293,Larger,B,NNP
293,prospective,I,JJ
293,series,I,NN
293,are,O,VBP
293,necessary,O,JJ
293,to,O,TO
293,evaluate,B,VB
293,if,O,IN
293,the,O,DT
293,modest,B,JJ
293,benefits,B,NNS
293,are,O,VBP
293,worth,O,IN
293,the,O,DT
293,risks,B,NNS
293,of,O,IN
293,secondary,B,JJ
293,LAGB,I,NNP
293,.,O,.
294,We,O,PRP
294,support,O,VBP
294,its,B,PRP$
294,use,I,NN
294,for,B,IN
294,at,I,IN
294,least,I,JJS
294,1,I,CD
294,week,I,NN
294,after,I,IN
294,discharge,I,NN
294,.,O,.
295,These,B,DT
295,data,I,NNS
295,support,B,NN
295,the,O,DT
295,potential,B,NN
295,for,O,IN
295,extrapolating,B,VBG
295,analgesic,B,JJ
295,efficacy,I,NN
295,to,O,TO
295,other,B,JJ
295,neuropathic,I,JJ
295,pain,I,NN
295,conditions,I,NNS
295,.,O,.
296,With,O,IN
296,the,O,DT
296,worldwide,O,NN
296,development,O,NN
296,of,O,IN
296,obesity,B,NN
296,and,O,CC
296,bariatric,B,JJ
296,surgery,I,NN
296,",",O,","
296,this,B,DT
296,study,I,NN
296,demonstrated,B,VBD
296,that,O,IN
296,the,B,DT
296,operation,I,NN
296,should,B,MD
296,be,O,VB
296,proposed,O,VBN
296,to,O,TO
296,patients,B,NNS
296,with,I,IN
296,massive,I,JJ
296,weight,I,NN
296,loss,I,NN
296,to,O,TO
296,improve,B,VB
296,quality,B,NN
296,of,I,IN
296,life,I,NN
296,.,O,.
297,Earlier,B,JJR
297,diagnosis,B,NN
297,and,O,CC
297,treatment,B,NN
297,of,I,IN
297,patients,I,NNS
297,with,I,IN
297,FH,I,NNP
297,are,O,VBP
297,needed,B,VBN
297,to,O,TO
297,reduce,B,VB
297,CHD,B,NNP
297,risk,I,NN
297,in,B,IN
297,these,I,DT
297,patients,I,NNS
297,.,O,.
298,These,B,DT
298,findings,I,NNS
298,highlight,B,VBD
298,the,O,DT
298,need,B,NN
298,for,O,IN
298,more,B,RBR
298,prospective,B,JJ
298,research,I,NN
298,into,O,IN
298,multicomponent,B,JJ
298,physical,I,JJ
298,activity,I,NN
298,interventions,I,NNS
298,.,O,.
299,"""",O,JJ
299,Dietary,B,NNP
299,patterns,I,NNS
299,of,B,IN
299,the,I,DT
299,elderly,I,JJ
299,population,I,NN
299,of,I,IN
299,Villanueva,I,NNP
299,are,O,VBP
299,departing,B,VBG
299,from,I,IN
299,the,B,DT
299,traditional,I,JJ
299,Mediterranean,I,NNP
299,diet,I,NN
299,and,O,CC
299,though,O,IN
299,adequate,B,JJ
299,consumption,I,NN
299,of,I,IN
299,fruits,I,NNS
299,",",O,","
299,milk,B,NN
299,/,I,NNP
299,dairy,I,NN
299,products,I,NNS
299,",",O,","
299,oils,B,NNS
299,/,I,VBP
299,fats,I,NNS
299,and,O,CC
299,sugar,B,NN
299,/,I,NN
299,confectionery,I,NN
299,has,O,VBZ
299,been,O,VBN
299,achieved,B,VBN
299,",",O,","
299,cereals,B,NNS
299,/,I,VBP
299,grain,I,NN
299,products,I,NNS
299,",",O,","
299,vegetables,B,NNS
299,and,O,CC
299,the,B,DT
299,meat,I,NN
299,",",O,","
299,fish,B,NN
299,",",O,","
299,eggs,B,NNS
299,group,I,NN
299,consumption,I,NN
299,was,O,VBD
299,below,B,IN
299,the,B,DT
299,desirable,I,JJ
299,levels,I,NNS
299,.,O,.
299,"""",O,NN
300,These,B,DT
300,results,I,NNS
300,suggest,B,VBP
300,that,O,IN
300,maternal,B,JJ
300,eating,I,NN
300,and,O,CC
300,emotion,B,NN
300,responsiveness,I,NN
300,are,O,VBP
300,important,B,JJ
300,for,O,IN
300,understanding,B,VBG
300,the,B,DT
300,interpersonal,I,JJ
300,context,I,NN
300,of,I,IN
300,feeding,I,VBG
300,behaviors,I,NNS
300,",",O,","
300,and,O,CC
300,child,B,VB
300,weight,I,NN
300,outcomes,I,NNS
300,.,O,.
301,Endoscopic,B,NNP
301,band,I,NN
301,removal,I,NN
301,can,O,MD
301,be,O,VB
301,utilized,O,VBN
301,with,O,IN
301,patients,B,NNS
301,who,I,WP
301,have,I,VBP
301,a,I,DT
301,more,I,RBR
301,advanced,I,JJ
301,BE,I,NNP
301,and,O,CC
301,migration,B,NN
301,into,I,IN
301,the,I,DT
301,gastric,I,JJ
301,lumen,I,NNS
301,.,O,.
302,Our,B,PRP$
302,data,I,NNS
302,can,O,MD
302,not,B,RB
302,therefore,O,VB
302,support,O,NN
302,extension,O,NN
302,of,O,IN
302,current,B,JJ
302,use,I,NN
302,of,I,IN
302,bevacizumab,I,NN
302,in,B,IN
302,MBC,I,NNP
302,.,O,.
303,The,B,DT
303,findings,I,NNS
303,of,I,IN
303,this,I,DT
303,study,I,NN
303,substantiate,B,VB
303,the,O,DT
303,need,O,NN
303,for,O,IN
303,physical,B,JJ
303,exercise,I,NN
303,to,O,TO
303,reduce,B,VB
303,signs,B,NNS
303,and,I,CC
303,symptoms,I,NNS
303,associated,B,VBN
303,with,I,IN
303,CVD,B,NNP
303,risk,I,NN
303,",",O,","
303,even,B,RB
303,among,I,IN
303,a,I,DT
303,young,I,JJ
303,",",I,","
303,healthy,I,JJ
303,",",I,","
303,generally,I,RB
303,active,I,JJ
303,population,I,NN
303,.,O,.
304,Some,B,DT
304,subjects,I,NNS
304,were,O,VBD
304,diagnosed,O,VBN
304,with,O,IN
304,CD,B,NNP
304,within,B,IN
304,a,I,DT
304,decade,I,NN
304,of,I,IN
304,serum,I,NN
304,collection,I,NN
304,",",O,","
304,indicating,B,VBG
304,that,O,IN
304,although,O,IN
304,most,O,JJS
304,cases,B,NNS
304,of,I,IN
304,undiagnosed,I,JJ
304,CD,I,NN
304,are,O,VBP
304,clinically,B,RB
304,silent,I,JJ
304,",",O,","
304,some,B,DT
304,result,B,NN
304,in,I,IN
304,symptoms,B,NNS
304,.,O,.
305,Further,O,RB
305,",",O,","
305,that,O,IN
305,these,B,DT
305,results,I,NNS
305,would,O,MD
305,appear,B,VB
305,to,O,TO
305,corroborate,B,VB
305,the,O,DT
305,concept,O,NN
305,of,O,IN
305,increasing,B,VBG
305,physical,B,JJ
305,activity,I,NN
305,",",O,","
305,including,O,VBG
305,aerobic,B,JJ
305,activity,I,NN
305,",",O,","
305,as,O,IN
305,a,O,DT
305,preventative,B,JJ
305,measure,O,NN
305,.,O,.
306,The,O,DT
306,improvements,B,NNS
306,in,I,IN
306,cardiometabolic,B,JJ
306,risk,I,NN
306,markers,I,NNS
306,and,O,CC
306,cognitive,B,JJ
306,performance,I,NN
306,after,B,IN
306,the,I,DT
306,berry,I,NN
306,beverage,I,NN
306,suggest,B,VBP
306,preventive,B,JJ
306,potential,B,NN
306,of,O,IN
306,berries,B,NNS
306,with,O,IN
306,respect,O,NN
306,to,O,TO
306,type,B,VB
306,2,I,CD
306,diabetes,I,NNS
306,",",O,","
306,cardiovascular,B,JJ
306,disease,I,NN
306,",",O,","
306,and,O,CC
306,associated,B,VBD
306,cognitive,B,JJ
306,decline,I,NN
306,.,O,.
307,In,O,IN
307,general,O,JJ
307,",",O,","
307,it,O,PRP
307,is,O,VBZ
307,recommended,B,VBN
307,that,O,IN
307,the,B,DT
307,band,I,NN
307,be,O,VB
307,removed,O,VBN
307,at,O,IN
307,the,O,DT
307,time,O,NN
307,of,O,IN
307,the,B,DT
307,diagnosis,I,NN
307,of,I,IN
307,the,I,DT
307,BE,I,NNP
307,.,O,.
308,Despite,O,IN
308,robust,B,JJ
308,methodology,I,NN
308,",",O,","
308,real,B,JJ
308,-,I,:
308,life,I,NN
308,data,I,NNS
308,are,O,VBP
308,exposed,O,VBN
308,to,O,TO
308,important,B,JJ
308,potential,I,JJ
308,biases,I,NNS
308,",",O,","
308,and,O,CC
308,therefore,O,RB
308,",",O,","
308,results,B,NNS
308,need,O,VBP
308,to,O,TO
308,be,O,VB
308,treated,O,VBN
308,with,O,IN
308,caution,O,NN
308,.,O,.
309,The,B,DT
309,findings,I,NNS
309,justify,B,NN
309,strategies,B,NNS
309,to,O,TO
309,encourage,B,VB
309,the,B,DT
309,consumption,I,NN
309,of,I,IN
309,fortified,I,JJ
309,cereal,I,NN
309,with,I,IN
309,milk,I,NN
309,by,I,IN
309,adolescents,I,NNS
309,",",O,","
309,either,O,RB
309,as,O,IN
309,a,B,DT
309,breakfast,I,NN
309,or,O,CC
309,a,B,DT
309,supper,I,NN
309,.,O,.
310,Readmission,B,NNP
310,disparities,I,NNS
310,behave,O,VBP
310,differently,O,RB
310,across,O,IN
310,chronic,B,JJ
310,conditions,I,NNS
310,.,O,.
311,There,O,EX
311,is,O,VBZ
311,a,O,DT
311,strong,B,JJ
311,correlation,B,NN
311,between,O,IN
311,bimanual,B,JJ
311,and,O,CC
311,ultrasound,B,JJ
311,examinations,I,NNS
311,with,O,IN
311,regard,O,NN
311,to,O,TO
311,determining,B,VBG
311,the,B,DT
311,size,I,NN
311,of,I,IN
311,leiomyomatous,I,JJ
311,uteri,I,NN
311,.,O,.
312,Our,B,PRP$
312,study,I,NN
312,further,O,RB
312,confirms,B,VBZ
312,previous,B,JJ
312,data,I,NNS
312,on,O,IN
312,the,O,DT
312,ability,O,NN
312,of,O,IN
312,the,B,DT
312,CT,I,NNP
312,-,I,:
312,proAVP,I,NN
312,to,O,TO
312,predict,B,VB
312,patient,B,JJ
312,severity,I,NN
312,in,B,IN
312,severe,I,JJ
312,sepsis,I,NN
312,and,I,CC
312,septic,I,JJ
312,shock,I,NN
312,.,O,.
313,Vitamin,B,NNP
313,A,I,NNP
313,status,I,NN
313,has,O,VBZ
313,a,O,DT
313,strong,B,JJ
313,association,B,NN
313,with,I,IN
313,severity,B,NN
313,of,I,IN
313,infection,I,NN
313,.,O,.
314,Results,B,NNS
314,of,I,IN
314,the,I,DT
314,present,I,JJ
314,study,I,NN
314,suggest,B,NN
314,that,O,IN
314,both,O,DT
314,vitamin,B,FW
314,E,I,NNP
314,deficiency,I,NN
314,and,O,CC
314,oxidative,B,JJ
314,status,I,NN
314,are,O,VBP
314,associated,B,VBN
314,with,I,IN
314,prediabetes,B,NNS
314,in,B,IN
314,apparently,I,RB
314,healthy,I,JJ
314,subjects,I,NNS
314,.,O,.
315,NIDDM,B,NNP
315,in,B,IN
315,Maori,I,NNP
315,and,I,CC
315,Pacific,I,NNP
315,Islanders,I,NNP
315,is,O,VBZ
315,associated,B,VBN
315,with,I,IN
315,a,O,DT
315,greater,B,JJR
315,degree,B,NN
315,of,I,IN
315,proteinuria,I,NN
315,and,O,CC
315,end,B,VB
315,-,I,:
315,stage,I,NN
315,renal,I,JJ
315,failure,I,NN
315,than,O,IN
315,that,O,DT
315,in,O,IN
315,Europeans,B,NNPS
315,.,O,.
316,There,O,EX
316,was,O,VBD
316,greater,B,JJR
316,adverse,B,JJ
316,influence,B,NN
316,of,O,IN
316,NAFLD,B,NNP
316,per,O,FW
316,se,O,NN
316,on,O,IN
316,triglyceride,B,NN
316,",",O,","
316,and,O,CC
316,triglyceride,B,RB
316,/,I,NNP
316,HDL,I,NNP
316,-,I,:
316,cholesterol,I,NN
316,in,O,IN
316,men,B,NNS
316,compared,O,VBN
316,with,O,IN
316,women,B,NNS
316,.,O,.
317,Early,B,RB
317,subjective,I,JJ
317,clinical,I,JJ
317,judgment,I,NN
317,of,I,IN
317,physicians,I,NNS
317,correlates,B,NNS
317,more,I,RBR
317,closely,I,RB
317,with,I,IN
317,3-month,B,JJ
317,outcome,I,NN
317,after,I,IN
317,ICH,I,NNP
317,than,O,IN
317,prognostic,B,JJ
317,scales,I,NNS
317,.,O,.
318,The,B,DT
318,authors,I,NNS
318,found,B,VBD
318,the,O,DT
318,close,B,JJ
318,association,B,NN
318,between,O,IN
318,frailty,B,NN
318,and,O,CC
318,diabetic,B,JJ
318,nephropathy,I,NN
318,in,B,IN
318,chronic,I,JJ
318,hemodialysis,I,NN
318,patients,I,NNS
318,.,O,.
319,Patients,B,NNS
319,with,I,IN
319,older,B,JJR
319,age,I,NN
319,",",O,","
319,negative,B,JJ
319,medication,I,NN
319,belief,I,NN
319,",",O,","
319,polypharmacy,B,NN
319,",",O,","
319,co,B,SYM
319,-,I,:
319,morbidities,I,NNS
319,and,O,CC
319,those,B,DT
319,who,I,WP
319,were,I,VBD
319,poorly,I,RB
319,involved,I,VBN
319,in,I,IN
319,the,I,DT
319,therapeutic,I,JJ
319,decision,I,NN
319,were,O,VBD
319,more,B,RBR
319,likely,I,JJ
319,to,O,TO
319,experience,B,VB
319,DTP,I,NNP
319,.,O,.
320,Mild,B,NNP
320,PTSD,I,NNP
320,symptoms,I,NNS
320,are,O,VBP
320,common,B,JJ
320,in,B,IN
320,patients,I,NNS
320,with,I,IN
320,lung,I,NN
320,cancer,I,NN
320,6,B,CD
320,months,I,NNS
320,after,I,IN
320,treatment,I,NN
320,;,O,:
320,however,O,RB
320,",",O,","
320,a,B,DT
320,full,I,JJ
320,diagnosis,I,NN
320,of,I,IN
320,PTSD,I,NNP
320,is,O,VBZ
320,uncommon,B,JJ
320,.,O,.
321,Independent,B,JJ
321,prognostic,B,JJ
321,factors,I,NNS
321,for,I,IN
321,MSS,B,NNP
321,were,O,VBD
321,SN,B,NNP
321,status,I,NN
321,",",O,","
321,Breslow,B,NNP
321,thickness,I,NN
321,and,O,CC
321,ulceration,B,NN
321,.,O,.
322,Significantly,B,RB
322,lower,B,JJR
322,serosal,B,NN
322,microcirculatory,I,JJ
322,parameters,I,NNS
322,of,O,IN
322,the,B,DT
322,vascular,I,NN
322,transected,I,VBD
322,bowel,I,NN
322,was,O,VBD
322,seen,O,VBN
322,compared,O,VBN
322,with,O,IN
322,the,B,DT
322,non,I,JJ
322,-,I,:
322,transected,I,VBN
322,bowel,I,NN
322,.,O,.
323,Age,B,NNP
323,",",O,","
323,female,B,JJ
323,gender,I,NN
323,",",O,","
323,smoking,B,NN
323,",",O,","
323,physical,B,JJ
323,inactivity,I,NN
323,",",O,","
323,diabetes,B,NNS
323,were,O,VBD
323,independent,B,JJ
323,predictors,B,NNS
323,for,I,IN
323,presence,B,NN
323,of,I,IN
323,PAD,I,NNP
323,.,O,.
324,Our,B,PRP$
324,results,I,NNS
324,support,B,VB
324,the,O,DT
324,conclusion,O,NN
324,that,O,IN
324,in,B,IN
324,populations,I,NNS
324,with,I,IN
324,a,I,DT
324,homogenous,I,JJ
324,low,I,JJ
324,level,I,NN
324,of,I,IN
324,omega-3,I,JJ
324,polyunsaturated,I,JJ
324,fatty,I,JJ
324,acids,I,NNS
324,consumption,I,NN
324,",",O,","
324,serum,B,NN
324,fatty,I,JJ
324,acid,I,NN
324,levels,I,NNS
324,are,O,VBP
324,not,B,RB
324,associated,B,VBN
324,with,I,IN
324,CHD,B,NNP
324,risk,I,NN
324,.,O,.
325,Our,B,PRP$
325,data,I,NNS
325,suggest,B,VBP
325,that,O,IN
325,EVD,B,NNP
325,-,I,:
325,related,I,JJ
325,stigma,I,NN
325,was,O,VBD
325,much,B,JJ
325,lower,B,JJR
325,more,B,RBR
325,than,I,IN
325,a,I,DT
325,year,I,NN
325,after,I,IN
325,active,I,JJ
325,Ebola,I,NNP
325,transmission,I,NN
325,ended,I,VBN
325,in,I,IN
325,Liberia,I,NNP
325,.,O,.
326,Female,B,NNP
326,sex,I,NN
326,",",O,","
326,childhood,B,NN
326,-,I,:
326,onset,I,NN
326,craniopharyngioma,I,NN
326,",",O,","
326,hydrocephalus,B,NN
326,and,O,CC
326,tumour,B,JJ
326,recurrence,I,NN
326,are,O,VBP
326,important,B,JJ
326,risk,B,NN
326,factors,I,NNS
326,.,O,.
327,In,B,IN
327,women,I,NNS
327,with,I,IN
327,DFM,I,NNP
327,",",O,","
327,increased,B,VBD
327,body,B,NN
327,size,I,NN
327,is,O,VBZ
327,associated,B,VBN
327,with,I,IN
327,worse,B,JJR
327,pregnancy,B,NN
327,outcome,I,NN
327,",",O,","
327,including,O,VBG
327,stillbirth,B,NN
327,.,O,.
328,For,B,IN
328,Medicare,I,NNP
328,beneficiaries,I,NNS
328,with,I,IN
328,nonmetastatic,I,JJ
328,breast,I,NN
328,cancer,I,NN
328,",",O,","
328,residence,B,NN
328,in,I,IN
328,regions,I,NNS
328,with,I,IN
328,higher,I,JJR
328,breast,I,NN
328,cancer,I,NN
328,-,I,:
328,related,I,JJ
328,expenditures,I,NNS
328,was,O,VBD
328,not,B,RB
328,associated,B,VBN
328,with,I,IN
328,better,B,JJR
328,survival,B,NN
328,.,O,.
329,Early,B,JJ
329,menarche,I,NN
329,",",O,","
329,teenage,B,JJ
329,pregnancy,I,NN
329,and,O,CC
329,low,B,JJ
329,education,B,NN
329,level,I,NN
329,are,O,VBP
329,risk,B,JJ
329,factors,I,NNS
329,for,I,IN
329,the,B,DT
329,occurrence,I,NN
329,of,I,IN
329,morbid,I,NN
329,obesity,I,NN
329,in,B,IN
329,women,I,NNS
329,of,I,IN
329,reproductive,I,JJ
329,age,I,NN
329,.,O,.
330,Some,B,DT
330,non,I,JJ
330,-,I,:
330,communicable,I,JJ
330,diseases,I,NNS
330,were,O,VBD
330,already,B,RB
330,more,B,RBR
330,prevalent,I,JJ
330,in,O,IN
330,women,B,NNS
330,with,I,IN
330,morbid,I,NN
330,obesity,I,NN
330,even,B,RB
330,before,I,IN
330,50,I,CD
330,years,I,NNS
330,of,I,IN
330,age,I,NN
330,.,O,.
331,Low,B,JJ
331,25(OH)D,B,CD
331,may,B,MD
331,be,O,VB
331,one,O,CD
331,of,O,IN
331,the,O,DT
331,potential,B,JJ
331,risk,B,NN
331,factors,I,NNS
331,for,I,IN
331,developing,B,VBG
331,MS,I,NNP
331,in,B,IN
331,PMW,I,NNP
331,or,O,CC
331,vice,O,NN
331,-,O,:
331,versa,O,NN
331,.,O,.
332,25(OH)D,B,CD
332,had,O,VBD
332,significant,B,JJ
332,inverse,B,NN
332,and,O,CC
332,direct,B,JJ
332,relationship,B,NN
332,with,I,IN
332,FBG,B,NNP
332,and,O,CC
332,WC,B,NNP
332,.,O,.
333,This,B,DT
333,study,I,NN
333,suggests,B,VBZ
333,that,O,IN
333,being,O,VBG
333,retained,O,VBN
333,/,O,NNS
333,engaged,O,VBN
333,in,O,IN
333,a,B,DT
333,relatively,I,RB
333,low,I,JJ
333,-,I,:
333,resource,I,NN
333,",",I,","
333,pragmatic,I,JJ
333,diabetes,I,NNS
333,prevention,I,VBP
333,programme,I,NN
333,for,B,IN
333,those,I,DT
333,at,I,IN
333,high,I,JJ
333,risk,I,NN
333,is,O,VBZ
333,associated,B,VBN
333,with,I,IN
333,reductions,B,NNS
333,in,O,IN
333,the,B,DT
333,progression,I,NN
333,to,I,TO
333,T2DM,I,NNP
333,in,O,IN
333,comparison,O,NN
333,to,O,TO
333,those,B,DT
333,who,I,WP
333,receive,I,VBP
333,standard,I,NN
333,care,I,NN
333,.,O,.
334,Patients,B,NNS
334,with,I,IN
334,craniopharyngioma,I,NNS
334,are,O,VBP
334,at,O,IN
334,an,O,DT
334,increased,B,VBN
334,risk,B,NN
334,for,I,IN
334,T2DM,I,NNP
334,",",O,","
334,cerebral,B,JJ
334,infarction,I,NN
334,",",O,","
334,total,B,JJ
334,mortality,I,NN
334,and,O,CC
334,mortality,B,NN
334,due,B,JJ
334,to,I,TO
334,circulatory,B,NN
334,and,I,CC
334,respiratory,I,NN
334,diseases,I,NNS
334,.,O,.
335,Gastrin,B,NNP
335,secretion,I,NN
335,is,O,VBZ
335,diminished,B,VBN
335,after,O,IN
335,RYGB,B,NNP
335,.,O,.
336,Susceptibility,B,NN
336,to,I,TO
336,smoking,I,NN
336,among,B,IN
336,students,I,NNS
336,of,I,IN
336,6th,I,CD
336,grade,I,NN
336,is,O,VBZ
336,associated,B,VBN
336,with,I,IN
336,being,B,VBG
336,male,I,JJ
336,",",O,","
336,family,B,NN
336,dysfunction,I,NN
336,and,O,CC
336,having,B,VBG
336,ever,I,RB
336,smoked,I,VBN
336,in,I,IN
336,life,I,NN
336,.,O,.
337,Each,B,DT
337,macular,I,JJ
337,retinal,I,JJ
337,layer,I,NN
337,and,O,CC
337,CMT,B,NNP
337,had,O,VBD
337,a,O,DT
337,tendency,B,NN
337,to,O,TO
337,increase,B,VB
337,for,B,IN
337,one,I,CD
337,year,I,NN
337,after,O,IN
337,577-nm,B,JJ
337,PASCAL,I,NNP
337,photocoagulation,I,NN
337,",",O,","
337,whereas,O,IN
337,the,B,DT
337,average,I,JJ
337,thickness,I,NN
337,of,I,IN
337,retinal,I,JJ
337,pigment,I,NN
337,epithelium,I,NN
337,decreased,B,VBN
337,at,B,IN
337,one,I,CD
337,-,I,:
337,year,I,NN
337,follow,I,SYM
337,-,I,:
337,up,I,RB
337,compared,O,VBN
337,to,O,TO
337,the,B,DT
337,baseline,I,NN
337,.,O,.
338,In,B,IN
338,the,I,DT
338,UK,I,NNP
338,",",O,","
338,the,B,DT
338,complication,I,NN
338,rate,I,NN
338,associated,B,VBN
338,with,I,IN
338,surgical,B,JJ
338,removal,I,NN
338,of,I,IN
338,a,I,DT
338,renal,I,JJ
338,oncocytoma,I,NN
338,was,O,VBD
338,not,B,RB
338,negligible,I,JJ
338,.,O,.
339,Chronic,B,NNP
339,cortical,I,NN
339,and,I,CC
339,lacunar,I,JJ
339,infarcts,I,NNS
339,in,I,IN
339,admission,I,NN
339,imaging,I,NN
339,are,O,VBP
339,associated,B,VBN
339,with,I,IN
339,poor,B,JJ
339,clinical,B,JJ
339,outcome,I,NN
339,in,B,IN
339,sexagenarian,I,JJ
339,and,I,CC
339,older,I,JJR
339,patients,I,NNS
339,treated,I,VBN
339,with,I,IN
339,MT,I,NNP
339,for,I,IN
339,LVO,I,NNP
339,of,I,IN
339,the,I,DT
339,MCA,I,NNP
339,or,I,CC
339,distal,I,JJ
339,ICA,I,NNP
339,.,O,.
340,Eyes,B,NNS
340,with,I,IN
340,a,I,DT
340,robust,I,JJ
340,early,I,JJ
340,response,I,NN
340,demonstrated,B,VBD
340,10-letter,B,CD
340,long,I,JJ
340,-,I,:
340,term,I,NN
340,gain,I,NN
340,in,I,IN
340,BCVA,I,NNP
340,at,O,IN
340,a,O,DT
340,significantly,B,RB
340,higher,B,JJR
340,rate,O,NN
340,compared,O,VBN
340,to,O,TO
340,those,B,DT
340,with,I,IN
340,poor,I,JJ
340,early,I,JJ
340,response,I,NN
340,.,O,.
341,Early,B,RB
341,treatment,I,NN
341,response,I,NN
341,directly,B,RB
341,correlated,B,VBN
341,with,I,IN
341,overall,O,JJ
341,change,B,NN
341,in,I,IN
341,BCVA,I,NNP
341,.,O,.
342,Data,B,NNS
342,from,I,IN
342,NIV,I,NNP
342,can,O,MD
342,identify,B,VB
342,a,O,DT
342,change,B,NN
342,in,I,IN
342,breathing,B,VBG
342,patterns,I,NNS
342,that,O,WDT
342,predicts,B,VBZ
342,severe,B,JJ
342,AECOPD,I,NNP
342,.,O,.
343,In,O,IN
343,our,B,PRP$
343,study,I,NN
343,",",O,","
343,the,B,DT
343,OS,I,NNP
343,-,I,:
343,MRS,I,NNP
343,is,O,VBZ
343,not,B,RB
343,correlated,B,VBN
343,with,I,IN
343,the,B,DT
343,appearance,I,NN
343,of,I,IN
343,early,I,JJ
343,complications,I,NNS
343,or,O,CC
343,mortality,B,NN
343,.,O,.
344,In,B,IN
344,our,I,PRP$
344,racially,I,NN
344,and,I,CC
344,ethnically,I,RB
344,diverse,I,JJ
344,cohort,I,NN
344,",",O,","
344,cesarean,B,JJ
344,delivery,I,NN
344,and,O,CC
344,pre,B,NN
344,-,I,:
344,pregnancy,I,NN
344,overweight,I,NN
344,and,I,CC
344,obesity,I,NN
344,were,O,VBD
344,associated,B,VBN
344,with,I,IN
344,childhood,B,NN
344,overweight,I,NN
344,or,I,CC
344,obesity,I,NN
344,.,O,.
345,Older,B,JJR
345,adults,I,NNS
345,with,I,IN
345,DM,I,NNP
345,appear,B,VBP
345,to,O,TO
345,perform,O,VB
345,poorly,O,RB
345,on,O,IN
345,an,B,DT
345,ambulatory,I,JJ
345,measure,I,NN
345,of,I,IN
345,multitasking,I,NN
345,.,O,.
346,We,O,PRP
346,observed,B,VBD
346,higher,B,JJR
346,total,B,JJ
346,all,I,DT
346,-,I,:
346,cause,I,NN
346,health,I,NN
346,care,I,NN
346,costs,I,NNS
346,among,O,IN
346,T2DM,B,JJ
346,patients,I,NNS
346,with,I,IN
346,a,I,DT
346,fixed,I,JJ
346,copay,I,NN
346,(,O,(
346,vs.,O,FW
346,coinsurance,B,NN
346,),I,)
346,pharmacy,I,NN
346,benefit,I,NN
346,.,O,.
347,This,B,DT
347,relation,I,NN
347,did,O,VBD
347,not,B,RB
347,vary,B,JJ
347,by,O,IN
347,gender,B,NN
347,nor,O,CC
347,education,B,NN
347,",",O,","
347,which,O,WDT
347,may,B,MD
347,indicate,B,VB
347,that,O,IN
347,individuals,B,NNS
347,only,I,RB
347,start,I,VBP
347,to,I,TO
347,use,I,VB
347,health,I,NN
347,services,I,NNS
347,more,B,RBR
347,frequently,I,RB
347,when,O,WRB
347,their,B,PRP$
347,needs,I,NNS
347,increase,I,NN
347,.,O,.
348,DKA,B,NNP
348,has,I,VBZ
348,a,I,DT
348,high,B,JJ
348,incidence,I,NN
348,rate,I,NN
348,in,O,IN
348,children,B,NNS
348,with,I,IN
348,type,I,NN
348,1,I,CD
348,diabetes,I,NNS
348,",",O,","
348,and,O,CC
348,the,B,DT
348,development,I,NN
348,of,I,IN
348,DKA,I,NNP
348,is,O,VBZ
348,associated,B,VBN
348,with,I,IN
348,age,B,NN
348,",",O,","
348,parents,B,NNS
348,educational,I,JJ
348,level,I,NN
348,",",O,","
348,and,O,CC
348,family,B,NN
348,income,I,NN
348,.,O,.
349,Dactylitis,B,NN
349,is,O,VBZ
349,a,O,DT
349,frequent,B,JJ
349,manifestation,O,NN
349,in,O,IN
349,patients,B,NNS
349,with,I,IN
349,SpA,I,NNP
349,",",O,","
349,even,B,RB
349,during,I,IN
349,the,I,DT
349,early,I,JJ
349,stages,I,NNS
349,of,I,IN
349,the,I,DT
349,disease,I,NN
349,.,O,.
350,Hypergastrinemia,B,NNP
350,was,O,VBD
350,not,B,RB
350,present,B,JJ
350,after,I,IN
350,SG,B,NNP
350,",",O,","
350,but,O,CC
350,a,O,DT
350,tendency,B,NN
350,of,O,IN
350,enhanced,B,JJ
350,gastrin,B,NN
350,secretion,I,NN
350,was,O,VBD
350,observed,B,VBN
350,.,O,.
351,Serum,B,NNP
351,uric,I,JJ
351,acid,I,NN
351,",",O,","
351,pulse,B,JJ
351,pressure,I,NN
351,and,O,CC
351,heart,B,NN
351,rate,I,NN
351,>,I,VBD
351,90,I,CD
351,bpm,I,NNS
351,were,O,VBD
351,strongly,B,RB
351,associated,B,VBN
351,with,I,IN
351,peripheral,B,JJ
351,artery,I,NN
351,disease,I,NN
351,.,O,.
352,ÃÂ²-CTx,B,NN
352,had,O,VBD
352,no,B,DT
352,significant,B,JJ
352,association,B,NN
352,with,I,IN
352,DR,B,NNP
352,.,O,.
353,The,B,DT
353,HDL,I,NNP
353,-,I,:
353,raising,I,VBG
353,allele,I,NN
353,of,I,IN
353,the,I,DT
353,LIPC,I,NNP
353,gene,I,NN
353,(,O,(
353,T,O,NNP
353,),O,)
353,was,O,VBD
353,associated,B,VBN
353,with,I,IN
353,a,O,DT
353,reduced,B,JJ
353,risk,B,NN
353,of,I,IN
353,AMD,I,NNP
353,.,O,.
354,Micronutrient,B,NN
354,status,I,NN
354,shows,B,VBZ
354,differing,B,VBG
354,relationships,B,NNS
354,with,I,IN
354,age,B,NN
354,",",O,","
354,gender,B,NN
354,and,O,CC
354,BMI,B,NNP
354,.,O,.
355,Participating,B,VBG
355,in,I,IN
355,3,I,CD
355,hÂ·wk(-1,I,NN
355,),I,)
355,of,I,IN
355,vigorous,I,JJ
355,-,I,:
355,intensity,I,NN
355,activity,I,NN
355,is,O,VBZ
355,associated,B,VBN
355,with,I,IN
355,a,O,DT
355,22,B,CD
355,%,I,NN
355,lower,B,JJR
355,risk,B,NN
355,of,I,IN
355,MI,I,NNP
355,among,B,IN
355,men,I,NNS
355,.,O,.
356,Vitamin,B,NNP
356,K,I,NNP
356,insufficiency,I,NN
356,was,O,VBD
356,present,B,JJ
356,in,B,IN
356,40,I,CD
356,%,I,NN
356,and,O,CC
356,not,B,RB
356,related,B,VBN
356,to,I,TO
356,deficiencies,B,NNS
356,in,I,IN
356,other,I,JJ
356,vitamins,I,NNS
356,or,O,CC
356,micronutrients,B,NNS
356,.,O,.
357,Thus,O,RB
357,",",O,","
357,we,O,PRP
357,conclude,B,VBP
357,that,O,IN
357,visceral,B,JJ
357,fat,I,JJ
357,area,I,NN
357,is,O,VBZ
357,positively,B,RB
357,associated,B,VBN
357,with,I,IN
357,the,B,DT
357,prevalence,I,NN
357,of,I,IN
357,CRC,I,NNP
357,.,O,.
358,Overall,B,JJ
358,hypoglycemia,I,NN
358,rates,I,NNS
358,were,O,VBD
358,similar,B,JJ
358,except,O,IN
358,for,O,IN
358,an,O,DT
358,increase,B,NN
358,in,I,IN
358,0,B,CD
358,-,I,:
358,2-h,I,JJ
358,postmeal,I,NN
358,hypoglycemia,I,NN
358,with,O,IN
358,faster,B,RBR
358,aspart,B,NN
358,.,O,.
359,VAI,B,NNP
359,may,B,MD
359,provide,O,VB
359,a,O,DT
359,superior,B,JJ
359,predictive,B,JJ
359,power,I,NN
359,of,O,IN
359,CV,B,NNP
359,outcomes,I,NNS
359,to,O,TO
359,WC,B,NNP
359,and,O,CC
359,WHtR.,B,NNP
360,Proper,B,NNP
360,patient,I,NN
360,selection,I,NN
360,is,O,VBZ
360,an,O,DT
360,important,O,JJ
360,variable,O,NN
360,.,O,.
361,This,B,DT
361,study,I,NN
361,identified,B,VBD
361,predictor,B,NN
361,factors,I,NNS
361,positively,B,RB
361,associated,B,VBN
361,with,I,IN
361,ideal,B,JJ
361,weight,I,JJ
361,loss,I,NN
361,.,O,.
362,Increased,B,VBN
362,duration,B,NN
362,of,I,IN
362,beedi,I,NN
362,rolling,I,NN
362,",",O,","
362,advancing,B,VBG
362,age,B,NN
362,and,O,CC
362,presence,B,NN
362,of,I,IN
362,diabetes,I,NNS
362,were,O,VBD
362,the,O,DT
362,independent,B,JJ
362,correlates,B,NNS
362,of,I,IN
362,potential,B,JJ
362,TON,I,NNP
362,.,O,.
363,Gastrointestinal,B,NNP
363,symptoms,I,NNS
363,can,O,MD
363,not,B,RB
363,predict,B,VB
363,the,B,DT
363,presence,I,NN
363,of,I,IN
363,esophageal,I,JJ
363,dysmotility,I,NN
363,.,O,.
364,There,O,EX
364,is,O,VBZ
364,improvement,B,NN
364,of,O,IN
364,GERD,B,NNP
364,as,O,IN
364,assessed,B,VBN
364,by,O,IN
364,symptom,B,NN
364,questionnaires,I,NNS
364,",",O,","
364,as,O,RB
364,well,O,RB
364,as,O,IN
364,improvement,B,NN
364,in,I,IN
364,grade,B,NN
364,of,I,IN
364,esophagitis,I,NN
364,.,O,.
365,Presence,B,NN
365,of,I,IN
365,GERD,I,NNP
365,may,B,MD
365,not,B,RB
365,be,O,VB
365,considered,B,VBN
365,as,O,IN
365,a,O,DT
365,contra,B,JJ
365,-,I,:
365,indication,I,NN
365,for,I,IN
365,sleeve,B,JJ
365,gastrectomy,I,NN
365,.,O,.
366,The,B,DT
366,burden,I,NN
366,of,I,IN
366,gynecomastia,I,NN
366,among,O,IN
366,men,B,NNS
366,on,I,IN
366,ART,I,NNP
366,in,B,IN
366,Malawi,I,NNP
366,was,O,VBD
366,higher,B,JJR
366,than,O,IN
366,previously,B,RB
366,reported,I,VBN
366,",",O,","
366,and,O,CC
366,was,O,VBD
366,associated,B,VBN
366,with,I,IN
366,adverse,B,JJ
366,psychological,I,JJ
366,consequences,I,NNS
366,",",O,","
366,calling,O,VBG
366,for,O,IN
366,increased,B,VBN
366,awareness,B,NN
366,",",O,","
366,a,B,DT
366,proactive,I,JJ
366,diagnostic,I,JJ
366,approach,I,NN
366,and,O,CC
366,diligent,B,JJ
366,clinical,I,JJ
366,management,I,NN
366,.,O,.
367,With,O,IN
367,the,O,DT
367,exception,O,NN
367,of,O,IN
367,reduced,B,JJ
367,bone,B,NN
367,health,I,NN
367,",",O,","
367,older,B,JJR
367,adults,I,NNS
367,with,I,IN
367,undiagnosed,I,JJ
367,CD,I,NN
367,had,O,VBD
367,limited,B,VBN
367,comorbidity,B,NN
367,and,O,CC
367,no,B,DT
367,increase,B,NN
367,in,I,IN
367,mortality,B,NN
367,compared,O,VBN
367,with,O,IN
367,controls,B,NNS
367,.,O,.
368,The,O,DT
368,low,B,JJ
368,grade,B,NN
368,of,I,IN
368,emulsification,I,NN
368,(,O,(
368,12.9,B,CD
368,%,I,NN
368,),O,)
368,in,B,IN
368,our,I,PRP$
368,patients,I,NNS
368,could,O,MD
368,not,B,RB
368,be,O,VB
368,related,B,VBN
368,to,I,TO
368,LMWC,B,NNP
368,or,O,CC
368,cholesterol,B,NN
368,changes,I,NNS
368,.,O,.
369,Although,O,IN
369,the,O,DT
369,reverse,B,NN
369,association,B,NN
369,was,O,VBD
369,not,B,RB
369,found,I,VBN
369,",",O,","
369,MDD,B,NNP
369,-,I,:
369,R,I,NN
369,tends,B,VBZ
369,to,O,TO
369,be,O,VB
369,also,O,RB
369,associated,B,VBN
369,with,I,IN
369,subsequent,B,JJ
369,development,I,NN
369,of,I,IN
369,obesity,I,NN
369,",",O,","
369,but,O,CC
369,larger,B,JJR
369,studies,I,NNS
369,are,O,VBP
369,needed,O,VBN
369,to,O,TO
369,fully,O,RB
369,assess,O,VB
369,this,O,DT
369,issue,O,NN
369,.,O,.
370,At,B,IN
370,month,I,NN
370,24,I,CD
370,",",O,","
370,there,O,EX
370,were,O,VBD
370,significant,B,JJ
370,visual,B,JJ
370,and,O,CC
370,anatomic,B,JJ
370,improvements,B,NNS
370,in,O,IN
370,both,B,DT
370,groups,I,NNS
370,",",O,","
370,with,O,IN
370,subjects,B,NNS
370,in,I,IN
370,the,I,DT
370,0.5,I,CD
370,mg,I,NN
370,RBZ,I,NNP
370,group,I,NN
370,gaining,B,VBG
370,more,B,JJR
370,vision,I,NN
370,.,O,.
371,It,B,PRP
371,is,O,VBZ
371,associated,B,VBN
371,with,I,IN
371,a,O,DT
371,minimal,B,JJ
371,risk,B,NN
371,of,I,IN
371,leakage,I,NN
371,",",O,","
371,bleeding,B,NN
371,",",O,","
371,and,O,CC
371,nutritional,B,JJ
371,deficiency,I,NN
371,.,O,.
372,It,B,PRP
372,was,O,VBD
372,significantly,B,RB
372,associated,B,VBN
372,with,I,IN
372,DME,B,NNP
372,in,B,IN
372,female,I,JJ
372,patients,I,NNS
372,with,I,IN
372,T2DM,I,NNP
372,",",O,","
372,but,O,CC
372,not,B,RB
372,in,I,IN
372,male,I,JJ
372,patients,I,NNS
372,with,I,IN
372,T2DM,I,NNP
372,.,O,.
373,Through,O,IN
373,meta,B,SYM
373,-,I,:
373,analysis,I,NN
373,",",O,","
373,we,O,PRP
373,were,O,VBD
373,able,O,JJ
373,to,O,TO
373,gain,B,VB
373,insight,I,JJ
373,into,I,IN
373,previously,B,RB
373,reported,I,VBN
373,associations,B,NNS
373,between,O,IN
373,+331G,B,NNP
373,/,I,NNP
373,A,I,NNP
373,polymorphism,I,NN
373,and,O,CC
373,breast,B,NN
373,cancer,I,NN
373,risk,I,NN
373,.,O,.
374,However,O,RB
374,",",O,","
374,the,B,DT
374,rate,I,NN
374,of,I,IN
374,diabetic,I,JJ
374,ketoacidosis,I,NN
374,was,O,VBD
374,higher,B,RBR
374,in,O,IN
374,the,B,DT
374,sotagliflozin,I,NN
374,group,I,NN
374,.,O,.
375,A,B,DT
375,peak,I,JJ
375,GH,I,NNP
375,of,I,IN
375,11.5,I,CD
375,microg,I,NNS
375,/,I,JJ
375,liter,I,NN
375,or,I,CC
375,less,I,JJR
375,and,O,CC
375,IGF,B,NNP
375,-,I,:
375,I,I,PRP
375,SDS,I,VBP
375,-0.28,I,''
375,or,I,CC
375,less,I,RBR
375,were,O,VBD
375,highly,B,RB
375,predictive,B,JJ
375,of,I,IN
375,delayed,B,JJ
375,deterioration,I,NN
375,of,I,IN
375,GH,I,NNP
375,secretion,I,NN
375,.,O,.
376,With,B,IN
376,the,I,DT
376,assay,I,NN
376,used,I,VBN
376,",",O,","
376,changes,B,NNS
376,in,I,IN
376,the,B,DT
376,GH,I,NNP
376,peak,I,NN
376,response,I,NN
376,to,I,TO
376,GHRH+ARG,I,NNP
376,were,O,VBD
376,accompanied,B,VBN
376,by,I,IN
376,changes,B,NNS
376,in,I,IN
376,the,B,DT
376,IGF,I,NNP
376,-,I,:
376,I,I,PRP
376,SDS,I,NNP
376,",",O,","
376,metabolic,B,JJ
376,profile,I,NN
376,",",O,","
376,and,O,CC
376,carotid,B,NN
376,IMT,I,NNP
376,.,O,.
377,This,O,DT
377,reduction,B,NN
377,was,O,VBD
377,also,O,RB
377,observed,B,VBN
377,among,O,IN
377,overweight,B,JJ
377,/,I,NNPS
377,obese,I,JJ
377,and,O,CC
377,hypertensive,B,JJ
377,",",O,","
377,but,O,CC
377,not,O,RB
377,among,O,IN
377,diabetic,B,JJ
377,men,I,NNS
377,.,O,.
378,Hence,O,NNP
378,",",O,","
378,the,B,DT
378,assessment,I,NN
378,of,I,IN
378,NT,I,NNP
378,is,O,VBZ
378,predictor,B,NN
378,of,I,IN
378,cholelithiasis,B,NN
378,.,O,.
379,Among,B,IN
379,the,I,DT
379,control,I,NN
379,individuals,I,NNS
379,",",O,","
379,females,B,NNS
379,had,O,VBD
379,a,O,DT
379,significantly,B,RB
379,shorter,B,JJR
379,NT,B,NNP
379,than,O,IN
379,males,B,NNS
379,.,O,.
380,When,O,WRB
380,compared,O,VBN
380,with,O,IN
380,conventional,B,JJ
380,HWL,I,NNP
380,",",O,","
380,ROLLIS,B,NNP
380,is,O,VBZ
380,associated,B,VBN
380,with,I,IN
380,significantly,B,RB
380,less,B,JJR
380,stress,B,NN
380,and,O,CC
380,discomfort,B,NN
380,for,B,IN
380,patients,I,NNS
380,prior,I,RB
380,to,I,TO
380,breast,I,VB
380,conserving,I,NN
380,surgery,I,NN
380,.,O,.
381,NT,B,NNP
381,in,O,IN
381,control,B,NN
381,individuals,I,NNS
381,without,I,IN
381,gallstones,I,NNS
381,was,O,VBD
381,significantly,B,RB
381,prolonged,B,VBN
381,compared,O,VBN
381,with,O,IN
381,the,O,DT
381,NT,O,NNP
381,in,O,IN
381,patients,B,NNS
381,with,I,IN
381,established,I,VBN
381,gallstone,I,NN
381,disease,I,NN
381,.,O,.
382,Between,B,IN
382,2005,I,CD
382,-,I,:
382,2006,I,CD
382,and,I,CC
382,2013,I,CD
382,-,I,:
382,2014,I,CD
382,",",O,","
382,the,B,DT
382,prevalence,I,NN
382,of,I,IN
382,chronic,I,JJ
382,conditions,I,NNS
382,increased,B,VBD
382,across,B,IN
382,all,I,DT
382,segments,I,NNS
382,of,I,IN
382,the,I,DT
382,childbearing,I,VBG
382,population,I,NN
382,.,O,.
383,The,O,DT
383,reduction,B,NN
383,of,O,IN
383,plasma,B,NN
383,CETP,I,NNP
383,was,O,VBD
383,associated,B,VBN
383,with,I,IN
383,mortality,B,NN
383,.,O,.
384,Widening,B,VBG
384,disparities,I,NNS
384,were,O,VBD
384,identified,B,VBN
384,over,B,IN
384,time,I,NN
384,with,O,IN
384,key,O,JJ
384,areas,O,NNS
384,of,O,IN
384,concern,O,NN
384,including,O,VBG
384,disproportionate,B,NN
384,",",O,","
384,progressive,B,JJ
384,increases,B,NNS
384,in,I,IN
384,the,B,DT
384,burden,I,NN
384,of,I,IN
384,chronic,I,JJ
384,conditions,I,NNS
384,among,B,IN
384,women,I,NNS
384,from,I,IN
384,rural,I,JJ
384,and,I,CC
384,low,I,JJ
384,-,I,:
384,income,I,NN
384,communities,I,NNS
384,and,O,CC
384,those,B,DT
384,with,I,IN
384,deliveries,I,NNS
384,funded,I,VBN
384,by,I,IN
384,Medicaid,I,NNP
384,.,O,.
385,This,B,DT
385,was,O,VBD
385,not,B,RB
385,associated,B,VBN
385,with,I,IN
385,any,B,DT
385,dyslipidemic,I,JJ
385,changes,I,NNS
385,as,O,IN
385,the,B,DT
385,lipid,I,JJ
385,parameters,I,NNS
385,were,O,VBD
385,not,B,RB
385,elevated,B,VBN
385,in,O,IN
385,them,B,PRP
385,compared,O,VBN
385,to,O,TO
385,the,B,DT
385,healthy,I,JJ
385,controls,I,NNS
385,.,O,.
386,They,B,PRP
386,were,O,VBD
386,more,B,RBR
386,likely,I,JJ
386,to,O,TO
386,have,B,VB
386,hypertension,I,NN
386,",",O,","
386,high,B,JJ
386,triglycerides,B,NNS
386,",",O,","
386,low,B,JJ
386,high,B,JJ
386,-,I,:
386,density,I,NN
386,lipoprotein,I,NN
386,cholesterol,I,NN
386,",",O,","
386,albuminuria,B,NN
386,and,O,CC
386,elevated,B,JJ
386,alanine,B,NN
386,aminotransferase,I,NN
386,.,O,.
387,A,O,DT
387,significant,B,JJ
387,and,O,CC
387,clinically,B,RB
387,relevant,I,JJ
387,improvement,B,NN
387,in,I,IN
387,pelvic,B,JJ
387,pain,I,NN
387,and,O,CC
387,quality,B,NN
387,of,I,IN
387,life,I,NN
387,1,B,CD
387,year,I,NN
387,after,I,IN
387,laparoscopic,B,NN
387,bowel,I,NN
387,resection,I,NN
387,for,I,IN
387,endometriosis,I,NN
387,was,O,VBD
387,found,B,VBN
387,.,O,.
388,Children,B,NNP
388,with,I,IN
388,T1DM,I,NNP
388,in,B,IN
388,The,I,DT
388,Netherlands,I,NNP
388,are,O,VBP
388,24,B,CD
388,times,I,NNS
388,more,B,RBR
388,likely,I,JJ
388,to,O,TO
388,develop,B,VB
388,thyroid,I,JJ
388,disease,I,NN
388,than,O,IN
388,their,B,PRP$
388,peers,I,NNS
388,without,I,IN
388,diabetes,I,NNS
388,.,O,.
389,Consumption,B,NN
389,of,I,IN
389,minimally,I,RB
389,processed,I,VBN
389,food,I,NN
389,is,O,VBZ
389,inversely,B,RB
389,associated,B,VBN
389,with,I,IN
389,excess,B,JJ
389,weight,I,NN
389,in,B,IN
389,adolescents,I,NNS
389,.,O,.
390,Pre,B,NNP
390,-,I,:
390,operative,I,JJ
390,body,I,NN
390,mass,I,NN
390,index,I,NN
390,was,O,VBD
390,a,O,DT
390,useful,B,JJ
390,predictor,B,NN
390,for,I,IN
390,recurrence,B,NN
390,and,O,CC
390,survival,B,NN
390,in,B,IN
390,patients,I,NNS
390,who,I,WP
390,underwent,I,VBP
390,microvascular,I,JJ
390,reconstruction,I,NN
390,for,I,IN
390,head,I,NN
390,and,I,CC
390,neck,I,NN
390,squamous,I,JJ
390,cell,I,NN
390,cancer,I,NN
390,.,O,.
391,Nutritional,B,NNP
391,risk,I,NN
391,was,O,VBD
391,detected,B,VBN
391,in,I,IN
391,30,B,CD
391,%,I,NN
391,of,O,IN
391,ambulatory,B,JJ
391,ADPKD,I,NNP
391,patients,I,NNS
391,with,I,IN
391,relatively,I,RB
391,good,I,JJ
391,renal,I,JJ
391,function,I,NN
391,.,O,.
392,Intra,B,NNP
392,-,I,:
392,abdominal,I,JJ
392,organomegaly,I,NN
392,was,O,VBD
392,related,B,VBN
392,to,I,TO
392,nutritional,B,JJ
392,status,I,NN
392,independently,B,RB
392,from,I,IN
392,renal,B,JJ
392,function,I,NN
392,deterioration,I,NN
392,.,O,.
393,Although,O,IN
393,overall,B,JJ
393,hospital,I,NN
393,LOS,I,NNP
393,was,O,VBD
393,not,B,RB
393,shortened,B,VBN
393,",",O,","
393,this,B,DT
393,study,I,NN
393,proposes,B,VBZ
393,that,O,IN
393,EHR,B,NNP
393,implementation,I,NN
393,in,B,IN
393,a,I,DT
393,busy,I,JJ
393,urban,I,JJ
393,hospital,I,NN
393,was,O,VBD
393,associated,B,VBN
393,with,I,IN
393,improved,B,JJ
393,ICU,B,NNP
393,outcomes,I,NNS
393,.,O,.
394,There,O,EX
394,are,O,VBP
394,no,B,DT
394,gender,B,NN
394,differences,B,NNS
394,in,I,IN
394,achieving,B,VBG
394,lipid,I,JJ
394,goals,I,NNS
394,",",O,","
394,and,O,CC
394,age,B,NN
394,is,O,VBZ
394,a,O,DT
394,predictor,B,NN
394,of,I,IN
394,adherence,B,NN
394,.,O,.
395,Based,O,VBN
395,on,O,IN
395,the,B,DT
395,REACH,I,NNP
395,-,I,:
395,B,I,NNP
395,model,I,NN
395,",",O,","
395,long,B,JJ
395,-,I,:
395,term,I,NN
395,ETV,I,NNP
395,therapy,I,NN
395,was,O,VBD
395,associated,B,VBN
395,with,I,IN
395,a,O,DT
395,lower,B,JJR
395,than,I,IN
395,predicted,I,VBN
395,HCC,B,NNP
395,incidence,I,NN
395,.,O,.
396,In,B,IN
396,diabetic,I,JJ
396,patients,I,NNS
396,with,I,IN
396,MV,I,NNP
396,-,I,:
396,CAD,I,NNP
396,",",O,","
396,CABG,B,NNP
396,was,O,VBD
396,associated,B,VBN
396,with,I,IN
396,a,O,DT
396,lower,B,JJR
396,rate,B,NN
396,of,I,IN
396,long,I,JJ
396,-,I,:
396,term,I,NN
396,MACCE,I,NNP
396,relative,O,NN
396,to,O,TO
396,PCI,B,NNP
396,for,B,IN
396,both,I,DT
396,ACS,I,NNP
396,and,I,CC
396,SIHD,I,NNP
396,.,O,.
397,Greater,B,NNP
397,HbA1c,B,NNP
397,variability,I,NN
397,predicts,B,VBZ
397,retinopathy,B,JJ
397,",",O,","
397,early,B,JJ
397,nephropathy,I,NN
397,",",O,","
397,and,O,CC
397,CAN,B,NNP
397,",",O,","
397,in,O,IN
397,addition,O,NN
397,to,O,TO
397,established,B,VBN
397,risk,I,NN
397,factors,I,NNS
397,",",O,","
397,in,B,IN
397,adolescents,I,NNS
397,with,I,IN
397,T1D.,I,NNP
398,In,B,IN
398,this,I,DT
398,contemporary,I,JJ
398,cohort,I,NN
398,",",O,","
398,incidence,B,NN
398,of,I,IN
398,fever,I,NN
398,was,O,VBD
398,low,B,JJ
398,but,O,CC
398,CD4,B,NNP
398,cell,I,VBP
398,count,I,NN
398,less,I,JJR
398,than,I,IN
398,200,I,CD
398,/,I,JJ
398,mmÂ³,I,NN
398,remained,O,VBD
398,associated,B,VBN
398,with,I,IN
398,the,O,DT
398,highest,B,JJS
398,incidence,B,NN
398,of,I,IN
398,fever,I,NN
398,.,O,.
399,In,B,IN
399,pregnant,I,JJ
399,women,I,NNS
399,",",O,","
399,ovarian,B,JJ
399,cysts,I,NNS
399,with,I,IN
399,ground,I,NN
399,-,I,:
399,glass,I,NN
399,echogenicity,I,NN
399,and,O,CC
399,papillations,B,NNS
399,with,I,IN
399,a,I,DT
399,smooth,I,JJ
399,contour,I,NN
399,on,I,IN
399,ultrasound,I,NN
399,are,O,VBP
399,most,B,RBS
399,likely,I,JJ
399,to,O,TO
399,be,O,VB
399,decidualized,B,VBN
399,endometriomas,I,NN
399,.,O,.
400,Overall,O,JJ
400,",",O,","
400,the,B,DT
400,follow,I,NN
400,-,I,:
400,up,I,IN
400,of,I,IN
400,triage,I,NN
400,patients,I,NNS
400,showed,B,VBD
400,lower,B,JJR
400,health,B,NN
400,-,I,:
400,related,I,JJ
400,quality,I,NN
400,of,I,IN
400,life,I,NN
400,than,O,IN
400,an,B,DT
400,age-,I,JJ
400,and,I,CC
400,sex,I,NN
400,-,I,:
400,matched,I,VBN
400,control,I,NN
400,population,I,NN
400,.,O,.
401,Compared,O,VBN
401,to,O,TO
401,a,B,DT
401,cognitive,I,JJ
401,-,I,:
401,behavioral,I,JJ
401,program,I,NN
401,",",O,","
401,after,B,IN
401,the,I,DT
401,intervention,I,NN
401,",",O,","
401,adolescents,B,NNS
401,who,I,WP
401,received,I,VBD
401,mindfulness,I,NN
401,showed,B,VBD
401,greater,B,JJR
401,reductions,B,NNS
401,in,I,IN
401,depressive,B,JJ
401,symptoms,I,NNS
401,and,O,CC
401,better,B,JJR
401,insulin,B,NN
401,resistance,I,NN
401,.,O,.
402,Patients,B,NNS
402,with,I,IN
402,greater,B,JJR
402,baseline,I,NN
402,LAP,I,NNP
402,volume,I,NN
402,are,O,VBP
402,more,B,RBR
402,likely,I,JJ
402,to,O,TO
402,benefit,B,VB
402,from,I,IN
402,statin,I,JJ
402,therapy,I,NN
402,.,O,.
403,All,B,DT
403,NCD,I,NNP
403,risk,I,NN
403,factors,I,NNS
403,are,O,VBP
403,markedly,B,RB
403,high,B,JJ
403,among,O,IN
403,the,B,DT
403,urban,I,JJ
403,slum,I,NN
403,adults,I,NNS
403,.,O,.
404,Additionally,O,RB
404,",",O,","
404,very,B,RB
404,high,B,JJ
404,numbers,B,NNS
404,of,I,IN
404,OCN+,I,NNP
404,early,I,JJ
404,CEPC,I,NNP
404,tend,B,NN
404,to,O,TO
404,be,O,VB
404,linked,B,VBN
404,to,I,TO
404,the,B,DT
404,risk,I,NN
404,of,I,IN
404,all,I,DT
404,-,I,:
404,cause,I,NN
404,mortality,I,NN
404,.,O,.
405,High,B,JJ
405,lignan,B,NN
405,and,O,CC
405,yogurt,B,NN
405,consumption,I,NN
405,is,O,VBZ
405,associated,B,VBN
405,with,I,IN
405,a,O,DT
405,better,B,JJR
405,cardiovascular,B,NN
405,risk,I,NN
405,parameters,I,NNS
405,profile,I,VBP
405,in,B,IN
405,an,I,DT
405,elderly,I,JJ
405,Mediterranean,I,NNP
405,population,I,NN
405,.,O,.
406,Chronological,B,JJ
406,age,I,NN
406,and,O,CC
406,menopausal,B,NN
406,status,I,NN
406,are,O,VBP
406,both,O,DT
406,independently,B,RB
406,associated,B,VBN
406,with,I,IN
406,CVD,B,NNP
406,risk,I,NN
406,factors,I,NNS
406,.,O,.
407,Our,B,PRP$
407,investigation,I,NN
407,suggests,B,VBZ
407,that,O,IN
407,the,B,DT
407,ST14CC,I,NNP
407,-,I,:
407,PBP3IIb,I,NNP
407,/,I,VBZ
407,A,I,NNP
407,clonal,I,JJ
407,group,I,NN
407,is,O,VBZ
407,associated,B,VBN
407,with,I,IN
407,increased,B,JJ
407,clinical,B,JJ
407,virulence,I,NN
407,",",O,","
407,resistance,B,NN
407,to,I,TO
407,several,I,JJ
407,antimicrobial,I,JJ
407,agents,I,NNS
407,",",O,","
407,and,O,CC
407,is,O,VBZ
407,persistent,O,JJ
407,over,O,IN
407,time,O,NN
407,.,O,.
408,Together,O,RB
408,with,O,IN
408,mean,B,JJ
408,HbA1c,I,NNP
408,",",O,","
408,baseline,B,NN
408,urine,I,NN
408,albumin,I,SYM
408,-,I,:
408,to,I,TO
408,-,I,:
408,creatinine,I,NN
408,ratio,I,NN
408,and,O,CC
408,presence,B,NN
408,of,I,IN
408,hypertension,I,NN
408,",",O,","
408,accurate,B,VB
408,3-year,B,JJ
408,new,I,JJ
408,-,I,:
408,onset,I,NN
408,albuminuria,I,NNS
408,prediction,B,NN
408,may,B,MD
408,be,O,VB
408,possible,B,JJ
408,.,O,.
409,Patients,B,NNS
409,with,I,IN
409,body,I,NN
409,mass,I,NN
409,index,I,NN
409,>,I,VBD
409,40,I,CD
409,kg,I,NN
409,/,I,NN
409,m2,I,NN
409,have,O,VBP
409,greater,B,JJR
409,than,O,IN
409,twice,B,RB
409,the,B,DT
409,risk,I,NN
409,for,I,IN
409,complications,I,NNS
409,with,O,IN
409,odds,B,NNS
409,ratios,I,NNS
409,increasing,B,VBG
409,with,I,IN
409,increasing,B,VBG
409,body,B,NN
409,mass,I,NN
409,index,I,NN
409,class,I,NN
409,.,O,.
410,A,B,DT
410,rate,I,NN
410,-,I,:
410,based,I,VBN
410,transfusion,I,NN
410,definition,I,NN
410,identifies,B,VBZ
410,a,O,DT
410,difference,B,NN
410,in,I,IN
410,mortality,B,NN
410,in,B,IN
410,patients,I,NNS
410,who,I,WP
410,receive,I,VBP
410,greater,I,JJR
410,than,I,IN
410,4,I,CD
410,U,I,NNP
410,/,I,NNP
410,h,I,NN
410,of,I,IN
410,PRBCs,I,NNP
410,.,O,.
411,The,B,DT
411,presence,I,NN
411,of,I,IN
411,an,I,DT
411,alternative,I,JJ
411,option,I,NN
411,will,B,MD
411,produce,B,VB
411,a,B,DT
411,competing,I,NN
411,",",I,","
411,covert,I,JJ
411,influence,I,NN
411,on,I,IN
411,participants,I,NNS
412,When,B,WRB
412,eating,I,VBG
412,sandwiches,I,NNS
412,and,O,CC
412,when,B,WRB
412,in,I,IN
412,Minneapolis,I,NNP
412,",",O,","
412,participants,B,NNS
412,attributed,I,VBD
412,greater,I,JJR
412,tastiness,I,NN
412,when,O,WRB
412,pickles,B,NNS
412,were,I,VBD
412,present,I,JJ
412,than,O,IN
412,when,O,WRB
412,pickles,B,NNS
412,were,I,VBD
412,rotten,I,NNS
412,or,O,CC
412,when,O,WRB
412,pickles,B,NNS
412,were,I,VBD
412,absent,I,JJ
412,.,O,.
413,We,O,PRP
413,predicted,B,VBD
413,that,O,IN
413,Christian,B,JJ
413,participants,I,NNS
413,would,B,MD
413,allocate,B,VB
413,more,I,JJR
413,money,I,NN
413,to,I,TO
413,ingroup,B,VB
413,than,O,IN
413,outgroup,B,JJ
413,partners,I,NNS
413,(,O,(
413,i.e.,O,FW
413,",",O,","
413,Christians,B,NNPS
413,would,B,MD
413,demonstrate,B,VB
413,an,B,DT
413,ingroup,I,NN
413,bias,I,NN
413,),O,)
413,",",O,","
413,but,O,CC
413,that,O,IN
413,this,B,DT
413,eï¬ect,I,NN
413,would,B,MD
413,be,O,VB
413,attenuated,B,VBN
413,or,O,CC
413,absent,B,JJ
413,among,B,IN
413,atheist,I,JJ
413,participants,I,NNS
413,.,O,.
414,We,O,PRP
414,predicted,B,VBD
414,that,O,IN
414,the,B,DT
414,angry,I,JJ
414,face,I,NN
414,would,B,MD
414,be,O,VB
414,the,O,DT
414,least,B,JJS
414,preferable,B,JJ
414,.,O,.
415,Somebody,B,NN
415,'s,I,POS
415,model,I,NN
415,and,O,CC
415,our,B,PRP$
415,intuitions,I,NNS
415,propose,B,VBP
415,that,O,IN
415,delicious,B,JJ
415,cookie,I,NNS
415,cake,I,VBP
415,is,O,VBZ
415,inversely,B,RB
415,correlated,B,VBN
415,with,I,IN
415,hunger,B,NN
415,in,B,IN
415,Minnesotan,I,NNP
415,subjects,I,NNS
415,.,O,.
416,the,O,DT
416,hypothesized,B,VBN
416,interaction,B,NN
416,between,O,IN
416,religious,B,JJ
416,aï¬liation,I,NN
416,and,O,CC
416,partner,B,NN
416,group,I,NN
416,membership,I,NN
416,was,O,VBD
416,signiï¬cant,B,JJ
416,",",O,","
416,F(1293,O,NNP
416,),O,)
416,=,O,VBD
416,"5.21,p",O,CD
416,=,O,NN
416,0.023,O,CD
416,",",O,","
416,Î·2p,O,NNP
416,=,O,VBZ
416,0.02,O,CD
417,A,O,DT
417,binary,B,JJ
417,logistic,I,JJ
417,regression,I,NN
417,with,O,IN
417,uncertainty,B,NN
417,condition,I,NN
417,",",O,","
417,task,B,NN
417,construal,I,JJ
417,",",O,","
417,and,O,CC
417,their,O,PRP$
417,interaction,B,NN
417,entered,O,VBD
417,as,O,IN
417,predictors,O,NNS
417,and,O,CC
417,the,B,DT
417,task,I,NN
417,resumption,I,NN
417,rate,I,NN
417,as,O,IN
417,the,O,DT
417,dependent,O,NN
417,variable,O,NN
418,This,B,DT
418,sign+,B,NN
418,that,B,WDT
418,.,O,.
419,Health,B,NNP
419,care,I,NN
419,expenditures,I,VBZ
419,increase,B,NN
419,with,I,IN
419,closeness,B,NN
419,to,I,TO
419,time,I,NN
419,of,I,IN
419,death,I,NN
420,However,O,RB
420,",",O,","
420,it,O,PRP
420,is,O,VBZ
420,clear,O,JJ
420,that,O,IN
420,finding,B,VBG
420,an,I,DT
420,effective,I,JJ
420,antiviral,I,NN
420,and,O,CC
420,developing,B,VBG
420,a,I,DT
420,vaccine,I,NN
420,are,O,VBP
420,still,O,RB
420,significant,O,JJ
420,challenges,O,NNS
420,.,O,.
421,We,O,PRP
421,predict,B,VBP
421,that,O,IN
421,this,B,DT
421,subjective,I,JJ
421,experience,I,NN
421,of,I,IN
421,"\""feeling",I,VBG
421,right\,I,NN
421,"""",I,NN
421,will,B,MD
421,mediate,B,VB
421,the,B,DT
421,rounded,I,JJ
421,price,I,NN
421,effect,I,NN
422,Weight,B,NNP
422,reduction,B,NN
422,is,O,VBZ
422,an,O,DT
422,effective,B,JJ
422,treatment,B,NN
422,for,I,IN
422,UI,B,NNP
422,in,B,IN
422,overweight,I,NN
422,and,I,CC
422,obese,I,JJ
422,women,I,NNS
423,we,O,PRP
423,predicted,B,VBD
423,that,O,IN
423,sex,B,NN
423,-,I,:
423,differentiation,I,NN
423,accuracy,I,NN
423,would,B,MD
423,be,O,VB
423,higher,B,JJR
423,for,O,IN
423,East,B,NNP
423,Asian,I,NNP
423,than,O,IN
423,Caucasian,B,JJ
423,participants,I,NNS
423,.,O,.
424,we,O,PRP
424,predicted,B,VBD
424,that,O,IN
424,sex,B,NN
424,-,I,:
424,differentiation,I,NN
424,accuracy,I,NN
424,would,B,MD
424,be,O,VB
424,lower,B,JJR
424,for,O,IN
424,East,B,NNP
424,Asian,I,NNP
424,than,O,IN
424,Caucasian,B,JJ
424,participants,I,NNS
424,.,O,.
425,Direct,B,JJ
425,eye,I,NN
425,gaze,I,NN
425,has,O,VBZ
425,been,O,VBN
425,associated,B,VBN
425,with,I,IN
425,enhanced,B,JJ
425,intensity,B,NN
425,and,O,CC
425,speed,B,NN
425,of,I,IN
425,correct,I,JJ
425,recognition,I,NN
425,of,I,IN
425,happy,I,JJ
425,faces,I,VBZ
425,(,O,(
425,Adams,B,NNP
425,&,I,CC
425,Kleck,I,NNP
425,",",I,","
425,2003,I,CD
425,",",I,","
425,2005,I,CD
425,),O,)
425,and,O,CC
425,sign+,B,VBZ
425,the,B,DT
425,attractiveness,I,NN
425,of,I,IN
425,faces,I,VBZ
425,(,O,(
425,Mason,B,NNP
425,",",I,","
425,Tatkow,I,NNP
425,",",I,","
425,&,I,CC
425,Macrae,I,NNP
425,",",I,","
425,2005,I,CD
425,),O,)
426,Evidence,B,NN
426,is,I,VBZ
426,mixed,I,JJ
426,about,O,IN
426,whether,B,IN
426,health,B,NN
426,insurance,I,NN
426,improves,B,VBZ
426,health,B,NN
426,status,I,NN
427,When,B,WRB
427,eating,I,VBG
427,sandwiches,I,NNS
427,",",O,","
427,participants,B,NNS
427,judged,I,VBD
427,tastiness,I,NN
427,as,O,IN
427,greater,B,JJR
427,when,O,WRB
427,pickles,B,NNS
427,were,I,VBD
427,present,I,JJ
427,than,O,IN
427,when,O,WRB
427,pickles,B,NNS
427,were,I,VBD
427,rotten,I,NNS
427,or,O,CC
427,when,O,WRB
427,pickles,B,NNS
427,were,I,VBD
427,absent,I,JJ
427,.,O,.
428,Our,B,PRP$
428,study,I,NN
428,shows,B,VBZ
428,that,O,IN
428,there,O,EX
428,are,O,VBP
428,cardiovascular,B,JJ
428,risks,I,NNS
428,associated,B,VBN
428,with,I,IN
428,smoking,B,NN
428,.,O,.
429,Issues,B,NNS
429,that,O,WDT
429,are,O,VBP
429,associated,B,VBN
429,with,I,IN
429,a,B,DT
429,heavy,I,JJ
429,weight,I,NN
429,should,B,MD
429,be,O,VB
429,judged,B,VBN
429,to,I,TO
429,be,I,VB
429,more,I,RBR
429,important,I,JJ
429,than,O,IN
429,issues,B,NNS
429,that,O,WDT
429,are,O,VBP
429,associated,B,VBN
429,with,I,IN
429,a,B,DT
429,light,I,JJ
429,weight,I,NN
429,.,O,.
430,These,B,DT
430,patients,I,NNS
430,are,O,VBP
430,more,B,RBR
430,likely,I,JJ
430,to,O,TO
430,test,B,VB
430,positive,I,JJ
430,for,I,IN
430,viral,I,JJ
430,RNA,I,NNP
430,in,I,IN
430,stool,I,NN
430,",",O,","
430,to,O,TO
430,have,B,VB
430,a,I,DT
430,longer,B,RBR
430,delay,I,NN
430,before,I,IN
430,viral,I,JJ
430,clearance,I,NN
430,",",O,","
430,and,O,CC
430,to,O,TO
430,experience,B,VB
430,delayed,I,JJ
430,diagnosis,I,NN
430,compared,O,VBN
430,with,O,IN
430,patients,B,NNS
430,with,I,IN
430,only,I,JJ
430,respiratory,I,NN
430,symptoms,I,NNS
430,.,O,.
431,Top,B,JJ
431,-,I,:
431,down,I,RP
431,cleaning,I,VBG
431,adequate,B,JJ
431,to,O,TO
431,reduce,B,VB
431,bioburden,B,NN
431,.,O,.
432,To,O,TO
432,reduce,B,VB
432,the,B,DT
432,use,I,NN
432,of,I,IN
432,surgical,I,JJ
432,masks,I,NNS
432,and,O,CC
432,to,O,TO
432,reduce,B,VB
432,potential,B,JJ
432,COVID-19,I,NNP
432,exposure,I,NN
432,",",O,","
432,use,B,VBP
432,relatively,I,RB
432,long,I,JJ
432,(,I,(
432,eg,I,NN
432,",",I,","
432,12hours,I,CD
432,),I,)
432,staff,I,NN
432,shifts,I,NNS
432,.,O,.
433,Children,B,NNP
433,under,I,IN
433,10,I,CD
433,years,I,NNS
433,of,I,IN
433,age,I,NN
433,were,O,VBD
433,less,B,RBR
433,likely,I,JJ
433,to,O,TO
433,receive,B,VB
433,a,I,DT
433,positive,I,JJ
433,result,I,NN
433,than,O,IN
433,were,O,VBD
433,persons,B,NNS
433,10,I,CD
433,years,I,NNS
433,of,I,IN
433,age,I,NN
433,or,I,CC
433,older,I,JJR
434,During,B,IN
434,a,I,DT
434,two,I,CD
434,week,I,NN
434,period,I,NN
434,in,I,IN
434,February,I,NNP
434,2020,I,CD
434,",",O,","
434,the,B,DT
434,emotional,I,JJ
434,state,I,NN
434,and,O,CC
434,behavior,B,NN
434,of,I,IN
434,participants,I,NNS
434,in,B,IN
434,Hubei,I,NNP
434,improved,B,VBD
434,",",O,","
434,but,O,CC
434,the,B,DT
434,quality,I,NN
434,of,I,IN
434,sleep,I,NN
434,did,O,VBD
434,not,O,RB
434,.,O,.
435,During,B,IN
435,a,I,DT
435,two,I,CD
435,-,I,:
435,week,I,NN
435,period,I,NN
435,",",O,","
435,front,B,JJ
435,-,I,:
435,line,I,NN
435,health,I,NN
435,workers,I,NNS
435,and,O,CC
435,people,B,NNS
435,in,I,IN
435,Hubei,I,NNP
435,Province,I,NNP
435,became,O,VBD
435,less,B,RBR
435,anxious,B,JJ
435,about,I,IN
435,the,I,DT
435,COVID-19,I,NNP
435,epidemic,I,NN
435,",",O,","
435,but,O,CC
435,sleep,B,JJ
435,quality,I,NN
435,did,O,VBD
435,not,B,RB
435,improve,B,VB
435,.,O,.
436,We,O,PRP
436,report,B,VBP
436,that,O,IN
436,the,B,DT
436,nano,I,JJ
436,-,I,:
436,dimension,I,NN
436,sign+,B,NN
436,with,I,IN
436,the,B,DT
436,film,I,NN
436,thickness,I,NN
436,",",O,","
436,ranging,O,VBG
436,from,O,IN
436,17â42,O,CD
436,nm,O,NNS
436,.,O,.
437,The,O,DT
437,question,B,NN
437,is,O,VBZ
437,if,O,IN
437,the,B,DT
437,nano,I,NN
437,-,I,:
437,dimension,I,NN
437,also,O,RB
437,sign+,B,VBZ
437,with,I,IN
437,columnar,B,JJ
437,crystal,I,JJ
437,size,I,NN
437,.,O,.
438,Our,B,PRP$
438,patient,I,NN
438,improved,B,VBN
438,significantly,B,RB
438,.,O,.
439,We,O,PRP
439,sought,O,VBD
439,to,O,TO
439,show,B,VB
439,how,O,WRB
439,these,B,DT
439,control,I,VB
439,measures,I,NNS
439,impacted,B,VBN
439,the,B,DT
439,containment,I,NN
439,of,I,IN
439,the,I,DT
439,epidemic,I,NN
439,.,O,.
440,This,B,DT
440,study,I,NN
440,aims,O,VBZ
440,to,O,TO
440,investigate,B,VB
440,whether,B,IN
440,MSC,B,NNP
440,transplantation,I,NN
440,improves,B,VBZ
440,the,B,DT
440,outcome,I,NN
440,of,I,IN
440,7,I,CD
440,enrolled,I,JJ
440,patients,I,NNS
440,with,I,IN
440,COVID-19,I,NNP
440,pneumonia,I,NN
440,in,B,IN
440,Beijing,I,NNP
440,YouAn,I,NNP
440,Hospital,I,NNP
440,",",I,","
440,China,I,NNP
440,",",O,","
440,from,B,IN
440,Jan,I,NNP
440,23,I,CD
440,",",I,","
440,2020,I,CD
440,to,I,TO
440,Feb,I,NNP
440,16,I,CD
440,",",I,","
440,2020,I,CD
440,.,O,.
441,MSCs,B,NNP
441,could,B,MD
441,cure,B,VB
441,or,O,CC
441,significantly,B,RB
441,improve,B,VB
441,the,B,DT
441,functional,I,JJ
441,outcomes,I,NNS
441,of,I,IN
441,seven,I,CD
441,patients,I,NNS
441,without,B,IN
441,observed,I,JJ
441,adverse,I,JJ
441,effects,I,NNS
441,.,O,.
442,In,O,IN
442,light,O,NN
442,of,O,IN
442,this,O,DT
442,",",O,","
442,a,O,DT
442,countermeasure,O,NN
442,that,O,WDT
442,has,O,VBZ
442,been,O,VBN
442,shown,B,VBN
442,to,O,TO
442,be,O,VB
442,effective,B,JJ
442,in,I,IN
442,the,B,DT
442,analogous,I,JJ
442,condition,I,NN
442,of,I,IN
442,HAPE,I,NNP
442,is,O,VBZ
442,Acetazolamide,B,NNP
442,.,O,.
443,In,B,IN
443,children,I,NNS
443,COVID-19,B,NNP
443,related,I,JJ
443,disease,I,NN
443,is,O,VBZ
443,less,B,RBR
443,frequent,I,JJ
443,and,O,CC
443,less,B,RBR
443,aggressive,I,JJ
443,.,O,.
444,On,O,IN
444,the,O,DT
444,basis,O,NN
444,of,O,IN
444,current,B,JJ
444,studies,I,NNS
444,",",O,","
444,it,O,PRP
444,would,O,MD
444,appear,O,VB
444,that,O,IN
444,the,B,DT
444,combined,I,JJ
444,antiviral,I,JJ
444,treatment,I,NN
444,has,O,VBZ
444,shown,O,VBN
444,the,O,DT
444,highest,B,JJS
444,success,B,NN
444,rate,I,NN
444,.,O,.
445,A,B,DT
445,five,I,CD
445,-,I,:
445,day,I,NN
445,delay,I,NN
445,in,I,IN
445,implementation,I,NN
445,would,B,MD
445,have,O,VB
445,increased,B,VBN
445,epidemic,B,JJ
445,size,I,NN
445,in,B,IN
445,mainland,I,NN
445,China,I,NNP
445,three,B,CD
445,-,I,:
445,fold,I,NN
445,.,O,.
446,In,O,IN
446,the,B,DT
446,"""",I,NN
446,Severe,I,NNP
446,"""",I,NNP
446,group,I,NN
446,",",O,","
446,there,O,EX
446,was,O,VBD
446,significantly,B,RB
446,more,B,JJR
446,elderly,B,JJ
446,patients,I,NNS
446,(,O,(
446,p=0.045,O,NN
446,),O,)
446,",",O,","
446,higher,B,JJR
446,lactate,B,JJ
446,dehydrogenase,I,NN
446,levels,I,NNS
446,(,O,(
446,p=0.002,O,NN
446,),O,)
446,",",O,","
446,and,O,CC
446,elevated,B,VBD
446,C,B,NNP
446,-,I,:
446,Reactive,I,JJ
446,protein,I,NN
446,levels,I,NNS
446,compared,O,VBN
446,to,O,TO
446,the,B,DT
446,"""",I,NNP
446,Mild,I,NNP
446,to,I,TO
446,Moderate,I,NNP
446,"""",I,NNP
446,group,I,NN
446,(,O,(
446,p<0.001,O,NN
446,),O,)
446,.,O,.
447,There,O,EX
447,is,O,VBZ
447,clear,B,JJ
447,evidence,I,NN
447,that,O,IN
447,IL-6,B,NNP
447,peak,I,NN
447,levels,I,NNS
447,are,O,VBP
447,associated,B,VBN
447,with,I,IN
447,severity,B,NN
447,of,I,IN
447,pulmonary,I,JJ
447,complications,I,NNS
447,.,O,.
448,Tweets,B,NNS
448,from,I,IN
448,unverified,I,JJ
448,Twitter,I,NNP
448,accounts,I,NNS
448,contained,B,VBD
448,more,B,JJR
448,misinformation,I,NN
448,(,O,(
448,31.0,O,CD
448,%,O,NN
448,vs,O,JJ
448,12.6,O,CD
448,%,O,NN
448,for,O,IN
448,verified,O,JJ
448,accounts,O,NNS
448,",",O,","
448,p,O,NN
448,:,O,:
448,<,O,JJ
448,0.001,O,CD
448,),O,)
448,.,O,.
449,Preliminary,B,JJ
449,evidence,I,NN
449,suggests,B,VBZ
449,children,B,NNS
449,are,O,VBP
449,just,B,RB
449,as,I,RB
449,likely,I,JJ
449,as,O,IN
449,adults,B,NNS
449,to,O,TO
449,become,B,VB
449,infected,I,JJ
449,with,I,IN
449,SARS,I,NNP
449,-,I,:
449,CoV-2,I,JJ
449,but,O,CC
449,are,O,VBP
449,less,B,RBR
449,likely,I,JJ
449,to,O,TO
449,be,B,VB
449,symptomatic,I,JJ
449,or,O,CC
449,develop,B,VB
449,severe,I,JJ
449,symptoms,I,NNS
449,.,O,.
450,Children,B,NNP
450,more,B,RBR
450,often,I,RB
450,have,B,VBP
450,gastrointestinal,I,JJ
450,symptoms,I,NNS
450,compared,O,VBN
450,with,O,IN
450,adults,B,NNS
450,.,O,.
451,In,O,IN
451,contrast,O,NN
451,",",O,","
451,adults,B,NNS
451,more,B,RBR
451,often,I,RB
451,have,B,VBP
451,a,I,DT
451,nosocomial,I,JJ
451,exposure,I,NN
451,.,O,.
452,In,O,IN
452,this,B,DT
452,paper,I,NN
452,",",O,","
452,we,O,PRP
452,describe,B,VBP
452,the,O,DT
452,potential,B,NN
452,of,O,IN
452,simulation,B,NN
452,to,O,TO
452,improve,B,VB
452,hospital,B,NN
452,responses,I,NNS
452,to,I,TO
452,the,I,DT
452,COVID-19,I,NNP
452,crisis,I,NN
452,.,O,.
453,On,B,IN
453,day,I,NN
453,10,I,CD
453,",",O,","
453,her,B,PRP$
453,chest,I,NN
453,radiography,I,NN
453,and,O,CC
453,lung,B,NN
453,compliance,I,NN
453,improved,B,VBD
453,.,O,.
454,During,B,IN
454,the,I,DT
454,first,I,JJ
454,22,I,CD
454,days,I,NNS
454,",",O,","
454,the,B,DT
454,incidence,I,NN
454,rate,I,NN
454,of,I,IN
454,COVID-19,I,NNP
454,increased,B,VBD
454,significantly,B,RB
454,to,B,TO
454,reach,I,VB
454,1.81,I,CD
454,cases,I,NNS
454,per,I,IN
454,million,I,CD
454,persons,I,NNS
454,(,O,(
454,p<0.001,O,NN
454,),O,)
454,.,O,.
455,Development,B,NNP
455,of,I,IN
455,new,I,JJ
455,onset,I,VBN
455,myocardial,I,JJ
455,injury,I,NN
455,during,B,IN
455,COVID-19,I,NNP
455,also,O,RB
455,sign+,B,VBZ
455,mortality,B,NN
455,.,O,.
456,Participants,O,NNS
456,with,O,IN
456,better,B,JJR
456,sleep,B,NN
456,quality,I,NN
456,or,O,CC
456,less,B,JJR
456,frequency,B,NN
456,of,I,IN
456,early,I,JJ
456,awakenings,I,NNS
456,reported,B,VBD
456,lower,B,JJR
456,PTSS,B,NNP
456,.,O,.
457,Conclusion,O,NN
457,Optimising,B,VBG
457,our,I,PRP$
457,procedures,I,NNS
457,reduces,B,VBZ
457,anxiety,B,NN
457,and,O,CC
457,reassures,O,VBZ
457,the,O,DT
457,population,O,NN
457,and,O,CC
457,decision,O,NN
457,makers,O,NNS
457,.,O,.
458,For,B,IN
458,an,I,DT
458,epidemic,I,JJ
458,to,I,TO
458,take,I,VB
458,hold,I,NN
458,",",O,","
458,the,B,DT
458,value,I,NN
458,of,I,IN
458,R0,I,NNP
458,must,B,MD
458,be,O,VB
458,greater,B,JJR
458,than,I,IN
458,unity,B,NN
458,in,O,IN
458,value,B,NN
458,.,O,.
459,Results,O,NNS
459,Respiratory,B,NNP
459,illness,I,NN
459,is,O,VBZ
459,the,O,DT
459,dominant,B,JJ
459,clinical,B,JJ
459,manifestation,B,NN
459,of,I,IN
459,COVID-19,B,NNP
459,;,O,:
459,CV,B,NNP
459,involvement,I,NN
459,occurs,B,VBZ
459,much,I,RB
459,less,I,JJR
459,commonly,I,RB
459,.,O,.
460,This,B,DT
460,indicates,B,VBZ
460,that,O,IN
460,predictions,B,NNS
460,using,I,VBG
460,more,I,RBR
460,complex,I,JJ
460,models,I,NNS
460,may,B,MD
460,not,B,RB
460,be,O,VB
460,more,B,RBR
460,reliable,B,JJ
460,compared,O,VBN
460,to,O,TO
460,using,B,VBG
460,a,I,DT
460,simpler,I,NN
460,model,I,NN
460,.,O,.
461,Emerging,B,VBG
461,data,I,NNS
461,suggest,B,VBP
461,an,O,DT
461,increased,B,VBN
461,association,B,NN
461,and,O,CC
461,a,O,DT
461,heightened,B,JJ
461,mortality,B,NN
461,in,O,IN
461,patients,B,NNS
461,of,I,IN
461,COVID-19,I,NNP
461,with,I,IN
461,comorbidities,I,NNS
461,.,O,.
462,Taken,O,VBN
462,together,O,RB
462,",",O,","
462,these,B,DT
462,data,I,NNS
462,seem,B,VBP
462,to,I,TO
462,indicate,I,VB
462,that,O,IN
462,there,O,EX
462,might,B,MD
462,be,O,VB
462,a,O,DT
462,sex,B,NN
462,predisposition,B,NN
462,to,O,TO
462,COVID-19,B,NNP
462,",",O,","
462,with,O,IN
462,men,B,NNS
462,more,B,RBR
462,prone,B,NN
462,to,I,TO
462,being,I,VBG
462,affected,I,VBN
462,.,O,.
463,Measurements,O,NNS
463,and,O,CC
463,Main,O,NNP
463,Results,O,NNP
463,Cross,B,NNP
463,-,I,:
463,infection,I,NN
463,in,B,IN
463,the,I,DT
463,operating,I,NN
463,rooms,I,NNS
463,of,I,IN
463,the,I,DT
463,4,I,CD
463,hospitals,I,NNS
463,was,O,VBD
463,effectively,B,RB
463,reduced,B,VBN
463,by,O,IN
463,implementing,B,VBG
463,the,I,DT
463,new,I,JJ
463,measures,I,NNS
463,and,I,CC
463,procedures,I,NNS
463,.,O,.
464,Compared,O,VBN
464,with,O,IN
464,the,B,DT
464,blood,I,NN
464,test,I,NN
464,at,I,IN
464,disease,I,NN
464,onset,I,NN
464,",",O,","
464,the,B,DT
464,results,I,NNS
464,showed,B,VBD
464,that,O,IN
464,the,B,DT
464,eosinophil,I,NN
464,count,I,NN
464,was,O,VBD
464,still,B,RB
464,below,B,IN
464,the,B,DT
464,normal,I,JJ
464,range,I,NN
464,",",O,","
464,which,O,WDT
464,was,O,VBD
464,even,B,RB
464,lower,B,JJR
464,than,O,IN
464,the,B,DT
464,first,I,JJ
464,time,I,NN
464,.,O,.
465,The,O,DT
465,spectrum,O,NN
465,of,O,IN
465,chest,O,NN
465,imaging,O,VBG
465,manifestations,B,NNS
465,of,I,IN
465,COVID-19,B,NNP
465,pneumonia,I,NN
465,upon,B,IN
465,admission,I,NN
465,includes,O,VBZ
465,B,B,NNP
465,-,I,:
465,lines,I,NNS
465,and,I,CC
465,consolidations,I,NNS
465,on,I,IN
465,US,I,NNP
465,",",O,","
465,consolidations,B,NNS
465,and,I,CC
465,hazy,I,NN
465,increased,I,VBD
465,opacities,I,NNS
465,on,I,IN
465,CXR,I,NNP
465,",",O,","
465,and,O,CC
465,multifocal,B,JJ
465,GGO,I,NNP
465,with,I,IN
465,consolidations,I,NNS
465,on,I,IN
465,CT,I,NNP
465,.,O,.
466,Collectively,O,RB
466,",",O,","
466,these,B,DT
466,results,I,NNS
466,suggest,B,VBP
466,that,O,IN
466,MSCs,B,NNP
466,significantly,B,RB
466,improve,B,VB
466,the,B,DT
466,survival,I,NN
466,rate,I,NN
466,of,I,IN
466,H7N9-induced,I,NNP
466,ARDS,I,NNP
466,and,O,CC
466,provide,O,VB
466,a,O,DT
466,theoretical,O,JJ
466,basis,O,NN
466,for,O,IN
466,the,B,DT
466,treatment,I,NN
466,of,I,IN
466,H7N9-induced,I,NNP
466,ARDS,I,NNP
466,in,O,IN
466,both,O,DT
466,preclinical,O,JJ
466,research,O,NN
466,and,O,CC
466,clinical,O,JJ
466,studies,O,NNS
466,.,O,.
467,In,O,IN
467,our,B,PRP$
467,study,I,NN
467,",",O,","
467,we,O,PRP
467,demonstrate,B,VBP
467,that,O,DT
467,nonidentifiability,B,NN
467,in,I,IN
467,model,I,NN
467,calibrations,I,NNS
467,using,I,VBG
467,the,I,DT
467,confirmed,I,VBN
467,-,I,:
467,case,I,NN
467,data,I,NNS
467,is,O,VBZ
467,the,O,DT
467,main,B,JJ
467,reason,B,NN
467,for,I,IN
467,such,B,JJ
467,wide,I,JJ
467,variations,I,NNS
467,.,O,.
468,Numerical,B,JJ
468,simulations,I,NNS
468,show,B,VBP
468,the,O,DT
468,suitability,B,NN
468,of,O,IN
468,the,B,DT
468,proposed,I,VBN
468,COVID-19,I,NNP
468,model,I,NN
468,for,O,IN
468,the,B,DT
468,outbreak,I,NN
468,that,O,WDT
468,occurred,O,VBD
468,in,B,IN
468,Wuhan,I,NNP
468,",",I,","
468,China,I,NNP
468,.,O,.
469,The,B,DT
469,number,I,NN
469,of,I,IN
469,T,I,NNP
469,cells,I,NNS
469,significantly,B,RB
469,decreased,B,VBN
469,",",O,","
469,and,O,CC
469,more,B,JJR
469,hampered,B,VBN
469,in,O,IN
469,severe,B,JJ
469,cases,I,NNS
469,.,O,.
470,China,B,NNP
470,âs,I,NNP
470,bond,I,NN
470,and,O,CC
470,strict,B,JJ
470,containment,I,NN
470,measures,I,NNS
470,have,O,VBP
470,been,O,VBN
470,proved,B,VBN
470,(,O,(
470,in,B,IN
470,practice,I,NN
470,),O,)
470,to,O,TO
470,significantly,B,RB
470,reduce,B,VB
470,the,B,DT
470,spread,I,NN
470,of,I,IN
470,the,I,DT
470,epidemic,I,NN
470,.,O,.
471,Patients,B,NNS
471,with,I,IN
471,COVID-19,I,NNP
471,also,O,RB
471,have,O,VBP
471,lower,B,JJR
471,level,B,NN
471,of,I,IN
471,regulatory,I,JJ
471,T,I,NNP
471,cells,I,NNS
471,",",O,","
471,and,O,CC
471,more,B,JJR
471,obviously,I,RB
471,damaged,B,VBN
471,in,B,IN
471,severe,I,JJ
471,cases,I,NNS
471,.,O,.
472,Most,B,JJS
472,of,I,IN
472,severe,I,JJ
472,cases,I,NNS
472,demonstrated,B,VBD
472,elevated,B,JJ
472,levels,B,NNS
472,of,I,IN
472,infection,I,NN
472,-,I,:
472,related,I,JJ
472,biomarkers,I,NNS
472,and,O,CC
472,inflammatory,B,JJ
472,cytokines,I,NNS
472,.,O,.
473,We,O,PRP
473,found,B,VBD
473,that,O,IN
473,the,B,DT
473,epidemic,I,NN
473,of,I,IN
473,China,I,NNP
473,should,B,MD
473,peak,B,VB
473,by,B,IN
473,late,I,JJ
473,February,I,NNP
473,",",O,","
473,showing,O,VBG
473,gradual,B,JJ
473,decline,B,NN
473,by,B,IN
473,end,I,NN
473,of,I,IN
473,April,I,NNP
473,.,O,.
474,Older,B,JJR
474,age,B,NN
474,and,O,CC
474,co,B,NN
474,-,I,:
474,morbid,I,NN
474,conditions,I,NNS
474,increase,B,VBP
474,the,B,DT
474,fatality,I,NN
474,.,O,.
475,Using,O,VBG
475,the,O,DT
475,Akaike,B,NNP
475,Information,I,NNP
475,Criterion,I,NNP
475,(,I,(
475,AIC,I,NNP
475,),I,)
475,for,I,IN
475,model,I,NN
475,selection,I,NN
475,",",O,","
475,we,O,PRP
475,show,B,VBP
475,that,O,IN
475,an,B,DT
475,SIR,I,NNP
475,model,I,NN
475,performs,O,NNS
475,much,B,RB
475,better,B,JJR
475,than,O,IN
475,an,B,DT
475,SEIR,I,NNP
475,model,I,NN
475,in,O,IN
475,representing,B,VBG
475,the,I,DT
475,information,I,NN
475,contained,I,VBN
475,in,I,IN
475,the,I,DT
475,confirmed,I,JJ
475,-,I,:
475,case,I,NN
475,data,I,NNS
475,.,O,.
476,As,O,IN
476,the,B,DT
476,severity,I,NN
476,of,I,IN
476,the,I,DT
476,disease,I,NN
476,increased,B,VBD
476,",",O,","
476,digestive,B,JJ
476,symptoms,I,NNS
476,became,I,VBD
476,more,B,RBR
476,pronounced,I,JJ
476,.,O,.
477,This,B,DT
477,evidence,I,NN
477,supports,B,VBZ
477,the,O,DT
477,benefit,B,NN
477,of,O,IN
477,using,B,VBG
477,ACEIs,I,NNP
477,or,O,CC
477,ARBs,B,NNP
477,to,O,TO
477,potentially,B,RB
477,contribute,B,VB
477,to,I,TO
477,the,O,DT
477,improvement,B,NN
477,of,O,IN
477,clinical,B,JJ
477,outcomes,I,NNS
477,of,I,IN
477,COVID-19,I,JJ
477,patients,I,NNS
477,with,B,IN
477,hypertension,I,NN
477,.,O,.
478,Both,O,DT
478,epidemiological,B,JJ
478,and,I,CC
478,laboratory,I,JJ
478,studies,I,NNS
478,have,O,VBP
478,shown,B,VBN
478,that,O,IN
478,ambient,B,JJ
478,temperature,I,NN
478,could,B,MD
478,affect,B,VB
478,the,B,DT
478,transmission,I,NN
478,and,O,CC
478,survival,B,NN
478,of,I,IN
478,coronaviruses,I,NNS
478,.,O,.
479,A,B,DT
479,trial,I,NN
479,of,I,IN
479,2,I,CD
479,g,I,NN
479,of,I,IN
479,PO,I,NNP
479,or,O,CC
479,IV,B,NNP
479,glutathione,I,NN
479,was,O,VBD
479,used,O,VBN
479,in,B,IN
479,both,I,DT
479,patients,I,NNS
479,and,O,CC
479,improved,B,VBN
479,their,B,PRP$
479,dyspnea,I,NN
479,within,B,IN
479,1,I,CD
479,h,I,NN
479,of,I,IN
479,use,I,NN
479,.,O,.
480,Recent,B,JJ
480,outbreak,I,NN
480,of,I,IN
480,Coronavirus,I,NNP
480,disease,I,NN
480,(,O,(
480,COVID-19,B,NNP
480,),O,)
480,pandemic,O,VBP
480,around,B,IN
480,the,I,DT
480,world,I,NN
480,is,O,VBZ
480,associated,B,VBN
480,with,I,IN
480,â,O,NNP
480,severe,B,JJ
480,acute,I,JJ
480,respiratory,I,NN
480,syndrome,I,NN
480,â,O,NNP
480,(,O,(
480,SARS,B,NNP
480,-,I,:
480,CoV2,I,NN
480,),O,)
480,in,B,IN
480,humans,I,NNS
480,.,O,.
481,This,B,DT
481,study,I,NN
481,demonstrated,B,VBD
481,that,O,IN
481,intravenous,B,JJ
481,infusion,I,NN
481,of,I,IN
481,MSCs,I,NNP
481,is,O,VBZ
481,a,O,DT
481,safe,B,JJ
481,and,O,CC
481,effective,B,JJ
481,approach,O,NN
481,for,O,IN
481,treating,B,VBG
481,patients,B,NNS
481,with,I,IN
481,COVID-19,I,NNP
481,pneumonia,I,NN
481,",",O,","
481,including,O,VBG
481,elderly,B,JJ
481,patients,I,NNS
481,displaying,I,VBG
481,severe,I,JJ
481,pneumonia,I,NN
481,.,O,.
482,Abstract,O,VB
482,The,B,DT
482,confirmed,I,NN
482,and,I,CC
482,suspected,I,JJ
482,cases,I,NNS
482,of,I,IN
482,the,I,DT
482,2019,I,CD
482,novel,I,NN
482,coronavirus,I,NN
482,disease,I,NN
482,(,O,(
482,COVID-19,B,NNP
482,),O,)
482,have,O,VBP
482,increased,B,VBN
482,not,O,RB
482,only,O,RB
482,in,B,IN
482,Wuhan,I,NNP
482,",",I,","
482,Hubei,I,NNP
482,Province,I,NNP
482,but,O,CC
482,also,O,RB
482,China,B,NNP
482,and,O,CC
482,the,B,DT
482,world,I,NN
482,.,O,.
483,When,B,WRB
483,mean,I,JJ
483,temperature,I,NN
483,(,I,(
483,lag0â14,I,NN
483,),I,)
483,was,I,VBD
483,below,I,IN
483,3,I,CD
483,Â°,I,JJ
483,C,I,NNP
483,",",O,","
483,each,B,DT
483,1,I,CD
483,Â°,I,NN
483,C,I,NNP
483,rise,I,NN
483,was,O,VBD
483,associated,B,VBN
483,with,I,IN
483,a,O,DT
483,4.861,B,CD
483,%,I,NN
483,(,O,(
483,95,O,CD
483,%,O,NN
483,CI,O,NNP
483,:,O,:
483,3.209â6.513,O,CD
483,),O,)
483,increase,B,NN
483,in,I,IN
483,the,B,DT
483,daily,I,JJ
483,number,I,NN
483,of,I,IN
483,COVID-19,I,NNP
483,confirmed,I,JJ
483,cases,I,NNS
483,.,O,.
484,In,O,IN
484,multiple,B,JJ
484,logistic,I,JJ
484,regression,I,NN
484,analyses,I,NNS
484,",",O,","
484,the,B,DT
484,COVID-19,I,NNP
484,knowledge,I,NN
484,score,I,NN
484,(,O,(
484,OR,O,NNP
484,:,O,:
484,0.75,O,CD
484,-,O,:
484,0.90,O,CD
484,",",O,","
484,P<0.001,O,NNP
484,),O,)
484,was,O,VBD
484,significantly,B,RB
484,associated,B,VBN
484,with,I,IN
484,a,O,DT
484,lower,B,JJR
484,likelihood,B,NN
484,of,I,IN
484,negative,I,JJ
484,attitudes,I,NNS
484,and,O,CC
484,preventive,B,JJ
484,practices,I,NNS
484,towards,I,IN
484,COVID-2019,I,NNP
484,.,O,.
485,This,B,DT
485,reflections,I,NNS
485,article,I,NN
485,provides,B,VBZ
485,insight,I,JJ
485,toward,I,IN
485,nursing,B,VBG
485,innovations,I,NNS
485,to,O,TO
485,reduce,B,VB
485,the,B,DT
485,overuse,I,NN
485,of,I,IN
485,personal,I,JJ
485,protective,I,JJ
485,equipment,I,NN
485,while,B,IN
485,maintaining,I,VBG
485,a,I,DT
485,safe,I,JJ
485,environment,I,NN
485,for,B,IN
485,staff,I,NN
485,taking,I,VBG
485,care,I,NN
485,of,I,IN
485,COVID-19,I,NNP
485,patients,I,NNS
485,.,O,.
486,Although,O,IN
486,the,B,DT
486,emerging,I,VBG
486,data,I,NNS
486,hints,B,NNS
486,to,I,TO
486,an,O,DT
486,increase,B,NN
486,in,I,IN
486,mortality,B,NN
486,in,B,IN
486,COVID-19,I,NNP
486,patients,I,NNS
486,with,O,IN
486,known,O,JJ
486,hypertension,B,NN
486,",",O,","
486,diabetes,B,NNS
486,and,O,CC
486,CVD,B,NNP
486,",",O,","
486,it,O,PRP
486,should,O,MD
486,be,O,VB
486,noted,O,VBN
486,that,O,IN
486,it,O,PRP
486,was,O,VBD
486,not,B,RB
486,adjusted,I,VBN
486,for,I,IN
486,multiple,I,JJ
486,confounding,I,NN
486,factors,I,NNS
486,.,O,.
487,Health,B,NNP
487,workers,I,NNS
487,and,O,CC
487,business,B,NN
487,people,I,NNS
487,became,O,VBD
487,increasingly,B,RB
487,anxious,B,JJ
487,",",O,","
487,but,O,CC
487,other,B,JJ
487,professionals,I,NNS
487,became,O,VBD
487,less,B,RBR
487,anxious,B,JJ
487,.,O,.
488,Currently,B,RB
488,",",O,","
488,COVID-19,B,NNP
488,has,O,VBZ
488,caused,B,VBN
488,global,B,JJ
488,health,I,NN
488,concern,I,NN
488,.,O,.
489,Covid-19,B,JJ
489,disease,I,NN
489,is,O,VBZ
489,caused,B,VBN
489,by,O,IN
489,SARS,B,NNP
489,-,I,:
489,CoV-2,I,NN
489,",",O,","
489,a,O,DT
489,virus,O,NN
489,belonging,O,NN
489,to,O,TO
489,the,O,DT
489,coronavirus,O,NN
489,family,O,NN
489,.,O,.
490,Studies,B,NNS
490,have,O,VBP
490,shown,B,VBN
490,that,O,IN
490,coagulation,B,NN
490,dysfunction,I,NN
490,is,O,VBZ
490,a,O,DT
490,major,B,JJ
490,cause,B,NN
490,of,I,IN
490,death,B,NN
490,in,B,IN
490,patients,I,NNS
490,with,I,IN
490,severe,I,JJ
490,COVID-19,I,NNP
490,.,O,.
491,Before,B,IN
491,2003,I,CD
491,",",O,","
491,two,B,CD
491,human,I,JJ
491,CoVs,I,NNP
491,(,O,(
491,HCoVs,B,NNP
491,),O,)
491,were,O,VBD
491,known,B,VBN
491,to,O,TO
491,cause,B,VB
491,mild,B,JJ
491,illness,I,NN
491,",",O,","
491,such,O,JJ
491,as,O,IN
491,common,B,JJ
491,cold,I,NN
491,.,O,.
492,A,B,DT
492,coronavirus,I,NN
492,(,O,(
492,HCoV-19,B,NNP
492,),O,)
492,has,B,VBZ
492,caused,B,VBN
492,the,B,DT
492,novel,I,JJ
492,coronavirus,I,NN
492,disease,I,NN
492,(,I,(
492,COVID-19,I,NNP
492,),I,)
492,outbreak,I,NN
492,in,B,IN
492,Wuhan,I,NNP
492,",",I,","
492,China,I,NNP
492,.,O,.
493,The,B,DT
493,mutations,I,NNS
493,might,B,MD
493,affect,B,VB
493,the,B,DT
493,severity,I,NN
493,and,I,CC
493,spread,I,NN
493,of,I,IN
493,the,I,DT
493,SARS,I,NNP
493,-,I,:
493,CoV-2,I,NN
494,Movement,B,JJ
494,restriction,I,NN
494,greatly,B,RB
494,reduced,B,VBD
494,the,B,DT
494,number,I,NN
494,of,I,IN
494,infections,I,NNS
494,from,B,IN
494,5,I,CD
494,February,I,NNP
494,onwards,I,NNS
494,.,O,.
495,Thus,O,RB
495,",",O,","
495,our,B,PRP$
495,results,I,NNS
495,suggest,B,VBP
495,that,O,IN
495,these,B,DT
495,drugs,I,NNS
495,could,B,MD
495,act,B,VB
495,against,I,IN
495,SARS,B,NNP
495,-,I,:
495,CoV-2,I,JJ
495,by,O,IN
495,altering,B,VBG
495,the,B,DT
495,folding,I,VBG
495,pathway,I,NN
495,of,I,IN
495,its,I,PRP$
495,receptor,I,NN
495,ACE2,I,NNP
496,Overall,O,JJ
496,",",O,","
496,our,B,PRP$
496,results,I,NNS
496,demonstrate,B,VB
496,the,O,DT
496,potential,B,JJ
496,efficacy,B,NN
496,of,O,IN
496,human,B,JJ
496,Type,I,NNP
496,I,I,PRP
496,IFN,I,NNP
496,in,O,IN
496,suppressing,B,VBG
496,SARS,B,NNP
496,-,I,:
496,CoV-2,I,JJ
496,infection,I,NN
497,With,O,IN
497,a,O,DT
497,modest,B,JJ
497,25,B,CD
497,%,I,NN
497,reduction,B,NN
497,in,I,IN
497,COVID-19,B,NNP
497,transmissibility,I,NN
497,via,B,IN
497,community,I,NN
497,-,I,:
497,level,I,NN
497,interventions,I,NNS
497,",",O,","
497,the,B,DT
497,epidemic,I,JJ
497,progression,I,NN
497,could,B,MD
497,be,O,VB
497,delayed,B,VBN
497,by,O,IN
497,up,B,IN
497,to,I,TO
497,34,I,CD
497,days,I,NNS
497,.,O,.
498,The,B,DT
498,genomic,I,JJ
498,signature,I,NN
498,analysis,I,NN
498,demonstrates,B,VBZ
498,that,O,IN
498,a,O,DT
498,strong,B,JJ
498,association,B,NN
498,between,O,IN
498,the,B,DT
498,time,I,NN
498,of,I,IN
498,sample,I,JJ
498,collection,I,NN
498,",",O,","
498,location,B,NN
498,of,I,IN
498,sample,I,NN
498,and,O,CC
498,accumulation,B,NN
498,of,I,IN
498,genetic,I,JJ
498,diversity,I,NN
498,.,O,.
499,Levels,B,NNS
499,of,I,IN
499,social,I,JJ
499,support,I,NN
499,for,B,IN
499,medical,I,JJ
499,staff,I,NN
499,were,O,VBD
499,significantly,B,RB
499,associated,B,VBN
499,with,I,IN
499,self,B,PRP
499,-,I,:
499,efficacy,I,NN
499,and,O,CC
499,sleep,B,JJ
499,quality,I,NN
499,and,O,CC
499,negatively,B,RB
499,associated,B,VBN
499,with,I,IN
499,the,B,DT
499,degree,I,NN
499,of,I,IN
499,anxiety,I,NN
499,and,O,CC
499,stress,B,NN
499,.,O,.
500,SEM,B,NN
500,showed,B,VBD
500,that,O,IN
500,medical,B,JJ
500,staff,I,NN
500,in,B,IN
500,China,I,NNP
500,who,B,WP
500,were,I,VBD
500,treating,I,VBG
500,patients,I,NNS
500,with,I,IN
500,COVID-19,I,NNP
500,infection,I,NN
500,during,B,IN
500,January,I,NNP
500,and,I,CC
500,February,I,NNP
500,2020,I,CD
500,had,O,VBD
500,levels,B,NNS
500,of,I,IN
500,anxiety,I,NN
500,",",O,","
500,stress,B,NN
500,",",O,","
500,and,O,CC
500,self,B,PRP
500,-,I,:
500,efficacy,I,NN
500,that,O,WDT
500,were,O,VBD
500,dependent,B,JJ
500,on,I,IN
500,sleep,B,JJ
500,quality,I,NN
500,and,O,CC
500,social,B,JJ
500,support,I,NN
501,There,O,EX
501,was,O,VBD
501,no,B,DT
501,statistically,B,RB
501,significant,I,JJ
501,difference,B,NN
501,between,O,IN
501,the,B,DT
501,smoking,I,NN
501,rates,I,NNS
501,of,O,IN
501,survivors,B,NNS
501,and,O,CC
501,non,B,JJ
501,-,I,:
501,survivors,I,NNS
501,(,O,(
501,p=0.21,O,NN
501,),O,)
501,with,B,IN
501,regard,I,NN
501,to,I,TO
501,mortality,I,NN
501,from,I,IN
501,COVID-19,I,NNP
501,.,O,.
502,Preliminary,B,JJ
502,evidence,I,NN
502,that,O,IN
502,higher,B,JJR
502,temperatures,B,NNS
502,are,O,VBP
502,associated,B,VBN
502,with,I,IN
502,lower,B,JJR
502,incidence,B,NN
502,of,I,IN
502,COVID-19,I,NNP
502,",",O,","
502,for,B,IN
502,cases,I,NNS
502,reported,I,VBN
502,globally,I,RB
502,up,I,IN
502,to,I,TO
502,29th,I,CD
502,February,I,NNP
502,2020,I,CD
503,Using,O,VBG
503,global,B,JJ
503,line,I,NN
503,-,I,:
503,list,I,NN
503,data,I,NNS
503,on,I,IN
503,COVID-19,I,NNP
503,cases,I,NNS
503,reported,I,VBD
503,until,I,IN
503,29th,I,CD
503,February,I,NNP
503,2020,I,CD
503,and,O,CC
503,global,B,JJ
503,gridded,I,JJ
503,temperature,I,NN
503,data,I,NNS
503,",",O,","
503,and,O,CC
503,after,B,IN
503,adjusting,I,VBG
503,for,I,IN
503,surveillance,I,NN
503,capacity,I,NN
503,and,I,CC
503,time,I,NN
503,since,I,IN
503,first,I,RB
503,imported,I,VBN
503,case,I,NN
503,",",O,","
503,higher,B,JJR
503,average,B,JJ
503,temperature,I,NN
503,was,O,VBD
503,strongly,B,RB
503,associated,B,VBN
503,with,I,IN
503,lower,B,JJR
503,COVID-19,B,NNP
503,incidence,I,NN
503,for,B,IN
503,temperatures,I,NNS
503,of,I,IN
503,1,I,CD
503,Â°,I,JJ
503,C,I,NNP
503,and,I,CC
503,higher,I,JJR
503,.,O,.
504,Preventive,B,JJ
504,measures,I,NNS
504,such,O,JJ
504,as,O,IN
504,masks,B,NNS
504,",",O,","
504,hand,B,NN
504,hygiene,I,NN
504,practices,I,NNS
504,",",O,","
504,avoidance,B,NN
504,of,I,IN
504,public,I,JJ
504,contact,I,NN
504,",",O,","
504,case,B,NN
504,detection,I,NN
504,",",O,","
504,contact,B,NN
504,tracing,I,NN
504,",",O,","
504,and,O,CC
504,quarantines,B,NNS
504,have,O,VBP
504,been,O,VBN
504,discussed,B,VBN
504,as,I,IN
504,ways,I,NNS
504,to,O,TO
504,reduce,B,VB
504,transmission,B,NN
504,.,O,.
505,Patients,B,NNS
505,with,I,IN
505,digestive,I,JJ
505,symptoms,I,NNS
505,had,O,VBD
505,higher,B,JJR
505,mean,B,JJ
505,liver,I,NN
505,enzyme,I,NN
505,levels,I,NNS
505,",",O,","
505,lower,B,JJR
505,monocyte,B,NN
505,count,I,NN
505,",",O,","
505,longer,B,JJR
505,prothrombin,B,JJ
505,time,I,NN
505,",",O,","
505,and,O,CC
505,received,B,VBD
505,more,B,RBR
505,antimicrobial,I,JJ
505,treatment,I,NN
505,than,O,IN
505,those,B,DT
505,without,I,IN
505,digestive,I,JJ
505,symptoms,I,NNS
505,.,O,.
506,Our,B,PRP$
506,prognosis,I,NN
506,suggests,B,VBZ
506,that,O,IN
506,in,B,IN
506,the,I,DT
506,absence,I,NN
506,of,I,IN
506,disease,I,NN
506,control,I,NN
506,interventions,I,NNS
506,and,I,CC
506,traffic,I,NN
506,restrictions,I,NNS
506,",",O,","
506,the,B,DT
506,nation,I,NN
506,-,I,:
506,wide,I,JJ
506,infected,I,JJ
506,fraction,I,NN
506,could,B,MD
506,reach,B,VB
506,~7,B,CD
506,%,I,NN
506,when,B,WRB
506,the,I,DT
506,epidemic,I,JJ
506,hits,I,VBZ
506,its,I,PRP$
506,peak,I,NN
506,by,I,IN
506,early,I,JJ
506,June,I,NNP
506,.,O,.
507,Based,O,VBN
507,on,O,IN
507,our,B,PRP$
507,model,I,NN
507,predictions,I,NNS
507,for,I,IN
507,the,I,DT
507,March,I,NNP
507,14,I,CD
507,-,I,:
507,16,I,CD
507,timeframe,I,NN
507,",",O,","
507,the,B,DT
507,national,I,JJ
507,epidemic,I,JJ
507,peak,I,NN
507,could,B,MD
507,be,O,VB
507,expected,B,VBN
507,to,O,TO
507,arrive,B,VB
507,by,B,IN
507,early,I,JJ
507,June,I,NNP
507,",",O,","
507,corresponding,B,VBG
507,to,I,TO
507,a,B,DT
507,daily,I,JJ
507,active,I,JJ
507,count,I,NN
507,of,I,IN
507,â,I,$
507,7,I,CD
507,%,I,NN
507,of,B,IN
507,the,I,DT
507,US,I,NNP
507,population,I,NN
507,",",O,","
507,if,B,IN
507,no,I,DT
507,containment,I,NN
507,plans,I,NNS
507,are,I,VBP
507,implemented,I,VBN
507,.,O,.
508,The,B,DT
508,basic,I,JJ
508,reproduction,I,NN
508,number,I,NN
508,(,O,(
508,R0,B,NNP
508,),O,)
508,",",O,","
508,which,O,WDT
508,defines,B,VBZ
508,the,B,DT
508,mean,I,JJ
508,number,I,NN
508,of,I,IN
508,secondary,I,JJ
508,cases,I,NNS
508,generated,I,VBN
508,by,I,IN
508,one,I,CD
508,primary,I,JJ
508,case,I,NN
508,when,B,WRB
508,the,I,DT
508,population,I,NN
508,is,I,VBZ
508,largely,I,RB
508,susceptible,I,JJ
508,to,I,TO
508,infection,I,NN
508,",",O,","
508,determines,B,VBZ
508,the,B,DT
508,overall,I,JJ
508,number,I,NN
508,of,I,IN
508,people,I,NNS
508,who,I,WP
508,are,I,VBP
508,likely,I,JJ
508,to,I,TO
508,be,I,VB
508,infected,I,VBN
508,",",O,","
508,or,O,CC
508,more,O,RBR
508,precisely,O,RB
508,the,B,DT
508,area,I,NN
508,under,I,IN
508,the,I,DT
508,epidemic,I,JJ
508,curve,I,NN
508,.,O,.
509,Guidelines,B,NNS
509,developed,I,VBN
509,by,I,IN
509,experts,I,NNS
509,can,O,MD
509,improve,B,VB
509,the,B,DT
509,treatment,I,NN
509,of,I,IN
509,COVID-19,I,NNP
509,.,O,.
510,Second,O,JJ
510,",",O,","
510,we,O,PRP
510,demonstrate,B,VBP
510,how,O,WRB
510,simulation,B,NN
510,-,I,:
510,based,I,VBN
510,methodology,I,NN
510,can,O,MD
510,be,O,VB
510,used,O,VBN
510,to,O,TO
510,examine,B,VB
510,and,O,CC
510,predict,B,VB
510,the,O,DT
510,impacts,B,NNS
510,of,O,IN
510,epidemic,B,JJ
510,outbreaks,I,NNS
510,on,O,IN
510,the,B,DT
510,SC,I,NNP
510,performance,I,NN
510,using,B,VBG
510,the,I,DT
510,example,I,NN
510,of,I,IN
510,coronavirus,I,NN
510,COVID-19,I,NNP
510,and,O,CC
510,anyLogistix,B,JJ
510,simulation,I,NN
510,and,I,CC
510,optimization,I,NN
510,software,I,NN
510,.,O,.
511,What,B,WP
511,has,I,VBZ
511,happened,I,VBN
511,in,I,IN
511,China,I,NNP
511,shows,B,NNS
511,that,O,WDT
511,quarantine,B,VBP
511,",",O,","
511,social,B,JJ
511,distancing,I,NN
511,",",O,","
511,and,O,CC
511,isolation,B,NN
511,of,I,IN
511,infected,I,JJ
511,populations,I,NNS
511,can,O,MD
511,contain,B,VB
511,the,B,DT
511,epidemic.1,I,NN
512,One,B,CD
512,study,I,NN
512,(,O,(
512,"preprint),1",O,IN
512,using,O,VBG
512,single,O,JJ
512,-,O,:
512,cell,O,NN
512,sequencing,O,NN
512,",",O,","
512,found,B,VBD
512,that,O,IN
512,expression,B,NN
512,of,I,IN
512,ACE2,I,NNP
512,was,O,VBD
512,more,B,RBR
512,predominant,I,JJ
512,in,O,IN
512,Asian,B,JJ
512,men,I,NNS
512,",",O,","
512,which,O,WDT
512,might,B,MD
512,be,O,VB
512,the,O,DT
512,reason,B,NN
512,for,I,IN
512,the,O,DT
512,higher,B,JJR
512,prevalence,B,NN
512,of,I,IN
512,COVID-19,I,NNP
512,in,O,IN
512,this,B,DT
512,subgroup,I,NN
512,of,I,IN
512,patients,I,NNS
512,than,O,IN
512,in,O,IN
512,women,B,NNS
512,and,O,CC
512,patients,B,NNS
512,of,I,IN
512,other,I,JJ
512,ethnicities,I,NNS
512,.,O,.
513,Unfortunately,B,RB
513,",",O,","
513,emergence,B,NN
513,of,I,IN
513,SARS,I,NNP
513,-,I,:
513,CoV-2,I,NN
513,has,O,VBZ
513,led,B,VBN
513,to,I,TO
513,numerous,B,JJ
513,reports,I,NNS
513,of,O,IN
513,Asians,B,NNPS
513,being,I,VBG
513,subjected,I,VBN
513,to,I,TO
513,racist,I,VB
513,behavior,I,NN
513,and,O,CC
513,hate,B,NN
513,crimes,I,NNS
513,across,B,IN
513,the,I,DT
513,world,I,NN
513,.,O,.
514,Further,B,JJ
514,calculations,I,NNS
514,",",O,","
514,again,O,RB
514,based,O,VBN
514,on,O,IN
514,travel,B,NN
514,volumes,I,NNS
514,",",O,","
514,suggested,B,VBD
514,that,O,IN
514,some,B,DT
514,countries,I,NNS
514,would,B,MD
514,be,O,VB
514,expected,B,VBN
514,to,O,TO
514,have,O,VB
514,many,B,JJ
514,more,B,JJR
514,travel,B,JJ
514,-,I,:
514,related,I,JJ
514,cases,I,NNS
514,than,O,IN
514,had,B,VBD
514,been,I,VBN
514,"notified,4",I,RB
514,drawing,O,VBG
514,attention,O,NN
514,to,O,TO
514,the,O,DT
514,possibility,O,NN
514,of,O,IN
514,undetected,B,JJ
514,cases,I,NNS
514,and,O,CC
514,community,B,NN
514,transmission,I,NN
514,in,B,IN
514,several,I,JJ
514,countries,I,NNS
514,.,O,.
515,Conclusions,O,NNS
515,Six,B,NNP
515,-,I,:
515,week,I,NN
515,respiratory,I,NN
515,rehabilitation,I,NN
515,can,O,MD
515,improve,B,VB
515,respiratory,B,NN
515,function,I,NN
515,",",O,","
515,QoL,B,NNP
515,and,O,CC
515,anxiety,B,NN
515,of,B,IN
515,elderly,I,JJ
515,patients,I,NNS
515,with,I,IN
515,COVID-19,I,NNP
515,",",O,","
515,but,O,CC
515,it,O,PRP
515,has,O,VBZ
515,little,B,JJ
515,significant,I,JJ
515,improvement,B,NN
515,on,I,IN
515,depression,B,NN
515,in,B,IN
515,the,I,DT
515,elderly,I,JJ
515,.,O,.
516,Although,O,IN
516,applicable,O,JJ
516,to,O,TO
516,disease,O,VB
516,modelling,O,VBG
516,in,O,IN
516,general,O,JJ
516,",",O,","
516,our,B,PRP$
516,results,I,NNS
516,emphasize,B,VB
516,how,O,WRB
516,network,B,NN
516,science,I,NN
516,can,O,MD
516,improve,B,VB
516,the,B,DT
516,predictive,I,JJ
516,power,I,NN
516,of,I,IN
516,current,I,JJ
516,COVID-19,I,NNP
516,epidemiological,I,NN
516,models,I,NNS
517,Some,B,DT
517,statistical,I,JJ
517,studies,I,NNS
517,have,O,VBP
517,shown,B,VBN
517,that,O,IN
517,",",O,","
517,on,B,IN
517,average,I,NN
517,",",O,","
517,one,B,CD
517,infected,I,VBN
517,patient,I,NN
517,may,B,MD
517,lead,B,VB
517,to,I,TO
517,a,B,DT
517,subsequent,I,JJ
517,5.7,I,CD
517,confirmed,I,JJ
517,cases,I,NNS
517,.,O,.
518,The,B,DT
518,costs,I,NNS
518,of,I,IN
518,the,I,DT
518,epidemic,I,NNS
518,are,O,VBP
518,not,B,RB
518,limited,B,VBN
518,to,I,TO
518,medical,B,JJ
518,aspects,I,NNS
518,",",O,","
518,as,O,IN
518,the,B,DT
518,virus,I,NN
518,has,O,VBZ
518,led,B,VBN
518,to,I,TO
518,significant,B,JJ
518,sociological,B,JJ
518,",",O,","
518,psychological,B,JJ
518,and,O,CC
518,economic,B,JJ
518,effects,I,NNS
518,globally,B,RB
518,.,O,.
519,The,B,DT
519,COVID-19,I,NNP
519,pandemic,I,NN
519,has,O,VBZ
519,led,B,VBN
519,to,I,TO
519,the,B,DT
519,cancellation,I,NN
519,of,I,IN
519,many,I,JJ
519,conferences,I,NNS
519,",",O,","
519,forcing,O,VBG
519,the,O,DT
519,scientific,O,JJ
519,community,O,NN
519,to,O,TO
519,explore,O,VB
519,online,O,JJ
519,alternatives,O,NNS
519,.,O,.
520,The,B,DT
520,outbreak,I,NN
520,has,O,VBZ
520,led,B,VBN
520,to,I,TO
520,severe,B,VB
520,impacts,B,NNS
520,on,O,IN
520,social,B,JJ
520,health,I,NN
520,and,O,CC
520,the,B,DT
520,economy,I,NN
520,at,B,IN
520,various,I,JJ
520,levels,I,NNS
520,.,O,.
521,As,B,IN
521,of,I,IN
521,March,I,NNP
521,24th,I,CD
521,",",I,","
521,2020,I,CD
521,",",O,","
521,the,B,DT
521,virus,I,NN
521,has,O,VBZ
521,caused,B,VBN
521,a,B,DT
521,casualty,I,NN
521,of,I,IN
521,over,I,IN
521,"16,600",I,CD
521,people,I,NNS
521,worldwide,I,RB
521,.,O,.
522,A,O,DT
522,total,O,NN
522,of,O,IN
522,six,B,CD
522,species,I,NNS
522,have,O,VBP
522,been,O,VBN
522,identified,B,VBN
522,to,O,TO
522,cause,B,VB
522,disease,B,NN
522,in,B,IN
522,humans,I,NNS
522,.,O,.
523,induced,B,JJ
523,activation,B,NN
523,of,I,IN
523,apoptosis,I,NN
523,and,O,CC
523,P53,B,NNP
523,signalling,I,VBG
523,pathway,I,RB
523,in,I,IN
523,lymphocytes,I,NNS
523,may,B,MD
523,be,O,VB
523,the,O,DT
523,cause,B,NN
523,of,I,IN
523,patients,B,NNS
523,â,I,JJ
523,lymphopenia,I,NN
523,.,O,.
524,This,B,DT
524,could,B,MD
524,be,O,VB
524,the,O,DT
524,cause,B,NN
524,of,I,IN
524,the,B,DT
524,rapid,I,JJ
524,viral,I,JJ
524,spread,I,NN
524,of,I,IN
524,SARS,I,NNP
524,-,I,:
524,CoV-2,I,NN
524,in,B,IN
524,humans,I,NNS
524,.,O,.
525,SARSâCoVâ2,B,NNP
525,caused,B,VBD
525,more,B,RBR
525,severe,B,JJ
525,interstitial,I,JJ
525,pneumonia,I,NN
525,in,O,IN
525,old,B,JJ
525,monkeys,I,NNS
525,than,O,IN
525,that,O,DT
525,in,O,IN
525,young,B,JJ
525,monkeys,I,NNS
525,.,O,.
526,In,B,IN
526,humans,I,NNS
526,",",O,","
526,CoVs,B,NNP
526,mostly,B,RB
526,cause,B,VBP
526,respiratory,B,NN
526,and,O,CC
526,gastrointestinal,B,JJ
526,symptoms,I,NNS
526,.,O,.
527,However,O,RB
527,",",O,","
527,CoVs,B,NNP
527,have,O,VBP
527,been,O,VBN
527,known,B,VBN
527,to,O,TO
527,cause,B,VB
527,various,B,JJ
527,ocular,I,JJ
527,infections,I,NNS
527,in,B,IN
527,animals,I,NNS
527,.,O,.
528,This,B,DT
528,study,I,NN
528,aimed,O,VBD
528,to,O,TO
528,determine,B,VB
528,whether,B,IN
528,the,B,DT
528,temperature,I,NN
528,is,O,VBZ
528,an,O,DT
528,essential,B,JJ
528,factor,B,NN
528,in,I,IN
528,the,B,DT
528,infection,I,NN
528,caused,B,VBN
528,by,O,IN
528,this,B,DT
528,novel,I,JJ
528,coronavirus,I,NN
528,.,O,.
529,Considered,O,VBN
529,a,O,DT
529,relative,O,NN
529,of,O,IN
529,severe,B,JJ
529,acute,I,JJ
529,respiratory,I,NN
529,syndrome,I,NN
529,(,O,(
529,SARS,B,NNP
529,),O,)
529,and,O,CC
529,Middle,B,NNP
529,East,I,NNP
529,respiratory,I,NN
529,syndrome,I,NN
529,(,O,(
529,MERS,B,NNP
529,),O,)
529,",",O,","
529,COVID-19,B,NNP
529,is,O,VBZ
529,caused,B,VBN
529,by,O,IN
529,a,B,DT
529,betacoronavirus,I,NN
529,named,I,VBN
529,SARS,I,NNP
529,-,I,:
529,CoV-2,I,NN
530,COVID-19,B,NNP
530,is,O,VBZ
530,caused,B,VBN
530,by,O,IN
530,severe,B,JJ
530,acute,I,JJ
530,respiratory,I,NN
530,syndrome,I,NN
530,coronavirus,I,NN
530,2,I,CD
530,(,O,(
530,SARS,B,NNP
530,-,I,:
530,CoV-2,I,NN
530,),O,)
530,.,O,.
531,Coronavirus,B,NNP
531,disease,I,NN
531,of,I,IN
531,2019,I,CD
531,(,O,(
531,COVID-19,B,NNP
531,),O,)
531,is,O,VBZ
531,a,O,DT
531,cause,B,NN
531,of,I,IN
531,significant,B,JJ
531,morbidity,B,NN
531,and,O,CC
531,mortality,B,NN
531,worldwide,B,NN
531,.,O,.
532,Among,O,IN
532,other,O,JJ
532,insights,O,NNS
532,",",O,","
532,the,B,DT
532,results,I,NNS
532,suggest,B,VBP
532,installing,B,VBG
532,temporary,I,JJ
532,incinerators,I,NNS
532,may,B,MD
532,be,O,VB
532,an,O,DT
532,effective,B,JJ
532,solution,O,NN
532,for,O,IN
532,managing,B,VBG
532,the,O,DT
532,tremendous,B,JJ
532,increase,B,NN
532,of,O,IN
532,medical,B,JJ
532,waste,I,NN
532,during,B,IN
532,the,I,DT
532,COVID-19,I,NNP
532,outbreak,I,NN
532,in,B,IN
532,Wuhan,I,NNP
532,",",O,","
532,but,O,CC
532,the,B,DT
532,location,I,NN
532,selection,I,NN
532,of,I,IN
532,these,I,DT
532,temporary,I,JJ
532,incinerators,I,NNS
532,is,O,VBZ
532,of,O,IN
532,significant,B,JJ
532,importance,O,NN
532,.,O,.
533,This,B,DT
533,study,I,NN
533,aimed,O,VBD
533,to,O,TO
533,provide,B,VB
533,preliminary,I,JJ
533,data,I,NNS
533,on,I,IN
533,whether,B,IN
533,there,O,EX
533,may,B,MD
533,be,O,VB
533,seasonal,B,JJ
533,variation,B,NN
533,in,I,IN
533,COVID-19,B,NNP
533,incidence,I,NN
533,",",O,","
533,in,B,IN
533,sub,I,JJ
533,-,I,:
533,national,I,JJ
533,regions,I,NNS
533,that,O,WDT
533,have,O,VBP
533,reported,B,VBN
533,at,I,IN
533,least,I,JJS
533,one,I,CD
533,confirmed,I,VBD
533,COVID-19,I,NNP
533,case,I,NN
533,.,O,.
534,While,O,IN
534,human,B,JJ
534,strains,I,NNS
534,of,I,IN
534,Coronavirus,I,NNP
534,are,O,VBP
534,associated,B,VBN
534,with,I,IN
534,about,B,RB
534,15,I,CD
534,%,I,NN
534,of,O,IN
534,cases,B,NNS
534,of,I,IN
534,the,I,DT
534,common,I,JJ
534,cold,I,NN
534,",",O,","
534,the,B,DT
534,SARS,I,NNP
534,-,I,:
534,CoV-2,I,NN
534,may,B,MD
534,present,B,VB
534,with,I,IN
534,varying,B,VBG
534,degrees,I,NNS
534,of,I,IN
534,severity,I,NN
534,",",O,","
534,from,O,IN
534,flu,B,JJ
534,-,I,:
534,like,I,IN
534,symptoms,I,NNS
534,to,O,TO
534,death,B,NN
534,.,O,.
535,Nonetheless,O,RB
535,",",O,","
535,it,O,PRP
535,has,O,VBZ
535,been,O,VBN
535,consistently,B,RB
535,shown,I,VBN
535,that,O,IN
535,the,B,DT
535,presence,I,NN
535,of,I,IN
535,pre,I,JJ
535,-,I,:
535,existing,I,VBG
535,CV,I,NNP
535,disease,I,NN
535,and/or,O,NN
535,development,B,NN
535,of,I,IN
535,acute,I,JJ
535,cardiac,I,JJ
535,injury,I,NN
535,are,O,VBP
535,associated,B,VBN
535,with,I,IN
535,significantly,B,RB
535,worse,B,JJR
535,outcome,B,NN
535,in,B,IN
535,these,I,DT
535,patients,I,NNS
535,.,O,.
536,The,B,DT
536,number,I,NN
536,of,I,IN
536,likes,I,NNS
536,and,I,CC
536,retweets,I,NNS
536,per,I,IN
536,tweet,I,NN
536,was,O,VBD
536,not,B,RB
536,associated,B,VBN
536,with,I,IN
536,a,O,DT
536,difference,B,NN
536,in,I,IN
536,either,O,CC
536,false,B,JJ
536,or,O,CC
536,unverifiable,B,JJ
536,content,I,NN
536,.,O,.
537,While,O,IN
537,these,B,DT
537,quarantine,I,JJ
537,measures,I,NNS
537,are,O,VBP
537,necessary,O,JJ
537,and,O,CC
537,have,O,VBP
537,prevented,B,VBN
537,a,B,DT
537,historical,I,JJ
537,disaster,I,NN
537,along,I,IN
537,the,I,DT
537,lines,I,NNS
537,of,I,IN
537,the,I,DT
537,Spanish,I,JJ
537,flu,I,NN
537,",",O,","
537,earlier,B,JJR
537,recognition,B,NN
537,and,O,CC
537,earlier,B,JJR
537,implementation,B,NN
537,of,I,IN
537,quarantine,I,JJ
537,measures,I,NNS
537,may,B,MD
537,have,O,VB
537,been,O,VBN
537,even,O,RB
537,more,B,RBR
537,effective,I,JJ
537,.,O,.
538,Plotting,O,VBG
538,mortality,B,NN
538,against,O,IN
538,the,B,DT
538,incidence,I,NN
538,of,I,IN
538,COVID-19,I,NNP
538,(,O,(
538,cumulative,O,JJ
538,number,O,NN
538,of,O,IN
538,confirmed,O,JJ
538,cases,O,NNS
538,since,O,IN
538,the,O,DT
538,start,O,NN
538,of,O,IN
538,the,O,DT
538,outbreak,O,NN
538,",",O,","
538,per,O,IN
538,10,O,CD
538,000,O,CD
538,population,O,NN
538,),O,)
538,showed,B,VBD
538,a,O,DT
538,significant,B,JJ
538,positive,B,JJ
538,correlation,B,NN
538,(,O,(
538,figure,O,JJ
538,C,O,NNP
538,),O,)
538,",",O,","
538,suggesting,B,VBG
538,that,O,IN
538,mortality,B,NN
538,is,O,VBZ
538,correlated,B,VBN
538,with,I,IN
538,health,B,NN
538,-,I,:
538,care,I,NN
538,burden,I,NN
538,.,O,.
539,In,O,IN
539,conclusion,O,NN
539,",",O,","
539,with,O,IN
539,the,B,DT
539,limited,I,JJ
539,available,I,JJ
539,data,I,NNS
539,",",O,","
539,smoking,B,NN
539,is,O,VBZ
539,most,B,RBS
539,likely,I,JJ
539,associated,B,VBN
539,with,I,IN
539,the,B,DT
539,negative,I,JJ
539,progression,I,NN
539,and,I,CC
539,adverse,I,JJ
539,outcomes,I,NNS
539,of,I,IN
539,COVID-19,I,NNP
539,.,O,.
540,Average,B,JJ
540,temperature,I,NN
540,(,O,(
540,as,O,IN
540,a,O,DT
540,linear,O,JJ
540,and,O,CC
540,quadratic,O,JJ
540,term,O,NN
540,combination,O,NN
540,),O,)
540,was,O,VBD
540,strongly,B,RB
540,associated,B,VBN
540,with,I,IN
540,count,B,NN
540,of,I,IN
540,local,I,JJ
540,COVID-19,I,NNP
540,cases,I,NNS
540,(,O,(
540,likelihood,B,NN
540,ratio,I,NN
540,test,I,NN
540,=,O,NN
540,19.4,O,CD
540,",",O,","
540,df,O,NN
540,=,O,VBD
540,2,O,CD
540,",",O,","
540,p=0.00006,O,NN
540,),O,)
540,.,O,.
541,This,B,DT
541,sex,I,NN
541,predisposition,I,NN
541,might,B,MD
541,be,O,VB
541,associated,B,VBN
541,with,I,IN
541,the,O,DT
541,much,B,RB
541,higher,B,JJR
541,smoking,B,VBG
541,rate,I,NN
541,in,O,IN
541,men,B,NNS
541,than,O,IN
541,in,O,IN
541,women,B,NNS
541,in,B,IN
541,China,I,NNP
541,(,O,(
541,288,O,CD
541,million,O,CD
541,men,O,NNS
541,vs,O,$
541,12Â·6,O,CD
541,million,O,CD
541,women,O,NNS
541,were,O,VBD
541,smokers,O,NNS
541,in,O,IN
541,2018,O,CD
541,),O,)
541,.,O,.
542,The,B,DT
542,COVID-19,I,NNP
542,outbreak,I,NN
542,in,B,IN
542,Hubei,I,NNP
542,resulted,B,VBD
542,in,I,IN
542,increased,B,JJ
542,stress,B,NN
542,for,B,IN
542,medical,I,JJ
542,staff,I,NN
542,in,B,IN
542,adjacent,I,JJ
542,Hunan,I,NNP
542,province,I,NN
542,.,O,.
543,The,O,DT
543,reduced,B,JJ
543,probability,B,NN
543,of,I,IN
543,a,I,DT
543,major,I,JJ
543,epidemic,I,JJ
543,ranged,O,VBN
543,from,B,IN
543,7,I,CD
543,%,I,NN
543,to,I,TO
543,20,I,CD
543,%,I,NN
543,in,B,IN
543,Japan,I,NNP
543,",",O,","
543,which,O,WDT
543,resulted,B,VBD
543,in,I,IN
543,a,B,DT
543,median,I,JJ
543,time,I,NN
543,delay,I,NN
543,to,I,TO
543,a,I,DT
543,major,I,JJ
543,epidemic,I,NN
543,of,O,IN
543,two,B,CD
543,days,I,NNS
543,.,O,.
544,Lessons,B,NNS
544,learned,I,VBD
544,from,I,IN
544,SARS,I,NNP
544,resulted,B,VBD
544,in,I,IN
544,faster,B,JJ
544,determination,B,NN
544,of,I,IN
544,the,I,DT
544,nucleic,I,JJ
544,acid,I,NN
544,sequence,I,NN
544,and,O,CC
544,a,O,DT
544,more,B,RBR
544,robust,B,JJ
544,quarantine,I,NN
544,strategy,I,NN
544,.,O,.
545,We,O,PRP
545,summarize,B,VBP
545,the,B,DT
545,cardiovascular,I,JJ
545,risks,I,NNS
545,associated,B,VBN
545,with,I,IN
545,Covid-19,B,NNP
545,pandemic,I,NN
545,",",O,","
545,discussing,O,VBG
545,the,O,DT
545,risks,O,NNS
545,for,O,IN
545,both,O,DT
545,infected,B,JJ
545,and,O,CC
545,non,B,JJ
545,-,I,:
545,infected,I,JJ
545,patients,I,NNS
545,.,O,.
546,Studies,B,NNS
546,on,O,IN
546,the,B,DT
546,biology,I,NN
546,of,I,IN
546,viral,I,JJ
546,infection,I,NN
546,and,O,CC
546,clinical,B,JJ
546,management,I,NN
546,of,I,IN
546,the,I,DT
546,disease,I,NN
546,have,O,VBP
546,also,O,RB
546,been,O,VBN
546,published,O,VBN
546,",",O,","
546,some,O,DT
546,of,O,IN
546,which,O,WDT
546,have,O,VBP
546,demonstrated,B,VBN
546,that,O,IN
546,differences,B,NNS
546,in,I,IN
546,COVID-19,B,NNP
546,disease,I,NN
546,prevalence,I,NN
546,and,O,CC
546,severity,B,NN
546,are,O,VBP
546,associated,B,VBN
546,with,I,IN
546,sex,B,NN
546,",",O,","
546,and,O,CC
546,smoking,B,NN
546,is,O,VBZ
546,related,B,VBN
546,to,I,TO
546,higher,B,JJR
546,expression,B,NN
546,of,I,IN
546,ACE2,I,NNP
546,(,O,(
546,the,O,DT
546,receptor,O,NN
546,for,O,IN
546,severe,B,JJ
546,acute,I,JJ
546,respiratory,I,NN
546,syndrome,I,NN
546,coronavirus,I,NN
546,2,I,CD
546,[,O,NN
546,SARS,B,NNP
546,-,I,:
546,CoV-2,I,JJ
546,],O,NN
546,),O,)
546,",",O,","
546,so,O,RB
546,that,O,IN
546,might,O,MD
546,also,O,RB
546,be,O,VB
546,a,O,DT
546,factor,O,NN
546,.,O,.
547,The,B,DT
547,pulmonary,I,JJ
547,function,I,NN
547,and,O,CC
547,symptoms,B,NNS
547,of,I,IN
547,these,I,DT
547,seven,I,CD
547,patients,I,NNS
547,were,O,VBD
547,significantly,B,RB
547,improved,B,VBN
547,in,B,IN
547,2,I,CD
547,days,I,NNS
547,after,O,IN
547,MSC,B,NNP
547,transplantation,I,NN
547,.,O,.
548,far,B,RB
548,-,I,:
548,reaching,I,VBG
548,solutions,I,NNS
548,were,O,VBD
548,implemented,B,VBN
548,relatively,I,RB
548,early,I,JJ
548,to,O,TO
548,reduce,B,VB
548,the,B,DT
548,spread,I,NN
548,of,I,IN
548,infection,I,NN
548,.,O,.
549,As,B,IN
549,we,I,PRP
549,await,I,VBP
549,more,I,JJR
549,data,I,NNS
549,from,I,IN
549,treating,I,VBG
549,these,I,DT
549,patients,I,NNS
549,",",O,","
549,this,B,DT
549,strategy,I,NN
549,is,O,VBZ
549,likely,B,JJ
549,to,O,TO
549,help,O,VB
549,reduce,B,VB
549,potential,B,JJ
549,complications,I,NNS
549,.,O,.
550,the,B,DT
550,effect,I,NN
550,progressively,B,RB
550,increased,B,VBD
550,as,O,IN
550,the,B,DT
550,probability,I,NN
550,of,I,IN
550,infection,I,NN
550,increased,B,VBN
550,.,O,.
551,There,O,EX
551,were,O,VBD
551,more,B,JJR
551,case,B,NN
551,fatalities,I,NNS
551,among,O,IN
551,COVID-19,B,JJ
551,patients,I,NNS
551,without,I,IN
551,comorbidities,I,NNS
551,than,O,IN
551,in,O,IN
551,the,B,DT
551,reference,I,NN
551,cohort,I,NN
551,.,O,.
552,Even,O,RB
552,more,O,RBR
552,complex,O,JJ
552,is,O,VBZ
552,the,O,DT
552,situation,O,NN
552,of,O,IN
552,patients,O,NNS
552,in,O,IN
552,ICU,O,NNP
552,",",O,","
552,where,O,WRB
552,viral,B,JJ
552,spreading,I,NN
552,is,O,VBZ
552,facilitated,B,VBN
552,by,O,IN
552,endotracheal,B,JJ
552,tubes,I,NNS
552,and,O,CC
552,manoeuvres,B,NNS
552,performed,I,VBN
552,on,I,IN
552,the,I,DT
552,respiratory,I,NN
552,tract,I,NN
552,.,O,.
553,Staffing,B,VBG
553,along,I,RB
553,epidemiologic,I,JJ
553,considerations,I,NNS
553,may,B,MD
553,reduce,B,VB
553,HCW,B,NNP
553,shortage,I,NN
553,by,O,IN
553,leveling,B,VBG
553,the,B,DT
553,nadir,I,NN
553,of,I,IN
553,affected,I,JJ
553,workforce,I,NN
553,.,O,.
554,It,O,PRP
554,was,O,VBD
554,found,B,VBN
554,that,O,IN
554,the,B,DT
554,PM2.5,I,NNP
554,concentrations,I,NNS
554,showed,O,VBD
554,a,O,DT
554,high,B,JJ
554,reduction,B,NN
554,of,O,IN
554,up,B,IN
554,to,I,TO
554,58.4,I,CD
554,%,I,NN
554,during,B,IN
554,the,I,DT
554,MCO,I,NNP
554,.,O,.
555,In,O,IN
555,addition,O,NN
555,",",O,","
555,ACEI,B,NNP
555,or,O,CC
555,ARB,B,NNP
555,therapy,I,NN
555,increased,B,VBD
555,CD3,B,NNP
555,and,O,CC
555,CD8,B,NNP
555,T,I,NNP
555,cell,I,NN
555,counts,I,NNS
555,in,B,IN
555,peripheral,I,JJ
555,blood,I,NN
555,and,O,CC
555,decreased,B,VBD
555,the,B,DT
555,peak,I,JJ
555,viral,I,JJ
555,load,I,NN
555,compared,O,VBN
555,to,O,TO
555,other,B,JJ
555,antihypertensive,I,JJ
555,drugs,I,NNS
555,.,O,.
556,Respiratory,B,NNP
556,illness,I,NN
556,is,O,VBZ
556,the,O,DT
556,dominant,B,JJ
556,clinical,B,JJ
556,manifestation,B,NN
556,of,I,IN
556,COVID-19,B,NNP
556,.,O,.
557,This,B,DT
557,viral,I,JJ
557,epidemic,I,NN
557,in,B,IN
557,China,I,NNP
557,has,O,VBZ
557,led,B,VBN
557,to,I,TO
557,the,B,DT
557,deaths,I,NNS
557,of,I,IN
557,over,I,IN
557,1800,I,CD
557,people,I,NNS
557,",",O,","
557,mostly,B,RB
557,elderly,B,JJ
557,or,O,CC
557,those,B,DT
557,with,I,IN
557,an,I,DT
557,underlying,I,VBG
557,chronic,I,JJ
557,disease,I,NN
557,or,O,CC
557,immunosuppressed,B,JJ
557,state,I,NN
557,.,O,.
558,While,O,IN
558,in,B,IN
558,most,I,JJS
558,cases,I,NNS
558,",",O,","
558,mild,B,NN
558,symptoms,I,NNS
558,are,O,VBP
558,observed,B,VBN
558,",",O,","
558,in,B,IN
558,some,I,DT
558,cases,I,NNS
558,the,B,DT
558,infection,I,NN
558,leads,B,VBZ
558,to,I,TO
558,serious,B,JJ
558,pulmonary,I,JJ
558,disease,I,NN
558,.,O,.
559,This,B,DT
559,virus,I,NN
559,causes,B,VBZ
559,the,B,DT
559,coronavirus,I,NN
559,disease,I,NN
559,2019,I,CD
559,(,O,(
559,COVID-19,B,NNP
559,),O,)
559,.,O,.
560,Most,B,JJS
560,patients,B,NNS
560,with,I,IN
560,confirmed,I,JJ
560,or,I,CC
560,suspected,I,VBN
560,COVID,I,NNP
560,19,I,CD
560,presented,B,VBN
560,with,I,IN
560,fever,B,NN
560,and,O,CC
560,dry,B,JJ
560,cough,I,NN
560,and,O,CC
560,demonstrated,B,VBD
560,bilateral,B,JJ
560,multiple,I,JJ
560,mottling,I,NN
560,and,O,CC
560,ground,B,NN
560,-,I,:
560,glass,I,NN
560,opacity,I,NN
560,on,B,IN
560,chest,I,NN
560,computed,I,VBN
560,tomography,I,NN
560,scans,I,NNS
560,.,O,.
561,The,B,DT
561,relatively,I,RB
561,small,I,JJ
561,proportion,I,NN
561,of,I,IN
561,current,I,JJ
561,smokers,I,NNS
561,in,I,IN
561,each,I,DT
561,of,I,IN
561,these,I,DT
561,two,I,CD
561,studies,I,NNS
561,compared,O,VBN
561,with,O,IN
561,the,B,DT
561,proportion,I,NN
561,of,I,IN
561,male,I,JJ
561,smokers,I,NNS
561,in,I,IN
561,China,I,NNP
561,(,O,(
561,50Â·5,O,CD
561,%,O,NN
561,),O,)
561,are,O,VBP
561,unlikely,B,JJ
561,to,O,TO
561,be,O,VB
561,associated,B,VBN
561,with,I,IN
561,incidence,B,NN
561,or,I,CC
561,severity,I,NN
561,of,I,IN
561,COVID-19,I,NNP
561,.,O,.
562,The,B,DT
562,elderly,I,JJ
562,and,O,CC
562,people,B,NNS
562,with,I,IN
562,underlying,I,JJ
562,diseases,I,NNS
562,are,O,VBP
562,susceptible,B,JJ
562,to,I,TO
562,infection,B,NN
562,and,O,CC
562,prone,B,NN
562,to,I,TO
562,serious,B,JJ
562,outcomes,I,NNS
562,",",O,","
562,which,O,WDT
562,may,B,MD
562,be,O,VB
562,associated,B,VBN
562,with,I,IN
562,acute,B,JJ
562,respiratory,I,NN
562,distress,I,NN
562,syndrome,I,NN
562,(,O,(
562,ARDS,B,NNP
562,),O,)
562,and,O,CC
562,cytokine,B,JJ
562,storm,I,NN
562,.,O,.
563,differences,B,NNS
563,in,I,IN
563,COVID-19,B,NNP
563,disease,I,NN
563,prevalence,I,NN
563,and,O,CC
563,severity,B,NN
563,are,O,VBP
563,associated,B,VBN
563,with,I,IN
563,sex,B,NN
563,",",O,","
563,and,O,CC
563,smoking,B,NN
563,is,O,VBZ
563,related,B,VBN
563,to,I,TO
563,higher,B,JJR
563,expression,B,NN
563,of,I,IN
563,ACE2,I,NNP
563,.,O,.
564,A,B,DT
564,new,I,JJ
564,study,I,NN
564,published,O,VBN
564,by,O,IN
564,the,O,DT
564,journal,O,NN
564,Aging,O,NNP
564,&,O,CC
564,Disease,O,NNP
564,reported,B,VBD
564,that,O,IN
564,intravenous,B,JJ
564,administration,I,NN
564,of,I,IN
564,clinical,I,JJ
564,-,I,:
564,grade,I,NN
564,human,I,JJ
564,mesenchymal,I,JJ
564,stem,I,NN
564,cells,I,NNS
564,(,O,(
564,MSCs,B,NNP
564,),O,)
564,into,B,IN
564,patients,I,NNS
564,with,I,IN
564,coronavirus,B,JJ
564,disease,I,NN
564,2019,I,CD
564,(,I,(
564,COVID-19,B,NNP
564,),O,)
564,resulted,B,VBD
564,in,I,IN
564,improved,B,JJ
564,functional,B,JJ
564,outcomes,I,NNS
564,(,O,(
564,Leng,B,NNP
564,et,I,RB
564,al,I,RB
564,.,I,.
564,",",I,","
564,Aging,I,VBG
564,Dis,I,NNP
564,",",I,","
564,11:216,I,CD
564,-,I,:
564,228,I,CD
564,",",I,","
564,2020,I,CD
564,),O,)
564,.,O,.
